Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,RNA Polymerase III Transcription Termination R-HSA-73980,0.9642945159515053,1.7249741001558012,0.0,0.25091742793665667,0.086,3/21,1.54%,Nfib;Nfia;Nfix
prerank,RNA Polymerase III Abortive And Retractive Initiation R-HSA-749476,0.9178352696100992,1.712925778354927,0.0,0.18370740259648075,0.123,3/38,1.54%,Nfib;Nfia;Nfix
prerank,RHO GTPases Activate WASPs And WAVEs R-HSA-5663213,0.8737851454116792,1.6625635394754454,0.0038910505836575876,0.537680202721407,0.408,14/34,4.63%,Wasf1;Wipf3;Nckap1;Baiap2;Abi2;Mapk1;Actr3;Ptk2;Arpc2;Cyfip1;Abi1;Cyfip2;Mapk3;Arpc1a
prerank,Protein-protein Interactions At Synapses R-HSA-6794362,0.7525468622208802,1.6493310828065837,0.0,0.55022607411824,0.506,18/86,1.59%,Lrrtm4;Ppfia2;Grin2a;Gria1;Dlgap1;Il1rapl1;Grm1;Il1rap;Dlgap2;Ntrk3;Grin2b;Gria3;Syt7;Nlgn1;Ptprd;Grm5;Sipa1l1;Epb41l1
prerank,COPII-mediated Vesicle Transport R-HSA-204005,0.7920684135390127,1.643035103089017,0.00392156862745098,0.5014764024048324,0.554,5/63,2.31%,Gria1;Nsf;Tgfa;Sec24d;Cnih3
prerank,Cargo Concentration In ER R-HSA-5694530,0.8726410340051769,1.6428236932783253,0.011194029850746268,0.41939055812269754,0.556,4/29,2.31%,Gria1;Tgfa;Sec24d;Cnih3
prerank,Receptor-type Tyrosine-Protein Phosphatases R-HSA-388844,0.9129842707089535,1.641198913527531,0.007722007722007722,0.3745838745625803,0.565,5/20,0.97%,Ppfia2;Il1rapl1;Il1rap;Ntrk3;Ptprd
prerank,EPHB-mediated Forward Signaling R-HSA-3928662,0.8999852529748763,1.625753158637924,0.0,0.45523590497079136,0.669,13/32,5.54%,Kalrn;Tiam1;Grin2b;Itsn1;Actr3;Ptk2;Arpc2;Arhgef28;Syngap1;Arpc1a;Fyn;Rock1;Gprin1
prerank,Signaling By NOTCH4 R-HSA-9013694,0.774498984456397,1.6219270122965999,0.007874015748031496,0.43572010502016256,0.687,5/80,2.89%,Maml2;Maml3;Notch2;Smad3;Ywhaz
prerank,Regulation Of Beta-Cell Development R-HSA-186712,0.8343900684771757,1.6142584057330507,0.011363636363636364,0.45487745150231046,0.734,6/36,3.32%,Maml2;Maml3;Foxo1;Akt3;Onecut1;Neurod1
prerank,HSP90 Chaperone Cycle For Steroid Hormone Receptors (SHR) In Presence Of Ligand R-HSA-3371497,0.8539202923953942,1.6085485270992876,0.004016064257028112,0.4607756403927695,0.768,7/37,5.60%,Nr3c2;Fkbp5;Dync1i2;Capza2;Dctn1;Hspa2;Capzb
prerank,Signaling By NOTCH2 R-HSA-1980145,0.8857842300532778,1.6070158136264243,0.0071174377224199285,0.43567031981620685,0.785,6/28,4.38%,Maml2;Maml3;Notch2;Cntn1;Mib1;Psen1
prerank,Oxidative Stress Induced Senescence R-HSA-2559580,0.7379552853123681,1.5945584656839684,0.009174311926605505,0.4996289883749691,0.846,25/78,8.25%,Tnrc6c;Tnik;Mapk1;Map2k6;Jun;Ago1;Tnrc6b;Phc2;Mapk14;Mink1;Cbx6;Mapk3;Map2k4;Map3k5;Mov10;Ezh2;Mapk10;Cdk6;Cbx4;H2az1;H2ax;Rbbp7;Suz12;Phc3;Uba52
prerank,Budding And Maturation Of HIV Virion R-HSA-162588,0.8803406776481354,1.5764597011903108,0.015267175572519083,0.620380538663795,0.916,3/27,2.86%,Nedd4l;Sgip1;Vps37b
prerank,Regulation Of TP53 Activity Thru Acetylation R-HSA-6804758,0.8181066229381138,1.5693863037130595,0.03773584905660377,0.6373302669591079,0.938,8/27,4.59%,Pdzd2;Chd4;Map2k6;Akt3;Chd3;Gatad2b;Hdac1;Mta2
prerank,Pre-NOTCH Transcription And Translation R-HSA-1912408,0.7905733674412793,1.5464735706560164,0.01984126984126984,0.8098808053491194,0.981,7/49,3.01%,Maml2;Maml3;Tnrc6c;Notch2;Jun;Ago1;Tnrc6b
prerank,Neuronal System R-HSA-112316,0.593355538971916,1.5459826093502969,0.0,0.7661415751326403,0.981,84/373,3.58%,Lrrtm4;Ppfia2;Grin2a;Kcnd2;Gria1;Cacna1e;Dlgap1;Il1rapl1;Cacnb2;Grm1;Il1rap;Lrrc7;Nbea;Camk2a;Dlgap2;Ntrk3;Gabrb3;Camk2b;Gria2;Gabra2;Kcnj6;Kcnj3;Rims1;Nsf;Adcy1;Gabrb1;Cacna2d1;Grin2b;Gria3;Ppm1e;Rasgrf1;Gabra4;Kcnab1;Syt7;Nlgn1;Grik4;Adcy2;Rasgrf2;Kcnh1;Gabrb2;Plcb1;Ptprd;Kcnc3;Grm5;Sipa1l1;Gnal;Gabbr2;Nptn;Kcnd3;Prkag2;Mapk1;Gabrg2;Arhgef9;Ncald;Epb41l1;Kcnq3;Camkk1;Adcy9;Gng7;Camk2g;Syn2;Nrgn;Gng2;Kcng2;Slc17a7;Slc1a1;Kcnk10;Gabra5;Rps6ka2;Kcnc4;Abcc8;Kcng1;Cacng8;Shank2;Syn3;Kcnk1;Tspan7;Lrfn2;Kcng3;Kcnmb4;Actn2;Lin7c;Slitrk3;Syt10
prerank,NOTCH4 Intracellular Domain Regulates Transcription R-HSA-9013695,0.8694752090729868,1.5274561935577684,0.05166051660516605,0.8972289456893704,0.991,4/19,2.52%,Maml2;Maml3;Notch2;Smad3
prerank,Diseases Of Programmed Cell Death R-HSA-9645723,0.7289405513887919,1.5273451590297535,0.02040816326530612,0.8510439980618483,0.991,4/57,4.09%,Erc2;Jun;Cdk5r1;Ywhae
prerank,Cardiac Conduction R-HSA-5576891,0.6837191385568036,1.526548877068995,0.012048192771084338,0.8149439605914128,0.991,22/120,3.17%,Kcnip4;Ryr2;Kcnd2;Cacna1c;Fgf14;Cacnb2;Camk2a;Camk2b;Scn3a;Atp2b1;Kcnd3;Slc8a2;Orai2;Kcnip2;Scn8a;Scn3b;Atp2b3;Camk2g;Kcnk10;Scn2a;Cacng8;Kcnk1
prerank,MAP3K8 (TPL2)-dependent MAPK1/3 Activation R-HSA-5684264,0.8620738959251064,1.5146782759859647,0.0642570281124498,0.8759066540523494,0.997,9/16,8.68%,Map2k1;Tnip2;Fbxw11;Btrc;Map2k4;Cul1;Uba52;Skp1;Nfkb1
prerank,EPH-Ephrin Signaling R-HSA-2682334,0.7027773296365635,1.4975162243609805,0.01639344262295082,0.9855026382304337,0.998,22/88,4.94%,Kalrn;Epha7;Tiam1;Epha4;Grin2b;Vav3;Epha6;Itsn1;Actr3;Ptk2;Arpc2;Sdcbp;Arhgef28;Nck2;Syngap1;Dnm1;Efnb3;Psen1;Arpc1a;Arhgef7;Fyn;Rock1
prerank,RUNX2 Regulates Osteoblast Differentiation R-HSA-8940973,-0.8785178138071521,-1.49672364404038,0.012987012987012988,1.0,0.936,4/22,0.70%,Satb2;Maf;Wwtr1;Gli3
prerank,Transmission Across Chemical Synapses R-HSA-112315,0.617758559310382,1.4931180210885222,0.012738853503184714,0.9827859009742589,0.998,49/236,2.48%,Ppfia2;Grin2a;Gria1;Cacna1e;Cacnb2;Lrrc7;Nbea;Camk2a;Gabrb3;Camk2b;Gria2;Gabra2;Kcnj6;Kcnj3;Rims1;Nsf;Adcy1;Gabrb1;Cacna2d1;Grin2b;Gria3;Ppm1e;Rasgrf1;Gabra4;Grik4;Adcy2;Rasgrf2;Gabrb2;Plcb1;Gnal;Gabbr2;Nptn;Prkag2;Mapk1;Gabrg2;Arhgef9;Ncald;Epb41l1;Camkk1;Adcy9;Gng7;Camk2g;Syn2;Nrgn;Gng2;Slc17a7;Slc1a1;Gabra5;Rps6ka2
prerank,Late Phase Of HIV Life Cycle R-HSA-162599,0.6673360525671125,1.4918024717960356,0.013824884792626729,0.9524407368762258,0.998,29/125,12.87%,Nedd4l;Sgip1;Gtf2h2;Nmt1;Vps37b;Gtf2h5;Gtf2f2;Ccnh;Ndc1;Ranbp2;Ncbp1;Ccnt2;Ssrp1;Uba52;Cdk9;Gtf2a1;Xpo1;Mvb12b;Mnat1;Tcea1;Polr2k;Pom121;Ercc2;Nup93;Gtf2f1;Ccnt1;Chmp5;Taf15;Polr2e
prerank,Defective Intrinsic Pathway For Apoptosis R-HSA-9734009,0.819873713368897,1.4916667732300941,0.06048387096774194,0.9152033957255311,0.998,4/22,4.09%,Erc2;Jun;Cdk5r1;Ywhae
prerank,Deregulated CDK5 Triggers Neurodegenerative Pathways In Alzheimers Disease Models R-HSA-8862803,0.8248010189047295,1.4704738871927403,0.06692913385826772,1.0,1.0,4/20,4.09%,Erc2;Jun;Cdk5r1;Ywhae
prerank,Regulation Of Gene Expression In Late Stage (Branching Morphogenesis) Pancreatic Bud Precursor Cells R-HSA-210744,0.8761606034832913,1.468290558920654,0.05223880597014925,1.0,1.0,3/15,2.74%,Maml2;Maml3;Onecut1
prerank,Synaptic Adhesion-Like Molecules R-HSA-8849932,0.8217733941072641,1.464845587987613,0.07394366197183098,1.0,1.0,5/21,0.97%,Grin2a;Gria1;Grin2b;Gria3;Ptprd
prerank,Pre-NOTCH Expression And Processing R-HSA-1912422,0.7059105550011918,1.458942218111116,0.04878048780487805,1.0,1.0,8/65,3.01%,Maml2;Maml3;Tnrc6c;Notch2;B4galt1;Jun;Ago1;Tnrc6b
prerank,Transcriptional Regulation By RUNX2 R-HSA-8878166,-0.7537527668556103,-1.4560287898816906,0.003911342894393742,1.0,0.999,13/114,5.52%,Satb2;Maf;Wwtr1;Gli3;Gli2;Itgbl1;Esr1;Bmp2;Dlx5;Twist2;Hdac4;Smurf1;Smad6
prerank,Muscle Contraction R-HSA-397014,0.6159720114596527,1.4514616332000043,0.005128205128205128,1.0,1.0,29/186,3.49%,Kcnip4;Ryr2;Kcnd2;Cacna1c;Fgf14;Cacnb2;Camk2a;Camk2b;Sorbs1;Scn3a;Atp2b1;Kcnd3;Slc8a2;Cacna1h;Orai2;Kcnip2;Scn8a;Scn3b;Cald1;Atp2b3;Camk2g;Kcnk10;Scn2a;Tmod1;Cacng8;Anxa6;Kcnk1;Actn2;Ryr1
prerank,RUNX1 Regulates Transcription Of Genes Involved In Differentiation Of HSCs R-HSA-8939236,-0.7643250774001369,-1.4483105212198684,0.018252933507170794,1.0,1.0,2/85,1.58%,Ldb2;Tcf7l1
prerank,Heparan Sulfate/Heparin (HS-GAG) Metabolism R-HSA-1638091,-0.809547205940676,-1.4482006202741353,0.009358288770053475,1.0,1.0,17/53,7.38%,Gpc6;Hs3st5;Xylt1;Gpc5;Hs6st2;Hs3st2;Ext1;Ndst3;Bcan;Hs6st3;Hs3st4;Vcan;Hspg2;Cspg5;Gusb;Gpc2;Dcn
prerank,mRNA Capping R-HSA-72086,0.7676669907865321,1.4481374793001391,0.0830188679245283,1.0,1.0,10/28,12.87%,Gtf2h2;Gtf2h5;Gtf2f2;Ccnh;Ncbp1;Mnat1;Polr2k;Ercc2;Gtf2f1;Polr2e
prerank,Expression And Translocation Of Olfactory Receptors R-HSA-9752946,-0.7582708754939224,-1.4467149754302977,0.013192612137203167,1.0,1.0,5/95,5.00%,Ldb2;Or51d1;Or52i2;Or52k2;Or51e1
prerank,Formation Of HIV-1 Elongation Complex Containing HIV-1 Tat R-HSA-167200,0.7402712457133188,1.4450489290676176,0.0728744939271255,1.0,1.0,15/39,13.61%,Gtf2h2;Gtf2h5;Gtf2f2;Ccnh;Ncbp1;Ssrp1;Cdk9;Mnat1;Tcea1;Polr2k;Ercc2;Gtf2f1;Ccnt1;Polr2e;Ctdp1
prerank,PTEN Regulation R-HSA-6807070,0.6407224659965518,1.4450093265904553,0.014285714285714285,1.0,1.0,32/136,8.59%,Tnrc6c;Mapk1;Chd4;Akt3;Jun;Chd3;Cnot6l;Gatad2b;Hdac1;Rragd;Ago1;Tnrc6b;Nedd4;Hdac7;Phc2;Cbx6;Prex2;Rptor;Mapk3;Mta2;Ago2;Mta3;Tnks;Mov10;Ezh2;Psmd13;Cbx4;Rbbp7;Suz12;Phc3;Uba52;Usp7
prerank,Formation Of HIV Elongation Complex In Absence Of HIV Tat R-HSA-167152,0.7386643601189752,1.4421429172264044,0.06666666666666667,1.0,1.0,18/41,15.60%,Gtf2h2;Gtf2h5;Gtf2f2;Ccnh;Ncbp1;Ccnt2;Ssrp1;Cdk9;Mnat1;Tcea1;Polr2k;Ercc2;Gtf2f1;Ccnt1;Polr2e;Ctdp1;Ccnk;Eloc
prerank,RUNX2 Regulates Bone Development R-HSA-8941326,-0.8372689896599007,-1.439313589201362,0.028985507246376812,1.0,1.0,7/28,5.52%,Satb2;Maf;Wwtr1;Gli3;Gli2;Hdac4;Smad6
prerank,Formation Of Early Elongation Complex R-HSA-113418,0.7484954419942065,1.4369388645204777,0.10546875,1.0,1.0,11/31,13.61%,Gtf2h2;Gtf2h5;Gtf2f2;Ccnh;Ncbp1;Mnat1;Polr2k;Ercc2;Gtf2f1;Polr2e;Ctdp1
prerank,Amine Ligand-Binding Receptors R-HSA-375280,-0.8201781844259868,-1.4332433975683623,0.02880658436213992,1.0,1.0,10/34,3.48%,Htr1f;Htr2c;Chrm3;Htr2a;Adra1b;Chrm2;Adra1a;Htr7;Drd2;Adrb3
prerank,HS-GAG Biosynthesis R-HSA-2022928,-0.837240362962474,-1.4259366855273297,0.04588394062078273,1.0,1.0,9/30,1.99%,Gpc6;Hs3st5;Gpc5;Hs6st2;Hs3st2;Ext1;Ndst3;Hs6st3;Hs3st4
prerank,Neurexins And Neuroligins R-HSA-6794361,0.693888816742909,1.4254477327178279,0.06976744186046512,1.0,1.0,11/55,1.59%,Lrrtm4;Grin2a;Dlgap1;Grm1;Dlgap2;Grin2b;Syt7;Nlgn1;Grm5;Sipa1l1;Epb41l1
prerank,Inflammasomes R-HSA-622312,-0.8792740306271876,-1.42388625344986,0.03283173734610123,1.0,1.0,4/19,4.54%,P2rx7;Bcl2;Casp1;App
prerank,N-glycan Antennae Elongation In medial/trans-Golgi R-HSA-975576,-0.8350470478290606,-1.422083309818382,0.046052631578947366,1.0,1.0,7/24,5.80%,Mgat4c;Chst8;St6gal1;Man2a1;Mgat5;St8sia2;Fuca1
prerank,Glutamate Neurotransmitter Release Cycle R-HSA-210500,0.7948223888219242,1.4175619051238035,0.09285714285714286,1.0,1.0,4/23,2.31%,Ppfia2;Rims1;Slc17a7;Slc1a1
prerank,Dopamine Neurotransmitter Release Cycle R-HSA-212676,0.8035576153600605,1.416767618818867,0.07903780068728522,1.0,1.0,6/23,3.92%,Ppfia2;Rims1;Syn2;Syn3;Lin7c;Tspoap1
prerank,RNA Pol II CTD Phosphorylation And Interaction With CE R-HSA-77075,0.7675181234589988,1.414901504719545,0.10317460317460317,1.0,1.0,9/26,12.87%,Gtf2h2;Gtf2h5;Gtf2f2;Ccnh;Mnat1;Polr2k;Ercc2;Gtf2f1;Polr2e
prerank,Binding And Uptake Of Ligands By Scavenger Receptors R-HSA-2173782,-0.8175924336863251,-1.411234302870947,0.03260869565217391,1.0,1.0,10/33,10.44%,Dlc1;Colec12;Apoe;Col1a2;Col4a2;Masp1;Col3a1;Scara5;Sparc;Col4a1
prerank,RNA Polymerase I Transcription Initiation R-HSA-73762,0.7261520788542928,1.4099110997679267,0.06172839506172839,1.0,1.0,10/45,4.89%,Chd4;Gtf2h2;Chd3;Gatad2b;Hdac1;Ubtf;Gtf2h5;Mta2;Ccnh;Mta3
prerank,Interactions Of Vpr With Host Cellular Proteins R-HSA-176033,0.7437267982682467,1.4085663616100836,0.1111111111111111,1.0,1.0,5/33,6.90%,Sgip1;Ndc1;Slc25a5;Psip1;Ranbp2
prerank,PKA Activation R-HSA-163615,0.8147714093038205,1.4072306003136164,0.12653061224489795,1.0,1.0,4/16,1.83%,Nbea;Adcy1;Adcy2;Adcy9
prerank,PKA-mediated Phosphorylation Of CREB R-HSA-111931,0.8092028179376738,1.4058419454564557,0.11693548387096774,1.0,1.0,4/18,1.83%,Nbea;Adcy1;Adcy2;Adcy9
prerank,Assembly And Cell Surface Presentation Of NMDA Receptors R-HSA-9609736,0.7538973985562059,1.403413115813022,0.12213740458015267,1.0,1.0,7/25,1.92%,Grin2a;Lrrc7;Nbea;Camk2a;Camk2b;Grin2b;Camk2g
prerank,Spry Regulation Of FGF Signaling R-HSA-1295596,0.8118085348639772,1.4024749794805507,0.1411764705882353,1.0,1.0,6/16,8.25%,Mapk1;Cbl;Mapk3;Src;Grb2;Uba52
prerank,Serotonin Neurotransmitter Release Cycle R-HSA-181429,0.8282165930100527,1.402176909784418,0.08275862068965517,0.9839158086466445,1.0,5/18,3.92%,Ppfia2;Rims1;Syn2;Syn3;Tspoap1
prerank,Regulation Of RUNX1 Expression And Activity R-HSA-8934593,0.805404702828668,1.39841555759821,0.11740890688259109,0.9855945049317368,1.0,9/17,6.48%,Tnrc6c;Ago1;Tnrc6b;Ccnd2;Cbfb;Ago2;Mov10;Src;Cdk6
prerank,Scavenging By Class A Receptors R-HSA-3000480,-0.8466460040431946,-1.3978048496478852,0.05390835579514825,1.0,1.0,8/17,10.44%,Colec12;Apoe;Col1a2;Col4a2;Masp1;Col3a1;Scara5;Col4a1
prerank,Neurotransmitter Receptors And Postsynaptic Signal Transmission R-HSA-112314,0.5949279223203001,1.3971374518097655,0.02127659574468085,0.9741346394999161,1.0,41/173,2.48%,Grin2a;Gria1;Lrrc7;Nbea;Camk2a;Gabrb3;Camk2b;Gria2;Gabra2;Kcnj6;Kcnj3;Nsf;Adcy1;Gabrb1;Grin2b;Gria3;Ppm1e;Rasgrf1;Gabra4;Grik4;Adcy2;Rasgrf2;Gabrb2;Plcb1;Gnal;Gabbr2;Nptn;Prkag2;Mapk1;Gabrg2;Arhgef9;Ncald;Epb41l1;Camkk1;Adcy9;Gng7;Camk2g;Nrgn;Gng2;Gabra5;Rps6ka2
prerank,Vpr-mediated Nuclear Import Of PICs R-HSA-180910,0.7476080838004687,1.395167950229969,0.13090909090909092,0.967495172937683,1.0,4/31,6.90%,Sgip1;Ndc1;Psip1;Ranbp2
prerank,Activation Of NMDA Receptors And Postsynaptic Events R-HSA-442755,0.6650241828017894,1.3936073664949433,0.08298755186721991,0.9583253479837879,1.0,19/72,2.48%,Grin2a;Gria1;Lrrc7;Nbea;Camk2a;Camk2b;Gria2;Adcy1;Grin2b;Gria3;Ppm1e;Rasgrf1;Rasgrf2;Prkag2;Mapk1;Camkk1;Camk2g;Nrgn;Rps6ka2
prerank,Norepinephrine Neurotransmitter Release Cycle R-HSA-181430,0.8201233809811268,1.3932352036375468,0.11702127659574468,0.9418540596821197,1.0,2/18,0.38%,Ppfia2;Rims1
prerank,Activation Of GABAB Receptors R-HSA-991365,0.740312424428405,1.3919081400468654,0.08050847457627118,0.9312552177775448,1.0,9/40,2.14%,Kcnj6;Kcnj3;Adcy1;Adcy2;Gnal;Gabbr2;Adcy9;Gng7;Gng2
prerank,Nonsense Mediated Decay (NMD) Enhanced By Exon Junction Complex (EJC) R-HSA-975957,0.6424154633037394,1.3914920257231023,0.057777777777777775,0.9157471628739438,1.0,37/107,13.26%,Rpl10a;Smg1;Rplp1;Rpl15;Pabpc1;Gspt1;Rpsa;Rplp0;Smg7;Rpl3;Mrpl13;Rps28;Rpl36a;Rpl4;Rps8;Upf2;Rpl8;Ncbp1;Rps21;Uba52;Rpl18a;Rps3;Rpl30;Smg6;Rpl38;Rsl24d1;Rpl41;Rps23;Rpl27a;Rpl9;Rps10;Rps13;Rps2;Pnrc2;Gspt2;Upf3b;Rps15
prerank,"Unblocking Of NMDA Receptors, Glutamate Binding And Activation R-HSA-438066",0.7781746306647989,1.388825280119753,0.13307984790874525,0.9127287391875738,1.0,8/21,0.56%,Grin2a;Gria1;Lrrc7;Camk2a;Camk2b;Gria2;Grin2b;Gria3
prerank,Signaling By ALK R-HSA-201556,-0.8024318785971933,-1.3885237535164656,0.07628294036061026,1.0,1.0,3/26,1.85%,Alk;Ptn;Pik3r1
prerank,Signaling By Cytosolic FGFR1 Fusion Mutants R-HSA-1839117,-0.8438143172697808,-1.3876619756396151,0.07651715039577836,1.0,1.0,4/17,2.21%,Stat5b;Gab2;Pik3r1;Cux1
prerank,ATF4 Activates Genes In Response To Endoplasmic Reticulum Stress R-HSA-380994,0.7679420098002319,1.3870903697683992,0.12,0.9071153820094431,1.0,4/25,5.78%,Atf6;Khsrp;Cebpb;Exosc8
prerank,Class A/1 (Rhodopsin-like Receptors) R-HSA-373076,-0.6580636128508577,-1.384195726467874,0.010739856801909307,1.0,1.0,59/263,11.38%,Htr1f;Htr2c;Chrm3;Htr2a;Adra1b;Rxfp1;Chrm2;Adra1a;Qrfpr;Htr7;Lpar1;Nmbr;Tacr3;Opn3;Ptger3;Cckbr;S1pr1;Gpr37l1;Drd2;Ccl28;Oprk1;Npsr1;Gpr17;Adrb3;Tshr;Lhcgr;App;Gnrh1;Plppr3;Ednrb;Oprd1;Mc5r;Ntsr2;Grpr;Rxfp2;Hrh2;Agtr2;Tacr1;Hcrt;Htr1d;Adora2b;Hrh3;Ttf2;P2ry1;Ucma;Nmur1;Cmklr1;Npb;Cd200r1;Anxa1;Npbwr1;Ccr5;Tac1;Bdkrb2;Prok2;S1pr2;Rxfp3;Chrm5;Lpar3
prerank,Signaling By KIT In Disease R-HSA-9669938,-0.8437234893698669,-1.3839069148053695,0.07366984993178717,1.0,1.0,3/19,1.85%,Kit;Stat5b;Pik3r1
prerank,Downstream Signaling Of Activated FGFR1 R-HSA-5654687,-0.8205107387327047,-1.3830987550275373,0.05555555555555555,1.0,1.0,4/28,2.21%,Flrt2;Pik3r1;Flrt1;Fgf1
prerank,RHOJ GTPase Cycle R-HSA-9013409,-0.7619270517358063,-1.3792008092853947,0.04838709677419355,1.0,1.0,8/53,4.59%,Fnbp1l;Cpne8;Rhoj;Pik3r1;Arhgap26;Gja1;Cav1;Syde1
prerank,GAG Synthesis Requires Tetrasaccharide Linker Sequence R-HSA-1971475,-0.8078861922895031,-1.377954659582577,0.057951482479784364,1.0,1.0,9/26,7.38%,Gpc6;Xylt1;Gpc5;Bcan;Vcan;Hspg2;Cspg5;Gpc2;Dcn
prerank,CLEC7A (Dectin-1) Signaling R-HSA-5607764,0.6286132302323387,1.3759332704588665,0.07234042553191489,0.9516619540429191,1.0,10/98,6.45%,Ppp3ca;Ppp3r1;Plcg2;Fbxw11;Calm1;Btrc;Itpr1;Src;Psmd13;Ube2d1
prerank,L13a-mediated Translational Silencing Of Ceruloplasmin Expression R-HSA-156827,0.6317709297300187,1.3744902592501582,0.05426356589147287,0.9423867459510697,1.0,41/101,16.38%,Eif4a2;Rpl10a;Rplp1;Rpl15;Pabpc1;Eif4b;Rpsa;Rplp0;Rpl3;Mrpl13;Rps28;Rpl36a;Rpl4;Rps8;Rpl8;Rps21;Uba52;Rpl18a;Rps3;Rpl30;Rpl38;Eif4e;Rsl24d1;Rpl41;Rps23;Rpl27a;Rpl9;Rps10;Rps13;Eif4a1;Rps2;Eif3b;Rps15;Eif3a;Eif3f;Eif3g;Rpl26;Eif3l;Eif3m;Rpl18;Rps19
prerank,FOXO-mediated Transcription R-HSA-9614085,0.6739967496736106,1.374034310224689,0.08139534883720931,0.9288270996206928,1.0,9/61,3.36%,Plxna4;Foxo1;Akt3;Bcl6;Smad3;Hdac1;Ywhaz;Btg1;Ywhab
prerank,Acetylcholine Neurotransmitter Release Cycle R-HSA-264642,0.8125163115223202,1.3735901228700855,0.13286713286713286,0.915210686304551,1.0,2/17,0.38%,Ppfia2;Rims1
prerank,GTP Hydrolysis And Joining Of 60S Ribosomal Subunit R-HSA-72706,0.6305604113121036,1.3731355545780255,0.06589147286821706,0.9026455758797489,1.0,42/102,16.38%,Eif4a2;Rpl10a;Rplp1;Rpl15;Eif4b;Rpsa;Rplp0;Rpl3;Mrpl13;Rps28;Rpl36a;Rpl4;Rps8;Rpl8;Eif5;Rps21;Uba52;Rpl18a;Eif5b;Rps3;Rpl30;Rpl38;Eif4e;Rsl24d1;Rpl41;Rps23;Rpl27a;Rpl9;Rps10;Rps13;Eif4a1;Rps2;Eif3b;Rps15;Eif3a;Eif3f;Eif3g;Rpl26;Eif3l;Eif3m;Rpl18;Rps19
prerank,NLRP3 Inflammasome R-HSA-844456,-0.8623194039571335,-1.3713116088374175,0.07132867132867132,1.0,1.0,3/15,4.54%,P2rx7;Casp1;App
prerank,WNT5A-dependent Internalization Of FZD4 R-HSA-5099900,-0.8421488106710446,-1.3707079360373904,0.07432432432432433,1.0,1.0,6/15,11.84%,Prkcb;Fzd4;Ap2b1;Prkcg;Wnt5a;Prkca
prerank,NCAM Signaling For Neurite Out-Growth R-HSA-375165,0.6991368394318677,1.3703783516104555,0.10984848484848485,0.9013635660703458,1.0,14/57,2.93%,Cacna1c;Cacnb2;Gfra1;Sptb;Cacna1d;Cacna1h;Mapk1;Ptpra;Ncam1;Ptk2;Sptbn1;Gfra2;Sptbn4;St8sia4
prerank,Vitamin B5 (Pantothenate) Metabolism R-HSA-199220,-0.8430582125920543,-1.3701047359015854,0.08119079837618404,1.0,1.0,3/16,7.66%,Enpp2;Enpp3;Ppcs
prerank,Post NMDA Receptor Activation Events R-HSA-438064,0.6702107081598615,1.3675883433581708,0.099601593625498,0.9022331616740774,1.0,16/59,2.48%,Grin2a;Gria1;Lrrc7;Camk2a;Camk2b;Gria2;Adcy1;Grin2b;Rasgrf1;Rasgrf2;Prkag2;Mapk1;Camkk1;Camk2g;Nrgn;Rps6ka2
prerank,CREB1 Phosphorylation Thru NMDA Receptor-Mediated Activation Of RAS Signaling R-HSA-442742,0.7386823181372031,1.3675832775135455,0.11481481481481481,0.8879688977536128,1.0,15/26,5.66%,Lrrc7;Camk2a;Camk2b;Grin2b;Rasgrf1;Rasgrf2;Mapk1;Camk2g;Rps6ka2;Actn2;Calm1;Mapk3;Gprin1;Nefl;Mpp3
prerank,Deadenylation-dependent mRNA Decay R-HSA-429914,0.6811220859491603,1.3646000443413366,0.09486166007905138,0.8887125642377008,1.0,22/54,14.33%,Cnot2;Cnot6l;Pan3;Eif4a2;Dcp1b;Pabpc1;Eif4b;Exosc8;Cnot1;Edc3;Cnot4;Lsm7;Eif4e;Ddx6;Patl1;Eif4a1;Edc4;Lsm4;Nt5c3b;Paip1;Tnks1bp1;Dcp2
prerank,Sensory Processing Of Sound By Outer Hair Cells Of Cochlea R-HSA-9662361,-0.7460814240808606,-1.3633457031512857,0.05614973262032086,1.0,1.0,10/53,8.67%,Pcdh15;Whrn;Epb41l3;Kcnn2;Myo1e;Xirp2;Ezr;Gsn;Slc26a5;Tmie
prerank,PERK Regulates Gene Expression R-HSA-381042,0.7399115502755651,1.3594900478127914,0.13402061855670103,0.8998836459495304,1.0,4/29,5.78%,Atf6;Khsrp;Cebpb;Exosc8
prerank,Cap-dependent Translation Initiation R-HSA-72737,0.6189590811931818,1.3557242815502113,0.06938775510204082,0.903357051703552,1.0,43/109,16.38%,Eif4a2;Rpl10a;Rplp1;Rpl15;Pabpc1;Eif4b;Rpsa;Rplp0;Rpl3;Mrpl13;Rps28;Rpl36a;Rpl4;Rps8;Rpl8;Eif5;Rps21;Uba52;Rpl18a;Eif5b;Rps3;Rpl30;Rpl38;Eif4e;Rsl24d1;Rpl41;Rps23;Rpl27a;Rpl9;Rps10;Rps13;Eif4a1;Rps2;Eif3b;Rps15;Eif3a;Eif3f;Eif3g;Rpl26;Eif3l;Eif3m;Rpl18;Rps19
prerank,Signaling By FLT3 ITD And TKD Mutants R-HSA-9703648,-0.8534973777734955,-1.355660970892325,0.08707482993197278,1.0,1.0,4/15,3.16%,Stat5b;Gab2;Pik3r1;Nox4
prerank,HIV Life Cycle R-HSA-162587,0.5969339918638166,1.3551385508266414,0.056338028169014086,0.8926293872940614,1.0,31/138,12.87%,Nedd4l;Sgip1;Gtf2h2;Nmt1;Vps37b;Gtf2h5;Gtf2f2;Ccnh;Ndc1;Psip1;Ranbp2;Ncbp1;Ccnt2;Ssrp1;Uba52;Cdk9;Gtf2a1;Xpo1;Mvb12b;Mnat1;Tcea1;Polr2k;Pom121;Ercc2;Nup93;Gtf2f1;Ccnt1;Chmp5;Taf15;Kpna1;Polr2e
prerank,Diseases Associated With Glycosaminoglycan Metabolism R-HSA-3560782,-0.7762083546274382,-1.3546357644242548,0.06542056074766354,1.0,1.0,11/39,7.38%,Gpc6;Gpc5;Ext1;Bcan;Vcan;Prelp;Chst3;Hspg2;Cspg5;Gpc2;Dcn
prerank,FOXO-mediated Transcription Of Cell Death Genes R-HSA-9614657,0.8037860934621501,1.3543750441793558,0.16906474820143885,0.8833242310786881,1.0,3/15,5.72%,Foxo1;Bcl6;Crebbp
prerank,NOTCH1 Intracellular Domain Regulates Transcription R-HSA-2122947,0.698287962868777,1.349411015876321,0.10583941605839416,0.8950167509744698,1.0,7/47,3.61%,Maml2;Nbea;Maml3;Tle1;Ncor1;Hdac1;Hdac7
prerank,Assembly Of HIV Virion R-HSA-175474,0.7677047774913885,1.3453308573628247,0.17670682730923695,0.9027394565500654,1.0,2/17,2.86%,Sgip1;Vps37b
prerank,"FOXO-mediated Transcription Of Oxidative Stress, Metabolic And Neuronal Genes R-HSA-9615017",0.7487526988484822,1.3420305198901652,0.14772727272727273,0.9061299791966023,1.0,4/26,2.61%,Plxna4;Foxo1;Smad3;Hdac1
prerank,Olfactory Signaling Pathway R-HSA-381753,-0.6945448270537866,-1.339127258707505,0.058900523560209424,1.0,1.0,6/103,5.28%,Ldb2;Or51d1;Or52i2;Or52k2;Or51e1;Adcy8
prerank,Phase 0 - Rapid Depolarisation R-HSA-5576892,0.7047181311563455,1.3389730675014762,0.15467625899280577,0.9087791130070895,1.0,11/32,2.93%,Cacna1c;Fgf14;Cacnb2;Camk2a;Camk2b;Scn3a;Scn8a;Scn3b;Camk2g;Scn2a;Cacng8
prerank,Regulation Of Gene Expression In Beta Cells R-HSA-210745,0.7271957426311936,1.3386250652756815,0.15547703180212014,0.8980241449744707,1.0,3/17,3.32%,Foxo1;Akt3;Neurod1
prerank,N-Glycan Antennae Elongation R-HSA-975577,-0.8184529758376939,-1.3367212671369961,0.11852861035422343,1.0,1.0,4/15,5.60%,Mgat4c;St6gal1;Mgat5;St8sia2
prerank,"Adrenaline,noradrenaline Inhibits Insulin Secretion R-HSA-400042",0.7356072340078631,1.3352985272474,0.1803921568627451,0.9012924947689966,1.0,5/27,2.14%,Cacna1c;Cacnb2;Cacna1d;Gng7;Gng2
prerank,Membrane Binding And Targetting Of GAG Proteins R-HSA-174490,0.7760800072260061,1.3346456226108652,0.21862348178137653,0.8924057551301434,1.0,2/15,2.86%,Sgip1;Vps37b
prerank,GABA Receptor Activation R-HSA-977443,0.6625348109452466,1.3345106522787742,0.12096774193548387,0.8814182130226016,1.0,18/57,2.38%,Gabrb3;Gabra2;Kcnj6;Kcnj3;Adcy1;Gabrb1;Gabra4;Adcy2;Gabrb2;Gnal;Gabbr2;Nptn;Gabrg2;Arhgef9;Adcy9;Gng7;Gng2;Gabra5
prerank,MECP2 Regulates Neuronal Receptors And Channels R-HSA-9022699,0.7733517302802585,1.3340884949003937,0.17692307692307693,0.8717634905854917,1.0,5/18,2.61%,Grin2a;Gria2;Grin2b;Fkbp5;Hdac1
prerank,"Defective B4GALT7 Causes EDS, Progeroid Type R-HSA-3560783",-0.797448402231248,-1.3314988584942031,0.1196236559139785,1.0,1.0,9/20,8.62%,Gpc6;Gpc5;Bcan;Vcan;Hspg2;Cspg5;Gpc2;Dcn;Sdc4
prerank,RHO GTPase Effectors R-HSA-195258,0.541017692413124,1.329038881083238,0.0446927374301676,0.8834729108733069,1.0,36/249,4.94%,Iqgap2;Diaph2;Wasf1;Wipf3;Nckap1;Baiap2;Pdzd2;Abi2;Mapk1;Actr3;Mrtfa;Ptk2;Cenpp;Ppp1cb;Arpc2;Cyfip1;Ppp1r12b;Fmnl2;Taok1;Abi1;Ywhaz;Ywhah;Ywhab;Dync1i2;Ctnnb1;Mapk14;Calm1;Cyfip2;Ywhae;Mapk3;Arpc1a;Fmnl1;Diaph1;Arhgef7;Rhob;Rock1
prerank,Metabolism Of Vitamins And Cofactors R-HSA-196854,-0.6598248326795455,-1.326688181803097,0.043859649122807015,1.0,1.0,31/171,13.84%,Gpc6;Gpc5;Enpp2;Akr1b10;Parp4;Parp8;Apoe;Prkg2;Enpp3;Aldh1l1;Hspg2;Aox1;Ttr;Cyb5a;Rbp4;Gpc2;Ppcs;Tacr1;Ldlrap1;Sdc4;Tcn2;Bco2;Ldlr;Bco1;Cblif;Cd38;Tpk1;Abcc1;Sp8;Pdss1;Acp5
prerank,Eukaryotic Translation Elongation R-HSA-156842,0.6282320706853275,1.3265347684186803,0.10080645161290322,0.8829298788823512,1.0,30/85,12.24%,Rpl10a;Rplp1;Eef1a1;Rpl15;Rpsa;Rplp0;Rpl3;Mrpl13;Rps28;Rpl36a;Rpl4;Rps8;Rpl8;Rps21;Uba52;Rpl18a;Eef1d;Rps3;Eef1a2;Rpl30;Rpl38;Rsl24d1;Rpl41;Rps23;Rpl27a;Rpl9;Rps10;Rps13;Eef1g;Rps2
prerank,Nephrin Family Interactions R-HSA-373753,0.7511906269395346,1.3261940318361676,0.17142857142857143,0.8734166826373657,1.0,11/21,5.25%,Kirrel3;Magi2;Sptbn1;Nck2;Actn2;Pik3cb;Cd2ap;Fyn;Actn1;Actn4;Sptan1
prerank,Signaling By FLT3 Fusion Proteins R-HSA-9703465,-0.8020220830497085,-1.3260709933833439,0.12806539509536785,1.0,1.0,5/18,3.16%,Stat5b;Gab2;Pik3r1;Etv6;Nox4
prerank,Signaling By Hippo R-HSA-2028269,-0.790382877596544,-1.3243957890980729,0.12672176308539945,1.0,1.0,2/20,1.01%,Wwtr1;Lats2
prerank,Defective B3GALT6 Causes EDSP2 And SEMDJL1 R-HSA-4420332,-0.7978631368330676,-1.3227441871954593,0.12348993288590604,1.0,1.0,9/20,8.62%,Gpc6;Gpc5;Bcan;Vcan;Hspg2;Cspg5;Gpc2;Dcn;Sdc4
prerank,NOTCH3 Intracellular Domain Regulates Transcription R-HSA-9013508,0.7359246928912795,1.322489074338599,0.1647940074906367,0.878233124535612,1.0,2/24,0.42%,Maml2;Maml3
prerank,Nonsense Mediated Decay (NMD) Independent Of Exon Junction Complex (EJC) R-HSA-975956,0.631711611819343,1.3218364872055564,0.11618257261410789,0.8704517916008145,1.0,31/87,13.26%,Rpl10a;Rplp1;Rpl15;Pabpc1;Gspt1;Rpsa;Rplp0;Rpl3;Mrpl13;Rps28;Rpl36a;Rpl4;Rps8;Rpl8;Ncbp1;Rps21;Uba52;Rpl18a;Rps3;Rpl30;Rpl38;Rsl24d1;Rpl41;Rps23;Rpl27a;Rpl9;Rps10;Rps13;Rps2;Gspt2;Rps15
prerank,Defective B3GAT3 Causes JDSSDHD R-HSA-3560801,-0.7971086860467347,-1.321312100695916,0.13611859838274934,1.0,1.0,9/20,8.62%,Gpc6;Gpc5;Bcan;Vcan;Hspg2;Cspg5;Gpc2;Dcn;Sdc4
prerank,Deadenylation Of mRNA R-HSA-429947,0.7271556970911575,1.31983610763824,0.21323529411764705,0.867910858955081,1.0,8/24,8.24%,Cnot2;Cnot6l;Pan3;Eif4a2;Pabpc1;Eif4b;Cnot1;Cnot4
prerank,Formation Of RNA Pol II Elongation Complex R-HSA-112382,0.6440290671999958,1.3198264480585538,0.12781954887218044,0.8575999233406443,1.0,18/53,13.61%,Gtf2h2;Gtf2h5;Aff4;Gtf2f2;Ccnh;Rtf1;Ncbp1;Ccnt2;Ssrp1;Cdk9;Mnat1;Tcea1;Polr2k;Ercc2;Gtf2f1;Ccnt1;Polr2e;Ctdp1
prerank,HS-GAG Degradation R-HSA-2024096,-0.7889695907877005,-1.3195476959526695,0.11413043478260869,1.0,1.0,6/21,8.62%,Gpc6;Gpc5;Hspg2;Gusb;Gpc2;Sdc4
prerank,Assembly Of Collagen Fibrils And Other Multimeric Structures R-HSA-2022090,-0.7385940096642113,-1.3189283328298371,0.07427785419532325,1.0,1.0,21/54,13.41%,Lama4;Col8a1;Col27a1;Col4a5;Col18a1;Col6a2;Col1a2;Col6a5;Col9a1;Col4a2;Col6a1;Col3a1;Mmp28;Pcolce;Col4a1;Itga6;Col24a1;Lamc2;Col11a1;Col8a2;Tll2
prerank,Stimuli-sensing Channels R-HSA-2672351,0.6137924844471846,1.3179626683309025,0.07377049180327869,0.8555440872714154,1.0,11/91,3.51%,Ryr2;Trpm3;Ano3;Trpc6;Nedd4l;Unc80;Unc79;Best3;Ano2;Ryr1;Trpm7
prerank,TBC/RABGAPs R-HSA-8854214,-0.7538511733662026,-1.315196625563052,0.08882907133243607,1.0,1.0,1/42,0.43%,Optn
prerank,Activation Of G Protein Gated Potassium Channels R-HSA-1296041,0.7116840547897639,1.314914746639231,0.1803921568627451,0.8580584103352129,1.0,5/27,2.14%,Kcnj6;Kcnj3;Gabbr2;Gng7;Gng2
prerank,Processing Of SMDT1 R-HSA-8949664,0.762439839016246,1.313553110092991,0.20522388059701493,0.8537784797542529,1.0,3/15,3.87%,Mcu;Micu1;Yme1l1
prerank,Ras Activation Upon Ca2+ Influx Thru NMDA Receptor R-HSA-442982,0.7358225644873868,1.3084207523580738,0.21299638989169675,0.8646875260128811,1.0,7/19,1.92%,Lrrc7;Camk2a;Camk2b;Grin2b;Rasgrf1;Rasgrf2;Camk2g
prerank,Interleukin Receptor SHC Signaling R-HSA-912526,-0.7666117372261009,-1.3073039007346656,0.13915416098226466,1.0,1.0,5/25,7.96%,Gab2;Pik3r1;Inppl1;Clstn1;Csf2rb
prerank,Glucagon-like Peptide-1 (GLP1) Regulates Insulin Secretion R-HSA-381676,-0.7533151588789121,-1.3071056287814786,0.10416666666666667,1.0,1.0,9/40,5.28%,Kcnc2;Kcns3;Itpr2;Gng4;Rapgef3;Gnas;Prkar1b;Iqgap1;Adcy8
prerank,FGFR1 Mutant Receptor Activation R-HSA-1839124,-0.773291238803232,-1.3068730701974982,0.12283044058744993,1.0,1.0,5/28,2.21%,Stat5b;Gab2;Pik3r1;Fgf1;Cux1
prerank,Metabolism Of Carbohydrates R-HSA-71387,-0.6227414130750324,-1.3051691339422435,0.04,1.0,1.0,34/263,7.63%,Gpc6;Hs3st5;Xylt1;Gpc5;Hs6st2;Hs3st2;Ext1;Aldh1a1;Phkg1;Ndst3;Bcan;Hs6st3;Hs3st4;Pfkp;Phkb;St3gal6;Pygm;Pfkfb3;Vcan;Prelp;Chst3;Ugp2;Hspg2;Cspg5;Gusb;Manba;Pck2;Slc25a13;Map4k2;Fut2;Gpc2;Dcn;Cd44;Glyctk
prerank,"Cell Death Signaling Via NRAGE, NRIF And NADE R-HSA-204998",0.6279541474838358,1.3041567001422363,0.09615384615384616,0.8720689580093833,1.0,10/73,1.50%,Kalrn;Tiam1;Plekhg5;Abr;Vav3;Rasgrf2;Itsn1;Arhgef4;Fgd4;Arhgef9
prerank,NCAM1 Interactions R-HSA-419037,0.683876093651971,1.303684873226291,0.17100371747211895,0.8643906251602,1.0,8/37,2.93%,Cacna1c;Cacnb2;Gfra1;Cacna1d;Cacna1h;Ncam1;Gfra2;St8sia4
prerank,EGR2 And SOX10-mediated Initiation Of Schwann Cell Myelination R-HSA-9619665,-0.7638242719996623,-1.303447432062524,0.1,1.0,1.0,10/27,6.39%,Wwtr1;Utrn;Adgrg6;Sox10;Pou3f2;Lama2;Pou3f1;Plppr3;Mag;Hmgcr
prerank,ERCC6 (CSB) And EHMT2 (G9a) Positively Regulate rRNA Expression R-HSA-427389,0.6778568190509622,1.302654537132042,0.1881918819188192,0.8588899619222653,1.0,14/32,11.12%,Chd4;Chd3;Gatad2b;Hdac1;Mta2;Mta3;Cbx3;H2az1;H2ax;Rbbp7;Rbbp4;H2ac4;Hdac2;H2ac6
prerank,Downregulation Of TGF-beta Receptor Signaling R-HSA-2173788,0.7262382523541762,1.3023432290612762,0.18702290076335878,0.8506841091389741,1.0,5/26,3.13%,Nedd4l;Tgfbr1;Ppp1cb;Smad3;Usp15
prerank,Cell Recruitment (Pro-Inflammatory Response) R-HSA-9664424,-0.7778749368762357,-1.301321396402758,0.12920592193808883,1.0,1.0,3/23,2.96%,P2rx7;Entpd1;Casp1
prerank,RNA Polymerase I Promoter Clearance R-HSA-73854,0.627750461891923,1.3010950998494375,0.1446280991735537,0.846663238213605,1.0,21/65,11.12%,Chd4;Gtf2h2;Chd3;Gatad2b;Hdac1;Ubtf;Gtf2h5;Mapk3;Mta2;Ccnh;Mta3;Cbx3;H2az1;H2ax;Rbbp7;Polr1h;Rbbp4;H2ac4;Hdac2;Mnat1;H2ac6
prerank,Signaling By PDGFR In Disease R-HSA-9671555,-0.7855290890481685,-1.3004893962629744,0.13788300835654596,1.0,1.0,4/19,4.04%,Pik3r1;Etv6;Pdgfra;Kank1
prerank,Signaling By NTRK2 (TRKB) R-HSA-9006115,0.757067957561677,1.3004400126923308,0.1752988047808765,0.8400776500675603,1.0,5/22,3.22%,Tiam1;Grin2b;Ntf3;Dock3;Cdk5r1
prerank,NRIF Signals Cell Death From Nucleus R-HSA-205043,-0.7918199468408906,-1.299268314748387,0.15205479452054796,1.0,1.0,1/16,0.95%,Ngf
prerank,Peptide Chain Elongation R-HSA-156902,0.618239254298106,1.2991395577335998,0.12015503875968993,0.836479467658307,1.0,27/81,12.24%,Rpl10a;Rplp1;Eef1a1;Rpl15;Rpsa;Rplp0;Rpl3;Mrpl13;Rps28;Rpl36a;Rpl4;Rps8;Rpl8;Rps21;Uba52;Rpl18a;Rps3;Rpl30;Rpl38;Rsl24d1;Rpl41;Rps23;Rpl27a;Rpl9;Rps10;Rps13;Rps2
prerank,Constitutive Signaling By NOTCH1 HD+PEST Domain Mutants R-HSA-2894862,0.647515431616934,1.298910846386636,0.137546468401487,0.8286996124443686,1.0,8/56,4.45%,Maml2;Maml3;Ncor1;Hdac1;Mib1;Hdac7;Psen1;Ncor2
prerank,"Synthesis, Secretion, And Inactivation Of Glucagon-like Peptide-1 (GLP-1) R-HSA-381771",-0.7748679958747783,-1.2943963487253292,0.1388888888888889,1.0,1.0,2/20,1.55%,Tcf7l2;Pcsk1
prerank,RA Biosynthesis Pathway R-HSA-5365859,-0.7782955839122858,-1.292725803301662,0.17774762550881953,1.0,1.0,4/17,10.63%,Aldh1a1;Aldh1a3;Cyp26b1;Aldh8a1
prerank,"Synthesis, Secretion, And Deacylation Of Ghrelin R-HSA-422085",-0.779919372439769,-1.2923522236476324,0.1539491298527443,1.0,1.0,7/17,17.07%,Pcsk1;Pla2g7;Igf1;Mboat4;Ache;Ucn;Ghrl
prerank,Deactivation Of Beta-Catenin Transactivating Complex R-HSA-3769402,-0.7313178569261394,-1.291505737688109,0.11002785515320335,1.0,1.0,9/41,7.41%,Sox6;Tcf7l2;Tcf7l1;Lef1;Tle3;Tle2;Tcf7;Sox2;Sox4
prerank,TP53 Regulates Metabolic Genes R-HSA-5628897,0.6115291451270901,1.2911577490811796,0.11304347826086956,0.8507357241890634,1.0,14/79,6.21%,Tnrc6c;Prkag2;Akt3;Rragd;Ywhaz;Ago1;Tnrc6b;Ywhah;Ywhab;Ywhae;Rptor;Ago2;Ddit4;Mov10
prerank,Oncogene Induced Senescence R-HSA-2559585,0.6790312111167672,1.2899397889270876,0.17692307692307693,0.8468646077284856,1.0,8/32,6.48%,Tnrc6c;Mapk1;Ago1;Tnrc6b;Mapk3;Ets2;Mov10;Cdk6
prerank,"Sensory Perception Of Sweet, Bitter, And Umami (Glutamate) Taste R-HSA-9717207",0.718568298678867,1.2899098198274412,0.1916376306620209,0.8384009383242789,1.0,3/21,2.66%,Grm1;Scn3a;Scn2a
prerank,Long-term Potentiation R-HSA-9620244,0.7019957796367077,1.2894449008254538,0.20848056537102475,0.8314148974681118,1.0,9/23,2.06%,Grin2a;Gria1;Lrrc7;Camk2a;Camk2b;Gria2;Grin2b;Camk2g;Nrgn
prerank,Signaling By SCF-KIT R-HSA-1433557,-0.7432937961204275,-1.28892265252179,0.12175102599179206,1.0,1.0,12/40,11.84%,Kit;Stat5b;Ptpru;Gab2;Pik3r1;Grb10;Fer;Vav1;Grb7;Socs1;Fes;Prkca
prerank,Impaired BRCA2 Binding To PALB2 R-HSA-9709603,-0.7798431626534293,-1.2884626258311616,0.14446002805049088,1.0,1.0,6/23,13.56%,Rbbp8;Brip1;Bard1;Top3a;Artn;Xrcc2
prerank,C-type Lectin Receptors (CLRs) R-HSA-5621481,0.5820417558123294,1.2881700411282424,0.10679611650485436,0.8279387860849072,1.0,20/124,8.68%,Ppp3ca;Ppp3r1;Plcg2;Fbxw11;Calm1;Arhgef7;Fyn;Btrc;Crebbp;Itpr1;Src;Psmd13;Ube2d1;Ppp3cb;Prkacb;Cul1;Muc15;Uba52;Skp1;Nfkb1
prerank,Non-integrin membrane-ECM Interactions R-HSA-3000171,-0.7452859206231298,-1.287654081965365,0.13297150610583447,1.0,1.0,16/41,12.33%,Ntn4;Dmd;Nrxn1;Lama4;Lama2;Itga2;Lama1;Hspg2;Ttr;Ddr2;Vtn;Itgb5;Sdc4;Itga6;Prkca;Lamc2
prerank,Signaling By FGFR1 In Disease R-HSA-5655302,-0.7556022404986221,-1.285271840335017,0.12158469945355191,1.0,1.0,5/34,2.21%,Stat5b;Gab2;Pik3r1;Fgf1;Cux1
prerank,NOTCH2 Activation And Transmission Of Signal To Nucleus R-HSA-2979096,0.7599782662357895,1.2852691331613488,0.17537313432835822,0.8306456282107542,1.0,4/20,4.38%,Notch2;Cntn1;Mib1;Psen1
prerank,Formation Of A Pool Of Free 40S Subunits R-HSA-72689,0.5965729412363361,1.2846266172044671,0.12698412698412698,0.8251390036585478,1.0,36/92,16.38%,Rpl10a;Rplp1;Rpl15;Rpsa;Rplp0;Rpl3;Mrpl13;Rps28;Rpl36a;Rpl4;Rps8;Rpl8;Rps21;Uba52;Rpl18a;Rps3;Rpl30;Rpl38;Rsl24d1;Rpl41;Rps23;Rpl27a;Rpl9;Rps10;Rps13;Rps2;Eif3b;Rps15;Eif3a;Eif3f;Eif3g;Rpl26;Eif3l;Eif3m;Rpl18;Rps19
prerank,Mitochondrial Calcium Ion Transport R-HSA-8949215,0.7283551721043023,1.2833217846065512,0.20973782771535582,0.8219613765705204,1.0,3/21,3.87%,Mcu;Micu1;Yme1l1
prerank,Metabolism Of Fat-Soluble Vitamins R-HSA-6806667,-0.736238184003666,-1.2830675097467779,0.11859838274932614,1.0,1.0,8/41,7.35%,Gpc6;Gpc5;Akr1b10;Apoe;Hspg2;Ttr;Rbp4;Gpc2
prerank,Signaling By FGFR In Disease R-HSA-1226099,-0.7156401698052673,-1.2830355348223246,0.11885245901639344,1.0,1.0,6/59,2.36%,Stat5b;Gab2;Pik3r1;Fgf1;Cux1;Fgfr3
prerank,SUMOylation Of Chromatin Organization Proteins R-HSA-4551638,-0.7114059772001767,-1.2829586761239533,0.1436388508891929,1.0,1.0,1/50,0.07%,Satb2
prerank,Selenocysteine Synthesis R-HSA-2408557,0.611722391574248,1.2807336074879956,0.1440329218106996,0.8232822710367909,1.0,28/84,12.24%,Rpl10a;Rplp1;Rpl15;Rpsa;Rplp0;Rpl3;Mrpl13;Rps28;Rpl36a;Rpl4;Rps8;Rpl8;Eefsec;Rps21;Uba52;Rpl18a;Rps3;Rpl30;Sephs2;Rpl38;Rsl24d1;Rpl41;Rps23;Rpl27a;Rpl9;Rps10;Rps13;Rps2
prerank,RNA Polymerase I Transcription R-HSA-73864,0.614647650498384,1.2793288887822052,0.15767634854771784,0.8208246264563972,1.0,21/66,11.12%,Chd4;Gtf2h2;Chd3;Gatad2b;Hdac1;Ubtf;Gtf2h5;Mapk3;Mta2;Ccnh;Mta3;Cbx3;H2az1;H2ax;Rbbp7;Polr1h;Rbbp4;H2ac4;Hdac2;Mnat1;H2ac6
prerank,Collagen Chain Trimerization R-HSA-8948216,-0.7226028402107154,-1.278820371552461,0.1221476510067114,1.0,1.0,21/43,13.08%,Col26a1;Col8a1;Col27a1;Col4a5;Col28a1;Col19a1;Col14a1;Col18a1;Col6a2;Col1a2;Col6a5;Col9a1;Col4a2;Col6a1;Col3a1;Col12a1;Col4a1;Col24a1;Col17a1;Col11a1;Col8a2
prerank,Resolution Of D-loop Structures Thru Synthesis-Dependent Strand Annealing (SDSA) R-HSA-5693554,-0.7640509542811297,-1.2784042095977017,0.14965986394557823,1.0,1.0,6/26,13.56%,Rbbp8;Brip1;Bard1;Top3a;Artn;Xrcc2
prerank,Defective HDR Thru Homologous Recombination (HRR) Due To BRCA1 Loss-Of-Function R-HSA-9701192,-0.7696165457068267,-1.2767284485917922,0.15760111576011157,1.0,1.0,6/24,13.56%,Rbbp8;Brip1;Bard1;Top3a;Artn;Xrcc2
prerank,TP53 Regulates Transcription Of DNA Repair Genes R-HSA-6796648,0.6141586526226986,1.2765550157064227,0.1225296442687747,0.8230527140536381,1.0,20/56,15.60%,Jun;Gtf2h2;Cdk12;Gtf2h5;Gtf2f2;Ccnh;Ccnt2;Ssrp1;Cdk9;Mnat1;Tcea1;Polr2k;Ercc2;Gtf2f1;Ccnt1;Polr2e;Ctdp1;Atm;Ccnk;Eloc
prerank,mRNA Splicing - Minor Pathway R-HSA-72165,0.6457082811556555,1.2750307827864484,0.16,0.8209746082972449,1.0,20/49,14.76%,Srsf1;Gtf2f2;Snrnp40;Ddx42;Eftud2;Srsf7;Srsf2;Sf3b3;Ncbp1;Sf3b1;Ybx1;Snrpb;Snrpd3;Polr2k;Srsf6;Gtf2f1;Polr2e;Snrpf;Ddx23;Prpf8
prerank,Response To Elevated Platelet Cytosolic Ca2+ R-HSA-76005,-0.6559757288285528,-1.2747123782204768,0.11197916666666667,1.0,1.0,28/119,12.02%,Pcdh7;Prkcb;Fn1;Phactr2;Cd109;Itih3;Sgpp2;Igf1;Vcl;App;Ttr;Timp3;Cyrib;Prkcg;Sccpdh;Tgfb3;Apoh;Cd63;Scg3;Vegfc;Clu;Tmx3;Sparc;Vegfd;Selenop;Vegfa;Prkca;Anxa5
prerank,ABC Transporters In Lipid Homeostasis R-HSA-1369062,-0.7834558556599924,-1.274490841245875,0.15459610027855153,1.0,1.0,2/17,2.37%,Abca9;Abca6
prerank,Retinoid Metabolism And Transport R-HSA-975634,-0.7392603240522967,-1.2734224299326806,0.13953488372093023,1.0,1.0,8/37,7.35%,Gpc6;Gpc5;Akr1b10;Apoe;Hspg2;Ttr;Rbp4;Gpc2
prerank,Translation Initiation Complex Formation R-HSA-72649,0.6395399158249522,1.2715575629556384,0.16988416988416988,0.8264325586844233,1.0,29/52,21.77%,Eif4a2;Pabpc1;Eif4b;Rpsa;Rps28;Rps8;Rps21;Rps3;Eif4e;Rps23;Rps10;Rps13;Eif4a1;Rps2;Eif3b;Rps15;Eif3a;Eif3f;Eif3g;Eif3l;Eif3m;Rps19;Eif3k;Rps29;Fau;Eif4h;Rps16;Rps12;Eif3i
prerank,Signaling By NOTCH3 R-HSA-9012852,0.6536675556605778,1.2713320759537887,0.15498154981549817,0.8197993757553819,1.0,2/47,0.42%,Maml2;Maml3
prerank,Activation Of Gene Expression By SREBF (SREBP) R-HSA-2426168,-0.7347378854111938,-1.2697151058026346,0.1489655172413793,1.0,1.0,12/40,14.80%,Tbl1x;Hmgcs1;Sqle;Hmgcr;Smarcd3;Fdft1;Elovl6;Ppara;Srebf2;Lmbr1;Rxra;Gpam
prerank,Glycosaminoglycan Metabolism R-HSA-1630316,-0.6554918909154649,-1.2682487084686664,0.10559796437659033,1.0,1.0,21/117,7.63%,Gpc6;Hs3st5;Xylt1;Gpc5;Hs6st2;Hs3st2;Ext1;Ndst3;Bcan;Hs6st3;Hs3st4;St3gal6;Vcan;Prelp;Chst3;Hspg2;Cspg5;Gusb;Gpc2;Dcn;Cd44
prerank,Negative Regulation Of NMDA Receptor-Mediated Neuronal Transmission R-HSA-9617324,0.7120086093228601,1.2655945454248985,0.23018867924528302,0.8328553314286157,1.0,7/21,1.92%,Grin2a;Lrrc7;Camk2a;Camk2b;Grin2b;Ppm1e;Camk2g
prerank,Cholesterol Biosynthesis R-HSA-191273,-0.748148944561213,-1.264679528708038,0.16826265389876882,1.0,1.0,8/25,13.62%,Msmo1;Hmgcs1;Sqle;Hmgcr;Fdft1;Dhcr24;Srebf2;Lmbr1
prerank,Eukaryotic Translation Termination R-HSA-72764,0.606598980139723,1.2642243381701044,0.1346938775510204,0.8301718320470582,1.0,29/85,13.26%,Rpl10a;Rplp1;Rpl15;Gspt1;Rpsa;Rplp0;Rpl3;Mrpl13;Rps28;Rpl36a;Rpl4;Rps8;Rpl8;Rps21;Uba52;Rpl18a;Rps3;Rpl30;Rpl38;Rsl24d1;Rpl41;Rps23;Rpl27a;Rpl9;Rps10;Rps13;Rps2;Gspt2;Rps15
prerank,"Incretin Synthesis, Secretion, And Inactivation R-HSA-400508",-0.7494712996736468,-1.2641942666857406,0.16986301369863013,1.0,1.0,4/23,8.93%,Tcf7l2;Pcsk1;C1qtnf1;Ucma
prerank,Peptide Ligand-Binding Receptors R-HSA-375276,-0.6303091891768487,-1.264076192353246,0.09570552147239264,1.0,1.0,47/153,19.08%,Rxfp1;Qrfpr;Nmbr;Tacr3;Cckbr;Gpr37l1;Ccl28;Oprk1;Npsr1;App;Ednrb;Oprd1;Mc5r;Ntsr2;Grpr;Rxfp2;Agtr2;Tacr1;Hcrt;Ttf2;Ucma;Nmur1;Npb;Cd200r1;Anxa1;Npbwr1;Ccr5;Tac1;Bdkrb2;Prok2;Rxfp3;Nln;Ntsr1;Tacr2;Edn3;Sst;Cxcr4;Ackr2;Gper1;Nts;Ghrl;Uts2;Nlrp3;Nmur2;Oprl1;Cxcr2;Avpr1b
prerank,Sensory Perception Of Taste R-HSA-9717189,0.6891810729371718,1.2626219750344105,0.22184300341296928,0.8283923099686245,1.0,5/26,5.15%,Grm1;Scn3a;Scn2a;Scn9a;Scnn1a
prerank,RNA Polymerase I Transcription Termination R-HSA-73863,0.6709266443858565,1.2620124127139563,0.18823529411764706,0.82327957589793,1.0,9/30,12.87%,Gtf2h2;Ubtf;Gtf2h5;Ccnh;Polr1h;Mnat1;Polr2k;Ercc2;Polr2e
prerank,Ribosomal Scanning And Start Codon Recognition R-HSA-72702,0.6322185451957804,1.2614758346478998,0.17110266159695817,0.8178193808059663,1.0,29/52,21.77%,Eif4a2;Eif4b;Rpsa;Rps28;Rps8;Eif5;Rps21;Rps3;Eif4e;Rps23;Rps10;Rps13;Eif4a1;Rps2;Eif3b;Rps15;Eif3a;Eif3f;Eif3g;Eif3l;Eif3m;Rps19;Eif3k;Rps29;Fau;Eif4h;Rps16;Rps12;Eif3i
prerank,SRP-dependent Cotranslational Protein Targeting To Membrane R-HSA-1799339,0.5855759682380928,1.2611598547743255,0.10756972111553785,0.8118507543677107,1.0,30/101,12.24%,Rpl10a;Rplp1;Rpl15;Ssr1;Rpsa;Rplp0;Rpl3;Mrpl13;Rps28;Rpl36a;Rpl4;Rps8;Rpl8;Rps21;Uba52;Rpl18a;Ssr3;Rps3;Rpl30;Rpl38;Rsl24d1;Rpl41;Srp68;Rps23;Rpl27a;Rpl9;Rps10;Rps13;Spcs2;Rps2
prerank,Notch-HLH Transcription Pathway R-HSA-350054,0.680024397366002,1.2598016404514747,0.20973782771535582,0.8091550902606884,1.0,7/28,4.45%,Maml2;Maml3;Notch2;Ncor1;Hdac1;Hdac7;Ncor2
prerank,Insertion Of Tail-Anchored Proteins Into Endoplasmic Reticulum Membrane R-HSA-9609523,-0.7631506297697254,-1.2574486189344054,0.1970899470899471,1.0,1.0,3/20,5.94%,Stx1a;App;Cyb5a
prerank,Interleukin-7 Signaling R-HSA-1266695,-0.7554517820669417,-1.2566208084860298,0.1597315436241611,1.0,1.0,9/25,14.72%,Socs2;Stat5b;Pik3r1;Il7;Cish;Socs1;H3c7;Stat5a;Il7r
prerank,Transcription Of HIV Genome R-HSA-167172,0.6000988034602335,1.2564791716390766,0.16317991631799164,0.81359824121398,1.0,22/64,16.14%,Gtf2h2;Gtf2h5;Gtf2f2;Ccnh;Ncbp1;Ccnt2;Ssrp1;Cdk9;Gtf2a1;Mnat1;Tcea1;Polr2k;Ercc2;Gtf2f1;Ccnt1;Taf15;Polr2e;Ctdp1;Taf6;Ccnk;Eloc;Rngtt
prerank,Signaling By Non-Receptor Tyrosine Kinases R-HSA-9006927,-0.7065858352378073,-1.255829660810857,0.15220293724966621,1.0,1.0,8/51,4.43%,Khdrbs3;Dock1;Erbb4;Elmo1;Nrg1;Erbb3;Epas1;Lrrk2
prerank,NRAGE Signals Death Thru JNK R-HSA-193648,0.6376721093587561,1.254622306541327,0.16538461538461538,0.8128610145959962,1.0,10/56,1.50%,Kalrn;Tiam1;Plekhg5;Abr;Vav3;Rasgrf2;Itsn1;Arhgef4;Fgd4;Arhgef9
prerank,Collagen Formation R-HSA-1474290,-0.6692409257431543,-1.254338569828724,0.12231182795698925,1.0,1.0,30/86,13.41%,Adamts2;Col26a1;Lama4;Col8a1;Col27a1;P4ha3;Col4a5;Col28a1;Col19a1;Col14a1;Col18a1;Col6a2;Col1a2;Col6a5;Col9a1;Col4a2;P3h2;Col6a1;Col3a1;Mmp28;Pcolce;Col12a1;Col4a1;Itga6;Col24a1;Col17a1;Lamc2;Col11a1;Col8a2;Tll2
prerank,VxPx Cargo-Targeting To Cilium R-HSA-5620916,-0.7482466823971474,-1.25195068931604,0.1813186813186813,1.0,1.0,1/21,0.34%,Asap1
prerank,Synthesis Of IP3 And IP4 In Cytosol R-HSA-1855204,-0.7386061122132223,-1.2517577945098435,0.17912552891396333,1.0,1.0,5/26,6.15%,Plcb4;Plch2;Inppl1;Plcb2;Plcd3
prerank,Transcriptional Regulation Of Pluripotent Stem Cells R-HSA-452723,-0.728032714937244,-1.2511019036319404,0.16666666666666666,1.0,1.0,7/27,13.31%,Sall1;Epas1;Pbx1;Smad2;Sox2;Foxp1;Nr6a1
prerank,"mRNA Activation Upon Binding Of Cap-Binding Complex And eIFs, Subsequent Binding To 43S R-HSA-72662",0.625743788014751,1.250805678078257,0.18532818532818532,0.818588237520969,1.0,22/53,16.38%,Eif4a2;Pabpc1;Eif4b;Rpsa;Rps28;Rps8;Rps21;Rps3;Eif4e;Rps23;Rps10;Rps13;Eif4a1;Rps2;Eif3b;Rps15;Eif3a;Eif3f;Eif3g;Eif3l;Eif3m;Rps19
prerank,Regulation Of PTEN Gene Transcription R-HSA-8943724,0.6129728893604249,1.2498223547090468,0.17716535433070865,0.8154816407941342,1.0,19/58,8.08%,Mapk1;Chd4;Jun;Chd3;Gatad2b;Hdac1;Rragd;Hdac7;Phc2;Cbx6;Rptor;Mapk3;Mta2;Mta3;Ezh2;Cbx4;Rbbp7;Suz12;Phc3
prerank,Signaling By FGFR3 In Disease R-HSA-5655332,-0.7615091403384314,-1.2487023783072757,0.18945868945868946,1.0,1.0,3/19,2.36%,Pik3r1;Fgf1;Fgfr3
prerank,Visual Phototransduction R-HSA-2187338,-0.6719103003971965,-1.2479308029338123,0.13219895287958114,1.0,1.0,19/83,11.84%,Gpc6;Gpc5;Akr1b10;Prkcq;Apoe;Gucy2f;Hspg2;Ttr;Rbp4;Camkmt;Pde6g;Gpc2;Slc24a1;Sdc4;Nmt2;Bco2;Ldlr;Bco1;Prkca
prerank,Nicotinamide Salvaging R-HSA-197264,-0.7521970285479186,-1.2438980096569023,0.19667590027700832,1.0,1.0,2/18,2.98%,Parp4;Parp8
prerank,Ion Channel Transport R-HSA-983712,0.5314392661402978,1.2438932840392953,0.09090909090909091,0.8279099864635961,1.0,20/162,3.70%,Ryr2;Trpm3;Camk2a;Ano3;Camk2b;Trpc6;Nedd4l;Atp2b1;Unc80;Unc79;Atp8a1;Atp2b3;Camk2g;Atp6v1a;Best3;Atp2c1;Ano2;Ryr1;Trpm7;Atp1b1
prerank,Striated Muscle Contraction R-HSA-390522,-0.7293090630926468,-1.2437803312207047,0.18132611637347767,1.0,1.0,12/32,11.81%,Dmd;Mybpc1;Tnni1;Neb;Ttr;Tnnt2;Myh6;Tcap;Tpm2;Myh3;Myl3;Tmod3
prerank,Clathrin-mediated Endocytosis R-HSA-8856828,-0.6338718827676479,-1.2437029215970155,0.11786600496277916,1.0,1.0,20/131,8.64%,Fnbp1l;Syt9;Synj2;Chrm2;Cftr;Hip1r;Eps15;Fzd4;Syt12;Dab2;Grk3;Sh3gl2;Hip1;Ap2b1;Syt2;Egfr;Stam2;Tacr1;Ldlrap1;Wnt5a
prerank,Signaling By NTRKs R-HSA-166520,0.5512453082605598,1.2436337284582033,0.0975609756097561,0.8220387164370782,1.0,24/129,5.13%,Ntrk3;Tiam1;Bcl11b;Grin2b;Pcsk5;Ntf3;Mapk1;Chd4;Map2k1;Adcyap1r1;Dock3;Mef2d;Tcf12;Rit2;Rps6ka2;Mef2c;Dnm1;Cdk5r1;Ywhab;Mapk14;Mapk3;Pik3cb;Fyn;Irs1
prerank,Glycogen Metabolism R-HSA-8982491,-0.7387512187243632,-1.2429871281985907,0.19129287598944592,1.0,1.0,6/22,10.83%,Phkg1;Phkb;Pygm;Ugp2;Gys1;Gbe1
prerank,PI-3K cascade:FGFR3 R-HSA-5654710,-0.7720578094939058,-1.2407673084619615,0.20821529745042494,1.0,1.0,3/16,2.36%,Pik3r1;Fgf1;Fgfr3
prerank,Downstream Signaling Of Activated FGFR3 R-HSA-5654708,-0.7501959120509842,-1.2398354563144276,0.19746121297602257,1.0,1.0,3/22,2.36%,Pik3r1;Fgf1;Fgfr3
prerank,mTORC1-mediated Signaling R-HSA-166208,0.6782672368479288,1.2377806355383765,0.26277372262773724,0.8353844805561604,1.0,7/24,11.08%,Rragd;Ywhab;Rptor;Eif4b;Fkbp1a;Eif4e;Slc38a9
prerank,Early SARS-CoV-2 Infection Events R-HSA-9772572,-0.703079281194898,-1.2376235068724235,0.17567567567567569,1.0,1.0,2/35,0.59%,Gpc6;Gpc5
prerank,Major Pathway Of rRNA Processing In Nucleolus And Cytosol R-HSA-6791226,0.5335792670137648,1.237538663126131,0.1145374449339207,0.8296477218685008,1.0,79/172,20.73%,Xrn2;Rpl10a;Bop1;Rplp1;Rpl15;Rpsa;Rplp0;Exosc8;Riok3;Rpl3;Mrpl13;Rcl1;Rps28;Rpl36a;Rpl4;Rps8;Rpl8;Nop58;Utp4;Wdr12;Senp3;Sppl2a;Rbm28;Rps21;Uba52;Rpl18a;Dnajc5;Heatr1;Riok2;Rrp1b;Rps3;Nol12;Ddx56;Rpl30;Wdr43;Rpl38;Rsl24d1;Rpl41;Rps23;Rpl27a;Rpl9;Rps10;Mtrex;Riok1;Rps13;Ddx47;Fbl;Rps2;Tsr1;Utp15;Rps15;Nol6;Rpl26;Gnl3;Ftsj3;Krr1;Wdr36;Rpl18;Wdr3;Rps19;Tbl3;Rpl13a;Rrp9;Emg1;Utp6;Rpl7;Dcaf13;Rpl28;Isg20l2;Nob1;Nip7;Dhx37;Rps29;Nop56;Rpp14;Pelp1;Exosc1;Fau;Rpl36
prerank,Collagen Biosynthesis And Modifying Enzymes R-HSA-1650814,-0.671878835422939,-1.2367295854701046,0.16532258064516128,1.0,1.0,26/66,13.41%,Adamts2;Col26a1;Col8a1;Col27a1;P4ha3;Col4a5;Col28a1;Col19a1;Col14a1;Col18a1;Col6a2;Col1a2;Col6a5;Col9a1;Col4a2;P3h2;Col6a1;Col3a1;Pcolce;Col12a1;Col4a1;Col24a1;Col17a1;Col11a1;Col8a2;Tll2
prerank,rRNA Processing In Nucleus And Cytosol R-HSA-8868773,0.5292132246154284,1.2354616376187477,0.13004484304932734,0.830545221076726,1.0,92/182,22.53%,Xrn2;Rpl10a;Bop1;Rplp1;Rpl15;Rpsa;Rplp0;Exosc8;Riok3;Rpl3;Mrpl13;Rcl1;Rps28;Rpl36a;Rpl4;Rps8;Rpl8;Nop58;Utp4;Wdr12;Senp3;Sppl2a;Rbm28;Rps21;Uba52;Rpl18a;Dnajc5;Heatr1;Riok2;Rrp1b;Rps3;Nol12;Ddx56;Rpl30;Wdr43;Rpl38;Rsl24d1;Rpl41;Rps23;Rpl27a;Rpl9;Rps10;Mtrex;Riok1;Rps13;Ddx47;Fbl;Rps2;Tsr1;Utp15;Dkc1;Rps15;Nop2;Nol6;Rpl26;Gnl3;Ftsj3;Krr1;Wdr36;Rpl18;Wdr3;Rps19;Tbl3;Rpl13a;Rrp9;Emg1;Utp6;Rpl7;Dcaf13;Rpl28;Isg20l2;Nob1;Nip7;Dhx37;Rps29;Nop56;Rpp14;Pelp1;Exosc1;Fau;Rpl36;Rps16;Rps12;Bud23;Rpl35;Thumpd1;Rpl7a;Ebna1bp2;Rpl5;Tsr3;Mphosph10;Bms1
prerank,Signaling By Retinoic Acid R-HSA-5362517,-0.7148642915426503,-1.2351776440918871,0.20383036935704515,1.0,1.0,11/35,16.94%,Aldh1a1;Rara;Cpt1a;Aldh1a3;Cyp26b1;Aldh8a1;Rxrg;Pdk4;Rxra;Ldhd;Dhrs3
prerank,Cellular Senescence R-HSA-2559583,0.5318976782046315,1.2324749608651286,0.11219512195121951,0.8337147857263141,1.0,35/138,8.92%,Tnrc6c;Tnik;Mapk1;Map2k6;Jun;Rps6ka2;Ago1;Tnrc6b;Phc2;Mapk14;Mink1;Cbx6;Cebpb;Mapk3;Map2k4;Ets2;Map3k5;Mov10;Ezh2;Mapk10;Ube2d1;Cdk6;Cbx4;Ehmt1;H2az1;Hira;H2ax;Rbbp7;Suz12;Phc3;Terf2;Uba52;Cdc27;Nfkb1;Mapk7
prerank,Interleukin-37 Signaling R-HSA-9008059,-0.7345196429062508,-1.23137588171662,0.21703296703296704,1.0,1.0,6/20,9.34%,Ptpn14;Casp1;Ptpn9;Ptpn20;Ptpn5;Ptpn4
prerank,mRNA Decay By 5 To 3 Exoribonuclease R-HSA-430039,0.728266302684606,1.2297738030622491,0.28846153846153844,0.8362327361179134,1.0,10/15,18.18%,Dcp1b;Edc3;Lsm7;Ddx6;Patl1;Edc4;Lsm4;Dcp2;Lsm2;Xrn1
prerank,Viral mRNA Translation R-HSA-192823,0.5901100843946138,1.2290306580961827,0.17573221757322174,0.8321677886873746,1.0,32/85,16.38%,Rpl10a;Rplp1;Rpl15;Rpsa;Rplp0;Rpl3;Mrpl13;Rps28;Rpl36a;Rpl4;Rps8;Rpl8;Rps21;Uba52;Rpl18a;Rps3;Rpl30;Rpl38;Rsl24d1;Rpl41;Rps23;Rpl27a;Rpl9;Rps10;Rps13;Rps2;Rps15;Rpl26;Gnl3;Bloc1s6;Rpl18;Rps19
prerank,GPCR Ligand Binding R-HSA-500792,-0.5728001805357718,-1.2287216573176183,0.08630609896432681,1.0,1.0,79/358,11.38%,Htr1f;Htr2c;Chrm3;Htr2a;Adra1b;Grm3;Grm8;Rxfp1;Chrm2;Adra1a;Qrfpr;Htr7;Lpar1;Nmbr;Tacr3;Opn3;Ptger3;Cckbr;S1pr1;Gpr37l1;Gng4;Drd2;Ccl28;Fzd2;Vipr2;Oprk1;Npsr1;Gpr17;Adrb3;Tshr;Grm4;Lhcgr;Fzd4;Wnt2;Gnas;App;Gnrh1;Plppr3;Ednrb;Oprd1;Mc5r;Shh;Crhbp;Ntsr2;Grpr;Rxfp2;Hrh2;Agtr2;Fzd9;C1qtnf1;Tacr1;Hcrt;Htr1d;Adora2b;Hrh3;Wnt5a;Ttf2;P2ry1;Ucma;Nmur1;Cmklr1;Crh;Wnt10a;Fzd6;Gnb4;Smox;Npb;Cd200r1;Anxa1;Npbwr1;Ccr5;Tac1;Bdkrb2;Prok2;S1pr2;Rxfp3;Chrm5;Gng12;Lpar3
prerank,p75NTR Signals Via NF-kB R-HSA-193639,-0.746250035356187,-1.2262472509176097,0.2349799732977303,1.0,1.0,2/16,9.18%,Ngf;Myd88
prerank,Phase I - Functionalization Of Compounds R-HSA-211945,-0.6802396158746159,-1.2261696512203375,0.1608876560332871,1.0,1.0,6/63,6.00%,Acss1;Aldh1a1;Arnt2;Tbxas1;Cyp27a1;Maob
prerank,Inwardly Rectifying K+ Channels R-HSA-1296065,0.6817862258488523,1.225982939487479,0.23809523809523808,0.8354309549822847,1.0,6/33,2.54%,Kcnj6;Kcnj3;Gabbr2;Gng7;Gng2;Abcc8
prerank,ER To Golgi Anterograde Transport R-HSA-199977,0.536152391097187,1.225632516999997,0.1278538812785388,0.8302712667264965,1.0,19/128,5.87%,Gria1;Ank3;Nsf;Sptb;Tgfa;Sptbn1;Sec24d;Cnih3;Sptbn4;Dync1i2;Capza2;Arf3;Dctn1;Sec23ip;Sec23a;Sptan1;Ank2;Capzb;Lman2l
prerank,Platelet Degranulation R-HSA-114608,-0.6315498083622499,-1.2249972804215772,0.1477124183006536,1.0,1.0,25/115,12.02%,Pcdh7;Fn1;Phactr2;Cd109;Itih3;Sgpp2;Igf1;Vcl;App;Ttr;Timp3;Cyrib;Sccpdh;Tgfb3;Apoh;Cd63;Scg3;Vegfc;Clu;Tmx3;Sparc;Vegfd;Selenop;Vegfa;Anxa5
prerank,"Antigen Presentation: Folding, Assembly, Peptide Loading Of Class I MHC R-HSA-983170",0.682156224607758,1.2248418918183945,0.22382671480144403,0.8265475338551933,1.0,6/21,11.82%,Sec24d;Sec14l2;Sec23a;Sar1b;Becn1;Sec24c
prerank,"Nucleotide-binding Domain, Leucine Rich Repeat Containing NLR Signaling Pathways R-HSA-168643",-0.6968460790340611,-1.224141667698513,0.18503937007874016,1.0,1.0,9/50,11.20%,P2rx7;Bcl2;Casp1;Birc3;App;Mapk11;Irak2;Mapk13;Casp4
prerank,Uptake And Actions Of Bacterial Toxins R-HSA-5339562,-0.723309158903622,-1.2240595606137852,0.21603260869565216,1.0,1.0,3/28,3.21%,Sv2b;Antxr1;Stx1a
prerank,FLT3 Signaling In Disease R-HSA-9682385,-0.722184897966542,-1.2227454155370965,0.23796791443850268,1.0,1.0,5/26,3.16%,Stat5b;Gab2;Pik3r1;Etv6;Nox4
prerank,WNT Ligand Biogenesis And Trafficking R-HSA-3238698,-0.7173541457740874,-1.2225159459895838,0.22356091030789826,1.0,1.0,6/25,13.50%,Wls;Wnt2;Wnt5a;Wnt10a;Wnt5b;Wnt3a
prerank,Integrin Signaling R-HSA-354192,-0.7242359859627427,-1.2217371484581068,0.23945578231292516,1.0,1.0,4/26,3.36%,Fn1;Rasgrp1;Rasgrp2;Rapgef3
prerank,Carboxyterminal Post-Translational Modifications Of Tubulin R-HSA-8955332,-0.7004498826817314,-1.221324470961424,0.19801980198019803,1.0,1.0,9/35,12.37%,Agbl4;Ttll9;Ttll8;Vash2;Tubb3;Ttll7;Ttl;Tubb4a;Agbl3
prerank,Regulation Of FZD By Ubiquitination R-HSA-4641263,-0.7363581114834675,-1.2212058089486806,0.22558459422283356,1.0,1.0,3/20,3.80%,Rspo2;Lgr5;Fzd4
prerank,Arachidonic Acid Metabolism R-HSA-2142753,-0.6939691197311654,-1.220630257310234,0.20926966292134833,1.0,1.0,14/41,17.45%,Tbxas1;Pon2;Fa2h;Alox12b;Ptgds;Hpgd;Ggt5;Alox5;Pla2g4a;Abcc1;Ptgs1;Cyp4b1;Ephx2;Gpx2
prerank,Death Receptor Signaling R-HSA-73887,0.5347730754094245,1.22028824607268,0.13793103448275862,0.8352639600321047,1.0,18/134,4.85%,Kalrn;Tiam1;Plekhg5;Abr;Vav3;Rasgrf2;Itsn1;Arhgef4;Fgd4;Arhgef9;Usp2;Hdac1;Bag4;Ywhae;Psen1;Prpf38b;Arhgef7;Arhgef2
prerank,Synthesis Of Active Ubiquitin: Roles Of E1 And E2 Enzymes R-HSA-8866652,0.6390506405822911,1.2199490680892089,0.26119402985074625,0.8299936562158438,1.0,12/29,12.58%,Ube2w;Ube2k;Ube2e3;Ube2b;Ube2g2;Ube2d1;Uba52;Usp7;Ube2l3;Ube2r2;Otulin;Ube2t
prerank,Interleukin-20 Family Signaling R-HSA-8854691,-0.7392411861936742,-1.216358661700029,0.2198100407055631,1.0,1.0,2/18,7.49%,Stat5b;Ifnlr1
prerank,RHOV GTPase Cycle R-HSA-9013424,-0.7020991771394168,-1.21622489929558,0.22344827586206897,1.0,1.0,4/35,5.04%,Sh3rf1;Pik3r1;Peak1;Iqgap1
prerank,Transcriptional Regulation By MECP2 R-HSA-8986944,0.6004987334406887,1.216196108162055,0.18672199170124482,0.8351169252342566,1.0,14/60,3.01%,Grin2a;Camk2a;Camk2b;Gria2;Grin2b;Tnrc6c;Rbfox1;Fkbp5;Ncor1;Camk2g;Hdac1;Mef2c;Ago1;Tnrc6b
prerank,HIV Elongation Arrest And Recovery R-HSA-167287,0.643004273390216,1.2152902784435313,0.22761194029850745,0.831901972475283,1.0,13/29,17.68%,Gtf2f2;Ccnt2;Ssrp1;Cdk9;Tcea1;Polr2k;Gtf2f1;Ccnt1;Polr2e;Ctdp1;Ccnk;Eloc;Nelfa
prerank,Basigin Interactions R-HSA-210991,-0.7287519864177195,-1.2151341937273596,0.22623828647925034,1.0,1.0,9/24,12.36%,Slc7a11;Cav1;Mag;L1cam;Slc7a7;Atp1b3;Slc7a10;Itga6;Slc16a1
prerank,Other Interleukin Signaling R-HSA-449836,-0.7312436254730649,-1.2138537089073798,0.21904761904761905,1.0,1.0,4/20,7.49%,Il34;Stx1a;Csf3r;Ifnlr1
prerank,Activation Of Matrix Metalloproteinases R-HSA-1592389,0.6952321052755139,1.2138226629438968,0.27037037037037037,0.8308401945166386,1.0,3/20,1.76%,Mmp16;Spock3;Mmp17
prerank,Late SARS-CoV-2 Infection Events R-HSA-9772573,-0.6580377859492692,-1.2138010749659551,0.21087533156498675,1.0,1.0,7/57,5.97%,Mgat4c;St6gal1;Parp4;Parp8;Man2a1;Mgat5;Zdhhc2
prerank,Signaling To RAS R-HSA-167044,-0.732426235142443,-1.2137983318624375,0.23180592991913745,1.0,1.0,5/19,13.39%,Ngf;Shc3;Mapk11;Mapk13;Rala
prerank,Ion Homeostasis R-HSA-5578775,0.6100754681286291,1.2113894336163094,0.22433460076045628,0.8329237787713044,1.0,8/48,1.92%,Ryr2;Camk2a;Camk2b;Atp2b1;Slc8a2;Orai2;Atp2b3;Camk2g
prerank,Insulin Processing R-HSA-264876,-0.7014510188324107,-1.20982774714968,0.2513812154696133,1.0,1.0,5/26,8.27%,Cpe;Pcsk1;Stx1a;Kif5a;Slc30a8
prerank,Impaired BRCA2 Binding To RAD51 R-HSA-9709570,-0.7079532259525304,-1.209412891213128,0.23255813953488372,1.0,1.0,5/33,12.19%,Rbbp8;Brip1;Bard1;Top3a;Artn
prerank,Formation Of TC-NER Pre-Incision Complex R-HSA-6781823,0.6055090378235313,1.2080239025845125,0.2151394422310757,0.8379043235886791,1.0,13/50,13.10%,Gtf2h2;Gtf2h5;Ccnh;Uba52;Usp7;Gps1;Mnat1;Cops2;Tcea1;Polr2k;Ercc2;Polr2e;Cops7a
prerank,P75 NTR Receptor-Mediated Signaling R-HSA-193704,0.5568053722363211,1.2077016102857583,0.1693548387096774,0.8329946531113456,1.0,10/94,1.50%,Kalrn;Tiam1;Plekhg5;Abr;Vav3;Rasgrf2;Itsn1;Arhgef4;Fgd4;Arhgef9
prerank,Neurotransmitter Release Cycle R-HSA-112310,0.6150016607433149,1.2070810144767665,0.21132075471698114,0.829260490433614,1.0,8/50,3.92%,Ppfia2;Rims1;Syn2;Slc17a7;Slc1a1;Syn3;Lin7c;Tspoap1
prerank,"Cobalamin (Cbl, Vitamin B12) Transport And Metabolism R-HSA-196741",-0.72259655087938,-1.2049915364937993,0.27358490566037735,1.0,1.0,4/17,13.48%,Ldlrap1;Tcn2;Cblif;Abcc1
prerank,Diseases Of DNA Repair R-HSA-9675135,-0.6842601514441266,-1.2041728972866923,0.24193548387096775,1.0,1.0,7/49,13.56%,Rbbp8;Nthl1;Brip1;Bard1;Top3a;Artn;Xrcc2
prerank,FCERI Mediated Ca+2 Mobilization R-HSA-2871809,0.672429912754253,1.2038004056164715,0.2690909090909091,0.8341742318793548,1.0,4/28,2.75%,Ppp3ca;Vav3;Ppp3r1;Plcg2
prerank,Intracellular Signaling By Second Messengers R-HSA-9006925,0.47826981754342845,1.199252607078485,0.0975609756097561,0.842729117733909,1.0,48/294,5.27%,Prkce;Il1rap;Nbea;Pip5k1b;Camk2a;Camk2b;Adcy1;Tnrc6c;Nrg3;Nrg2;Adcy2;Foxo1;Mapk1;Chd4;Tgfa;Camkk1;Pde1b;Adcy9;Akt3;Camk2g;Jun;Chd3;Cnot6l;Gatad2b;Hdac1;Rragd;Ago1;Tnrc6b;Nedd4;Flt3;Hdac7;Phc2;Calm1;Cbx6;Prex2;Strn;Pip5k1a;Rptor;Mapk3;Mta2;Pik3cb;Ago2;Fyn;Mta3;Kl;Irs1;Tnks;Fgf5
prerank,Signaling By NOTCH R-HSA-157118,0.5107733508298671,1.198832754996814,0.11891891891891893,0.8380343381860599,1.0,20/186,4.75%,Maml2;Nbea;Maml3;Tnrc6c;Tle1;Notch2;Ncor1;Cntn1;B4galt1;Jun;Smad3;Hdac1;Ywhaz;Ago1;Tnrc6b;Mib1;Hdac7;Psen1;Ncor2;Ago2
prerank,Peptide Hormone Metabolism R-HSA-2980736,-0.6328325412809721,-1.1981088198268262,0.1907356948228883,1.0,1.0,12/79,8.93%,Cpe;Tcf7l2;Pcsk1;Stx1a;Pla2g7;Igf1;Enpep;Kif5a;Aopep;C1qtnf1;Slc30a8;Ucma
prerank,Trafficking Of GluR2-containing AMPA Receptors R-HSA-416993,0.6751401680951268,1.1980964914533705,0.31417624521072796,0.8346403606612188,1.0,4/17,0.56%,Gria1;Gria2;Nsf;Gria3
prerank,DAG And IP3 Signaling R-HSA-1489509,0.6290210511531642,1.1977385962844458,0.2689075630252101,0.8300898472151039,1.0,10/38,1.92%,Prkce;Nbea;Camk2a;Camk2b;Adcy1;Adcy2;Camkk1;Pde1b;Adcy9;Camk2g
prerank,ISG15 Antiviral Mechanism R-HSA-1169408,0.5769613521375929,1.1962301418525052,0.18888888888888888,0.8292101647910572,1.0,8/69,6.90%,Sgip1;Pdzd2;Nedd4;Eif4a2;Mapk3;Eif4g2;Ndc1;Ranbp2
prerank,Beta-catenin Independent WNT Signaling R-HSA-3858494,0.5193367950668233,1.1954748334092455,0.13716814159292035,0.8260172663879997,1.0,11/141,3.01%,Ppp3ca;Prkg1;Camk2a;Tnrc6c;Plcb1;Prickle1;Ppp3r1;Gng7;Gng2;Ago1;Tnrc6b
prerank,MAPK6/MAPK4 Signaling R-HSA-5687128,0.5650839775757538,1.192895356888193,0.17916666666666667,0.8288695169827007,1.0,6/87,3.01%,Kalrn;Tnrc6c;Foxo1;Jun;Ago1;Tnrc6b
prerank,Presynaptic Phase Of Homologous DNA Pairing And Strand Exchange R-HSA-5693616,-0.6873904832020499,-1.1924064521393958,0.2727272727272727,1.0,1.0,6/38,13.56%,Rbbp8;Brip1;Bard1;Top3a;Artn;Xrcc2
prerank,PKA Activation In Glucagon Signaling R-HSA-164378,0.6814003969437539,1.192261710271476,0.3185483870967742,0.8255422348094992,1.0,3/15,1.83%,Adcy1;Adcy2;Adcy9
prerank,Pyroptosis R-HSA-5620971,-0.7179312207543992,-1.190556875160813,0.2489905787348587,1.0,1.0,6/20,18.82%,Casp1;Casp4;Gsdmd;Irf2;Il18;Il1a
prerank,Signaling By NOTCH1 R-HSA-1980143,0.5730585545619754,1.1901359343788,0.2076923076923077,0.8267693642552393,1.0,11/72,4.45%,Maml2;Nbea;Maml3;Tle1;Ncor1;Cntn1;Hdac1;Mib1;Hdac7;Psen1;Ncor2
prerank,MAP Kinase Activation R-HSA-450294,0.5923827401640736,1.1898601024949764,0.21717171717171718,0.8222615994907309,1.0,21/61,8.92%,Mapk1;Map2k1;Map2k6;Jun;Rps6ka2;Mef2c;Tnip2;Fbxw11;Mapk14;Mapk3;Btrc;Map2k4;Mapk10;Irak1;Dusp4;Cul1;Uba52;Skp1;Mef2a;Nfkb1;Mapk7
prerank,TNF Receptor Superfamily (TNFSF) Members Mediating Non-Canonical NF-kB Pathway R-HSA-5676594,-0.721887959229115,-1.1894880994270622,0.2472375690607735,1.0,1.0,8/16,22.05%,Birc3;Tnfsf12;Ltbr;Tnfrsf11a;Traf3;Cd40;Lta;Ltb
prerank,Ca2+ Pathway R-HSA-4086398,0.5823306332298944,1.1890255938394179,0.23076923076923078,0.8194293146136792,1.0,12/60,3.96%,Ppp3ca;Prkg1;Camk2a;Tnrc6c;Plcb1;Ppp3r1;Gng7;Gng2;Ago1;Tnrc6b;Ctnnb1;Calm1
prerank,Caspase Activation Via Extrinsic Apoptotic Signaling Pathway R-HSA-5357769,0.6733527224806046,1.1876806970090343,0.28205128205128205,0.8184028038002613,1.0,3/23,2.94%,Dapk1;Unc5a;Dcc
prerank,Regulation Of Lipid Metabolism By PPARalpha R-HSA-400206,-0.6164812231262655,-1.1876513760669445,0.19787516600265603,1.0,1.0,24/110,15.01%,Tbl1x;Arnt2;Npas2;Fhl2;Hmgcs1;Abca1;Cpt2;Cpt1a;Hmgcr;Smarcd3;Ppargc1a;Hmgcs2;Fdft1;Plin2;Ppara;Pparg;Angptl4;Ahr;Srebf2;Nr1h2;Ncoa3;Rxra;Trib3;Nr1h4
prerank,Cell Surface Interactions At Vascular Wall R-HSA-202733,-0.6202753609419789,-1.187520770802426,0.20178799489144317,1.0,1.0,24/107,13.05%,Mertk;Fn1;Slc7a11;Pik3r1;Jam3;Jam2;Angpt1;Cav1;Cxadr;Mag;L1cam;Slc7a7;Atp1b3;Slc7a10;Selplg;Cd44;Sdc4;Ttf2;Grb7;Selenop;Itga6;Cd74;Slc16a1;Inpp5d
prerank,Surfactant Metabolism R-HSA-5683826,-0.708862457629695,-1.1874312979910644,0.24407252440725244,1.0,1.0,9/22,20.04%,Lmcd1;Zdhhc2;Csf2rb;Adora2b;Ctsh;Adgrf5;Adra2a;Slc34a1;Sftpc
prerank,Chondroitin Sulfate/Dermatan Sulfate Metabolism R-HSA-1793185,-0.6685785996363504,-1.1872258612949176,0.2388888888888889,1.0,1.0,10/48,7.38%,Gpc6;Xylt1;Gpc5;Bcan;Vcan;Chst3;Hspg2;Cspg5;Gpc2;Dcn
prerank,Effects Of PIP2 Hydrolysis R-HSA-114508,0.6683613865653413,1.186792925840394,0.2596899224806202,0.8156319599905939,1.0,7/27,2.39%,Dgkh;Prkce;Dgki;Trpc6;Dgkg;Dagla;Dgkd
prerank,rRNA Processing R-HSA-72312,0.5071810468952775,1.186053765168823,0.14746543778801843,0.8124255951974697,1.0,92/192,22.53%,Xrn2;Rpl10a;Bop1;Rplp1;Rpl15;Rpsa;Rplp0;Exosc8;Riok3;Rpl3;Mrpl13;Rcl1;Rps28;Rpl36a;Rpl4;Rps8;Rpl8;Nop58;Utp4;Wdr12;Senp3;Sppl2a;Rbm28;Rps21;Uba52;Rpl18a;Dnajc5;Heatr1;Riok2;Rrp1b;Rps3;Nol12;Ddx56;Rpl30;Wdr43;Rpl38;Rsl24d1;Rpl41;Rps23;Rpl27a;Rpl9;Rps10;Mtrex;Riok1;Rps13;Ddx47;Fbl;Rps2;Tsr1;Utp15;Dkc1;Rps15;Nop2;Nol6;Rpl26;Gnl3;Ftsj3;Krr1;Wdr36;Rpl18;Wdr3;Rps19;Tbl3;Rpl13a;Rrp9;Emg1;Utp6;Rpl7;Dcaf13;Rpl28;Isg20l2;Nob1;Nip7;Dhx37;Rps29;Nop56;Rpp14;Pelp1;Exosc1;Fau;Rpl36;Rps16;Rps12;Bud23;Rpl35;Thumpd1;Rpl7a;Ebna1bp2;Rpl5;Tsr3;Mphosph10;Bms1
prerank,PPARA Activates Gene Expression R-HSA-1989781,-0.6174942232538064,-1.1852070742741003,0.204,1.0,1.0,24/108,15.01%,Tbl1x;Arnt2;Npas2;Fhl2;Hmgcs1;Abca1;Cpt2;Cpt1a;Hmgcr;Smarcd3;Ppargc1a;Hmgcs2;Fdft1;Plin2;Ppara;Pparg;Angptl4;Ahr;Srebf2;Nr1h2;Ncoa3;Rxra;Trib3;Nr1h4
prerank,Factors Involved In Megakaryocyte Development And Platelet Production R-HSA-983231,0.5423987751059389,1.1845135069031407,0.17903930131004367,0.8121368361360158,1.0,14/109,3.60%,Zfpm2;Dock10;Kif26b;Carmil1;Dock4;Dock11;Ehd3;Phf21a;Dock3;Ehd1;Hdac1;Jmjd1c;Capza2;Cbx5
prerank,Signaling By CSF3 (G-CSF) R-HSA-9674555,-0.6876798265008587,-1.1843761550258423,0.2486910994764398,1.0,1.0,5/28,11.06%,Stat5b;Gab2;Csf3r;Hck;Socs1
prerank,Inositol Phosphate Metabolism R-HSA-1483249,-0.6590100355869917,-1.1841223150992328,0.2674897119341564,1.0,1.0,5/47,6.15%,Plcb4;Plch2;Inppl1;Plcb2;Plcd3
prerank,SARS-CoV-2 Infection R-HSA-9694516,-0.5684090878429258,-1.183038742566828,0.162291169451074,1.0,1.0,14/252,5.97%,Gpc6;Mgat4c;St6gal1;Gpc5;Parp4;Gja1;Parp8;Cav1;Man2a1;Ikbke;Mgat5;Hspg2;Trim25;Zdhhc2
prerank,Gap Junction Trafficking R-HSA-190828,-0.7205603352581968,-1.1823889167702228,0.2601626016260163,1.0,1.0,6/20,9.16%,Gja1;Myo6;Gja3;Dab2;Gjb6;Gjd3
prerank,HIV Transcription Initiation R-HSA-167161,0.5899953943003294,1.1805336201019272,0.26436781609195403,0.8191682666566755,1.0,11/45,12.87%,Gtf2h2;Gtf2h5;Gtf2f2;Ccnh;Gtf2a1;Mnat1;Polr2k;Ercc2;Gtf2f1;Taf15;Polr2e
prerank,Transcriptional Regulation By AP-2 (TFAP2) Family Of Transcription Factors R-HSA-8864260,-0.6900104598128151,-1.180059995683226,0.2742616033755274,1.0,1.0,7/34,7.57%,Kit;Esr1;Tfap2d;Apoe;Kctd1;Egfr;Wwox
prerank,FGFR2 Alternative Splicing R-HSA-6803529,0.6528498427556182,1.179423374057552,0.2673992673992674,0.8174204457179933,1.0,10/25,12.87%,Hnrnph1;Gtf2f2;Rbfox2;Ncbp1;Hnrnpm;Tia1;Tial1;Polr2k;Gtf2f1;Polr2e
prerank,Biological Oxidations R-HSA-211859,-0.6006558836640066,-1.1794167829786304,0.20410783055198972,1.0,1.0,21/141,15.88%,Acss1;Aldh1a1;Arnt2;Tbxas1;Ugp2;Cyp27a1;Maob;Slc38a3;Cyp26b1;Smox;Ggt5;Fmo1;Ahr;Maoa;Gstt2;Ptgs1;Rxra;Glyat;Nr1h4;Slc38a1;Cyp4b1
prerank,HDR Thru Single Strand Annealing (SSA) R-HSA-5685938,-0.6842086082765336,-1.1774101472677723,0.26373626373626374,1.0,1.0,5/35,12.19%,Rbbp8;Brip1;Bard1;Top3a;Artn
prerank,Hedgehog Ligand Biogenesis R-HSA-5358346,-0.640418952307743,-1.1774033209202561,0.2632978723404255,1.0,1.0,2/64,6.11%,Gpc5;Shh
prerank,G Alpha (12/13) Signaling Events R-HSA-416482,0.5721158670263483,1.1772882081087546,0.20717131474103587,0.8190773771498335,1.0,12/76,2.14%,Kalrn;Tiam1;Plekhg5;Abr;Vav3;Rasgrf2;Itsn1;Arhgef4;Fgd4;Arhgef9;Gng7;Gng2
prerank,Defective Homologous Recombination Repair (HRR) Due To BRCA2 Loss Of Function R-HSA-9701190,-0.6786415464234817,-1.1764434567322224,0.2880658436213992,1.0,1.0,6/39,13.56%,Rbbp8;Brip1;Bard1;Top3a;Artn;Xrcc2
prerank,Signaling By Erythropoietin R-HSA-9006335,-0.6985324797498152,-1.175578117952459,0.25103448275862067,1.0,1.0,5/24,8.38%,Stat5b;Pik3r1;Clstn1;Pik3r5;Vav1
prerank,Interconversion Of Nucleotide Di- And Triphosphates R-HSA-499943,0.6541797603963216,1.1738712281459478,0.3,0.8242203356002687,1.0,1/27,0.43%,Ak5
prerank,RORA Activates Gene Expression R-HSA-1368082,-0.7197861836327223,-1.1732466160654023,0.2827868852459016,1.0,1.0,5/18,14.53%,Tbl1x;Cpt1a;Smarcd3;Ppara;Rxra
prerank,Role Of Phospholipids In Phagocytosis R-HSA-2029485,0.6506342628163562,1.1731724689234928,0.3096085409252669,0.821179280802396,1.0,4/21,4.61%,Prkce;Plcg2;Plpp4;Pik3cb
prerank,Signaling By PDGF R-HSA-186797,-0.6585080355522186,-1.1726035785478413,0.25102319236016374,1.0,1.0,14/52,10.44%,Stat5b;Pik3r1;Col4a5;Pdgfd;Pdgfra;Col6a2;Col6a5;Col9a1;Col4a2;Col6a1;Pdgfrb;Grb7;Thbs4;Col4a1
prerank,Sensory Perception R-HSA-9709957,-0.5599094303283252,-1.1725649610896567,0.16928657799274485,1.0,1.0,33/280,7.48%,Ldb2;Gpc6;Pcdh15;Whrn;Gpc5;Epb41l3;Kcnn2;Myo1e;Akr1b10;Cacna2d2;Prkcq;Or51d1;Apoe;Stx1a;Or52i2;Trpm4;Grm4;Xirp2;Or52k2;Gucy2f;Or51e1;Hspg2;Adcy8;Ttr;Plcb2;Ezr;Rbp4;Camkmt;Pde6g;Gsn;Gpc2;Slc24a1;Slc26a5
prerank,EPH-ephrin Mediated Repulsion Of Cells R-HSA-3928665,0.6020836377612951,1.1703087052611643,0.2620967741935484,0.8250917123110771,1.0,5/48,0.75%,Epha7;Tiam1;Epha4;Vav3;Epha6
prerank,Homologous DNA Pairing And Strand Exchange R-HSA-5693579,-0.6735236242149617,-1.169307795330659,0.2981029810298103,1.0,1.0,6/41,13.56%,Rbbp8;Brip1;Bard1;Top3a;Artn;Xrcc2
prerank,Depolymerisation Of Nuclear Lamina R-HSA-4419969,-0.721791342639966,-1.1680689831337805,0.2924137931034483,1.0,1.0,1/15,0.99%,Prkcb
prerank,RAC3 GTPase Cycle R-HSA-9013423,0.5396494954845987,1.1680123056395482,0.200836820083682,0.8270548793039303,1.0,14/90,3.52%,Dock10;Tiam1;Wasf1;Abr;Nckap1;Baiap2;Abi2;Arhgap15;Arhgap39;Arhgap21;Cyfip1;Abi1;Abl2;Slitrk3
prerank,RAS Processing R-HSA-9648002,-0.7167034845277103,-1.1664227497488764,0.2936400541271989,1.0,1.0,2/17,4.25%,Prkcq;Prkg2
prerank,Intrinsic Pathway Of Fibrin Clot Formation R-HSA-140837,-0.7081890080964337,-1.1659699249232938,0.29573590096286106,1.0,1.0,2/19,8.75%,Serpine2;Ttf2
prerank,Interleukin-1 Signaling R-HSA-9020702,0.5235922895416567,1.1657045394909034,0.1951219512195122,0.8289182147490105,1.0,11/109,4.92%,Il1rap;Il1r1;Map2k1;Map2k6;Tnip2;Peli1;Fbxw11;Map3k3;Peli2;Btrc;Map2k4
prerank,Meiotic Recombination R-HSA-912446,-0.6588498665542313,-1.1652253019836913,0.29450261780104714,1.0,1.0,6/42,12.69%,Rbbp8;Top3a;Cdk2;H2ac20;Artn;H3c7
prerank,Resolution Of D-Loop Structures R-HSA-5693537,-0.6842370884991292,-1.1651354319142353,0.2809917355371901,1.0,1.0,6/32,13.56%,Rbbp8;Brip1;Bard1;Top3a;Artn;Xrcc2
prerank,"Interleukin-3, Interleukin-5 And GM-CSF Signaling R-HSA-512988",-0.6626145443245396,-1.1631075253196326,0.29526462395543174,1.0,1.0,11/42,14.02%,Stat5b;Gab2;Pik3r1;Inppl1;Clstn1;Csf2rb;Vav1;Hck;Prkca;Inpp5d;Stat5a
prerank,Resolution Of D-loop Structures Thru Holliday Junction Intermediates R-HSA-5693568,-0.6844575650791149,-1.162434978952509,0.289875173370319,1.0,1.0,6/31,13.56%,Rbbp8;Brip1;Bard1;Top3a;Artn;Xrcc2
prerank,Fatty Acid Metabolism R-HSA-8978868,-0.5827920389780157,-1.1623742210903576,0.23209876543209876,1.0,1.0,34/147,17.45%,Tbxas1;Acot11;Pon2;Acsbg1;Prkaa2;Prkab2;Acsf2;Fa2h;Acsl3;Elovl7;Cpt2;Cpt1a;Crot;Alox12b;Ptgds;Elovl6;Hpgd;Ggt5;Alox5;Crat;Pctp;Pla2g4a;Abcc1;Ptgs1;Decr1;Tecrl;Phyh;Rxra;Cyp4b1;Hsd17b12;Ephx2;Nudt7;Elovl2;Gpx2
prerank,PI-3K cascade:FGFR4 R-HSA-5654720,-0.7173027206556609,-1.1619373629811,0.3161559888579387,1.0,1.0,2/17,2.21%,Pik3r1;Fgf1
prerank,IRS-related Events Triggered By IGF1R R-HSA-2428928,-0.6574558404699746,-1.1614420733016324,0.27671232876712326,1.0,1.0,5/47,3.52%,Gab2;Pik3r1;Fgf1;Fgfr3;Igf1
prerank,RAB Geranylgeranylation R-HSA-8873719,-0.6454151798094078,-1.1611583108688797,0.24114441416893734,1.0,1.0,4/57,3.42%,Rab3c;Rab31;Rab37;Rab3b
prerank,Conversion From APC/C:Cdc20 To APC/C:Cdh1 In Late Anaphase R-HSA-176407,-0.7039963025939614,-1.1594998238009249,0.2925170068027211,1.0,1.0,1/20,1.75%,Cdc14a
prerank,Detoxification Of Reactive Oxygen Species R-HSA-3299685,-0.6870917906645431,-1.1591720446944291,0.309114927344782,1.0,1.0,8/30,17.45%,Gpx7;Nox4;Ncf2;Gpx8;Glyat;Atp7a;Sod3;Gpx2
prerank,"Glutamate Binding, Activation Of AMPA Receptors And Synaptic Plasticity R-HSA-399721",0.6069005589584763,1.1590143206361234,0.28627450980392155,0.8434993140082315,1.0,10/31,3.20%,Gria1;Camk2a;Camk2b;Gria2;Nsf;Gria3;Epb41l1;Camk2g;Cacng8;Tspan7
prerank,Formation Of Incision Complex In GG-NER R-HSA-5696395,0.599463670878834,1.1583678977152105,0.26296296296296295,0.8399509194808568,1.0,7/42,8.25%,Gtf2h2;Gtf2h5;Ccnh;Pias1;Sumo2;Ercc4;Uba52
prerank,RNA Polymerase II Pre-transcription Events R-HSA-674695,0.5485951805246606,1.1578198716695591,0.2510460251046025,0.8363700899395411,1.0,23/74,15.60%,Gtf2h2;Gtf2h5;Aff4;Gtf2f2;Ccnh;Rtf1;Ncbp1;Ccnt2;Ssrp1;Cdk9;Gtf2a1;Mnat1;Tcea1;Polr2k;Ercc2;Gtf2f1;Ccnt1;Taf15;Polr2e;Ctdp1;Taf6;Ccnk;Eloc
prerank,Downstream Signaling Of Activated FGFR4 R-HSA-5654716,-0.6906087988702025,-1.1571068964915758,0.32098765432098764,1.0,1.0,2/23,2.21%,Pik3r1;Fgf1
prerank,FRS-mediated FGFR3 Signaling R-HSA-5654706,-0.7107064758329739,-1.1570231626913983,0.2959889349930844,1.0,1.0,2/17,2.36%,Fgf1;Fgfr3
prerank,IGF1R Signaling Cascade R-HSA-2428924,-0.6525998759177598,-1.1538450104619107,0.28904109589041094,1.0,1.0,5/48,3.52%,Gab2;Pik3r1;Fgf1;Fgfr3;Igf1
prerank,Zinc Transporters R-HSA-435354,0.6516317744414063,1.1526888770045118,0.32661290322580644,0.8467031500014679,1.0,3/17,5.45%,Slc39a6;Slc30a3;Slc39a14
prerank,Constitutive Signaling By Aberrant PI3K In Cancer R-HSA-2219530,-0.6295790320578132,-1.1522484263020398,0.28236914600550966,1.0,1.0,18/72,8.78%,Erbb4;Kit;Esr2;Nrg1;Gab2;Pik3r1;Fgf1;Fgfr3;Esr1;Pdgfra;Clstn1;Erbb3;Cd86;Cd80;Egfr;Vav1;Pdgfrb;Pik3ap1
prerank,Transcriptional Regulation Of Granulopoiesis R-HSA-9616222,-0.6572967074065271,-1.1508547125780848,0.2857142857142857,1.0,1.0,14/45,16.07%,Klf5;Lef1;Csf3r;Fli1;Rara;Cdk2;H2ac20;Myb;Tal1;H3c7;E2f1;Rxra;Runx1;Gata2
prerank,Signaling By Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) R-HSA-2404192,-0.6509592320805357,-1.1503162063350714,0.29532967032967034,1.0,1.0,5/49,3.52%,Gab2;Pik3r1;Fgf1;Fgfr3;Igf1
prerank,Association Of TriC/CCT With Target Proteins During Biosynthesis R-HSA-390471,-0.6649839731223126,-1.1502965525408857,0.30675675675675673,1.0,1.0,2/37,3.12%,Fkbp9;Kif13a
prerank,SHC-mediated cascade:FGFR3 R-HSA-5654704,-0.7115595014104796,-1.1500911213325336,0.32253521126760565,1.0,1.0,2/15,2.36%,Fgf1;Fgfr3
prerank,PI3K/AKT Signaling In Cancer R-HSA-2219528,-0.6081084732234701,-1.1499723758964637,0.2543978349120433,1.0,1.0,20/99,8.78%,Erbb4;Kit;Nr4a1;Esr2;Nrg1;Gab2;Pik3r1;Fgf1;Fgfr3;Esr1;Pdgfra;Clstn1;Erbb3;Prr5;Cd86;Cd80;Egfr;Vav1;Pdgfrb;Pik3ap1
prerank,Pausing And Recovery Of Tat-mediated HIV Elongation R-HSA-167238,0.6157845112297522,1.149456365203158,0.30451127819548873,0.8512742738968629,1.0,11/27,17.68%,Gtf2f2;Ssrp1;Cdk9;Tcea1;Polr2k;Gtf2f1;Ccnt1;Polr2e;Ctdp1;Eloc;Nelfa
prerank,Translation R-HSA-72766,0.47019679729451813,1.148789065353685,0.17801047120418848,0.8484551674561526,1.0,80/256,16.38%,Dtd1;Eif4a2;Rpl10a;Fars2;Rplp1;Eef1a1;Rpl15;Pabpc1;Gspt1;Ssr1;Eif4b;Rpsa;Rplp0;Rpl3;Farsa;Mrpl13;Rps28;Rpl36a;Rpl4;Rps8;Rpl8;Eif5;Rps21;Uba52;Rpl18a;Eif5b;Ssr3;Eef1d;Mrpl53;Rps3;Eef1a2;Rpl30;Mrps25;Mrps17;Ptcd3;Rpl38;Eif4e;Rsl24d1;Rpl41;Srp68;Mrps7;Rps23;Mrpl37;Rpl27a;Rpl9;Rps10;Rps13;Spcs2;Mrpl4;Eef1g;Eif4a1;Tars2;Rps2;Mrps9;Eif3b;Mrpl15;Mrpl49;Gspt2;Rps15;Mrpl32;Mrpl55;Lars2;Mrps18a;Iars2;Eif3a;Eif3f;Mrpl51;Mtif2;Eif3g;Mrps15;Rpl26;Mrps23;Eif3l;Eif3m;Eef2;N6amt1;Rpl18;Mrpl57;Mrpl23;Rps19
prerank,Interferon Alpha/Beta Signaling R-HSA-909733,-0.6396896431252548,-1.1469448243029383,0.28254847645429365,1.0,1.0,24/48,25.80%,Rnasel;Xaf1;Egr1;Irf8;Mx2;Bst2;Ifi35;Socs1;Psmb8;Isg15;Irf2;Ifitm1;Ifitm3;Ifit3;Ifitm2;Oas2;Ptpn1;Isg20;Irf7;Samhd1;Ifit2;Ifi27;Gbp2;Irf4
prerank,Laminin Interactions R-HSA-3000157,-0.6881639912788466,-1.1461830719570374,0.3194070080862534,1.0,1.0,12/22,15.97%,Lama4;Lama2;Itga2;Col18a1;Lama1;Hspg2;Nid1;Itga6;Lamc2;Itga1;Lamc3;Itgb1
prerank,Growth Hormone Receptor Signaling R-HSA-982772,-0.6899558519863381,-1.1456545758992485,0.32333767926988266,1.0,1.0,3/21,3.75%,Socs2;Stat5b;Prlr
prerank,Influenza Viral RNA Transcription And Replication R-HSA-168273,0.5208514722259724,1.1455536986111328,0.2062780269058296,0.8529837929180555,1.0,43/128,17.18%,Rpl10a;Rplp1;Gtf2f2;Rpl15;Rpsa;Rplp0;Rpl3;Ndc1;Mrpl13;Rps28;Rpl36a;Rpl4;Rps8;Ranbp2;Rpl8;Rps21;Uba52;Rpl18a;Rps3;Rpl30;Rpl38;Rsl24d1;Rpl41;Rps23;Rpl27a;Rpl9;Rps10;Rps13;Polr2k;Pom121;Rps2;Nup93;Gtf2f1;Polr2e;Rps15;Rpl26;Gnl3;Nup155;Bloc1s6;Rpl18;Rps19;Rpl13a;Nup54
prerank,Gap Junction Trafficking And Regulation R-HSA-157858,-0.6920607388652753,-1.145351803689215,0.31283422459893045,1.0,1.0,6/22,9.16%,Gja1;Myo6;Gja3;Dab2;Gjb6;Gjd3
prerank,Metabolism Of Porphyrins R-HSA-189445,-0.7047519073488037,-1.1448225998576524,0.3086900129701686,1.0,1.0,4/22,13.48%,Slco2b1;Gusb;Abcc2;Abcc1
prerank,Syndecan Interactions R-HSA-3000170,-0.6994471879294919,-1.1437392075842114,0.3172690763052209,1.0,1.0,10/20,20.76%,Itga2;Vtn;Itgb5;Sdc4;Itga6;Prkca;Itgb1;Sdc2;Itgb3;Sdc1
prerank,FLT3 Signaling R-HSA-9607240,-0.6538064003481059,-1.143701808525236,0.2965986394557823,1.0,1.0,5/36,2.53%,Socs2;Stat5b;Gab2;Pik3r1;Grb10
prerank,Hedgehog On State R-HSA-5632684,-0.6067129622332771,-1.14269030000094,0.2801556420233463,1.0,1.0,13/85,13.54%,Gli3;Gli2;Dzip1;Gpr161;Hhip;Smurf1;Shh;Smox;Gli1;Psmb8;Kif7;Gas1;Evc2
prerank,Interleukin-1 Family Signaling R-HSA-446652,0.500818314687896,1.142622667186987,0.1919191919191919,0.8570042275476486,1.0,13/140,4.92%,Il1rapl1;Il1rap;Il1r1;Map2k1;Map2k6;Smad3;Tnip2;Peli1;Fbxw11;Map3k3;Peli2;Btrc;Map2k4
prerank,VEGFR2 Mediated Cell Proliferation R-HSA-5218921,-0.7010328754226844,-1.1422186262750036,0.32212885154061627,1.0,1.0,2/18,1.60%,Prkcb;Itpr2
prerank,Platelet Aggregation (Plug Formation) R-HSA-76009,-0.6618532098021919,-1.1416543669873334,0.30307262569832405,1.0,1.0,4/35,3.36%,Fn1;Rasgrp1;Rasgrp2;Rapgef3
prerank,Other Semaphorin Interactions R-HSA-416700,0.6371907473127091,1.140930721037689,0.3382899628252788,0.8567758923786193,1.0,3/19,1.28%,Plxna4;Sema5a;Sema6d
prerank,Response Of EIF2AK4 (GCN2) To Amino Acid Deficiency R-HSA-9633012,0.5389259337749318,1.1396859717687795,0.2196078431372549,0.855648912319341,1.0,28/92,12.24%,Rpl10a;Cebpb;Rplp1;Rpl15;Rpsa;Rplp0;Gcn1;Rpl3;Mrpl13;Rps28;Rpl36a;Rpl4;Rps8;Rpl8;Rps21;Uba52;Rpl18a;Rps3;Rpl30;Rpl38;Rsl24d1;Rpl41;Rps23;Rpl27a;Rpl9;Rps10;Rps13;Rps2
prerank,Early Phase Of HIV Life Cycle R-HSA-162594,0.6617599488260957,1.138957763825783,0.36186770428015563,0.8529257715783504,1.0,1/15,0.68%,Sgip1
prerank,Synthesis Of PC R-HSA-1483191,0.6204888542493754,1.136532721049066,0.3029197080291971,0.8555291963828944,1.0,3/27,5.65%,Slc44a5;Slc44a1;Lpin2
prerank,"Tristetraprolin (TTP, ZFP36) Binds And Destabilizes mRNA R-HSA-450513",0.6500652880905909,1.1348407527380038,0.35185185185185186,0.8556465533157763,1.0,7/16,18.18%,Ywhab;Exosc8;Mapkapk2;Tnpo1;Dcp2;Zfp36;Xrn1
prerank,PI3K Cascade R-HSA-109704,-0.6523560670036948,-1.13319268921593,0.3238095238095238,1.0,1.0,4/40,2.36%,Gab2;Pik3r1;Fgf1;Fgfr3
prerank,RHOQ GTPase Cycle R-HSA-9013406,-0.6171245833989684,-1.1326096113519513,0.3010610079575597,1.0,1.0,11/58,6.20%,Cpne8;Dlc1;Cdc42ep3;Cftr;Arhgap26;Gja1;Cav1;Srgap2;Syde1;Iqgap1;Rhoq
prerank,MAPK Family Signaling Cascades R-HSA-5683057,0.45575314597016425,1.130751236267841,0.175,0.8625311616989367,1.0,55/300,5.79%,Kalrn;Lrrc7;Camk2a;Camk2b;Grin2b;Tnrc6c;Rasal2;Nrg3;Rasgrf1;Nrg2;Rasgrf2;Cnksr2;Foxo1;Gfra1;Sptb;Mapk1;Rapgef2;Ptpra;Ncam1;Map2k1;Tgfa;Ptk2;Ppp1cb;Sptbn1;Camk2g;Jun;Gfra2;Ptpn3;Sptbn4;Syngap1;Ksr2;Ago1;Tnrc6b;Ywhab;Actn2;Flt3;Ksr1;Rasgef1a;Calm1;Mapk3;Pik3cb;Ago2;Arhgef7;Fyn;Kl;Irs1;Sptan1;Fgf5;Mras;Gprin1;Paqr3;Nefl;Mpp3;Abhd17c;Araf
prerank,IRS-mediated Signaling R-HSA-112399,-0.6466971069217796,-1.1304844278111883,0.32005494505494503,1.0,1.0,4/43,2.36%,Gab2;Pik3r1;Fgf1;Fgfr3
prerank,Cargo Trafficking To Periciliary Membrane R-HSA-5620920,-0.6351965699476733,-1.129187833332155,0.3077922077922078,1.0,1.0,2/50,2.90%,Asap1;Bbs2
prerank,Signaling By FGFR2 IIIa TM R-HSA-8851708,-0.680881353847028,-1.128218550664695,0.3416666666666667,1.0,1.0,1/19,2.21%,Fgf1
prerank,Degradation Of DVL R-HSA-4641258,0.5517689438726294,1.1263039906750612,0.31851851851851853,0.8708228735112745,1.0,1/55,0.83%,Hecw1
prerank,FCERI Mediated NF-kB Activation R-HSA-2871837,-0.607824336899647,-1.1253669660682482,0.3232189973614776,1.0,1.0,3/76,2.48%,Rasgrp1;Prkcq;Rasgrp2
prerank,Signaling By BMP R-HSA-201451,-0.6631383636414593,-1.1243825285118276,0.359375,1.0,1.0,7/25,9.48%,Bmpr1b;Bmp2;Amhr2;Smurf1;Smad6;Smad9;Acvrl1
prerank,Fcgamma Receptor (FCGR) Dependent Phagocytosis R-HSA-2029480,0.5319699121159354,1.124200880425842,0.26693227091633465,0.872774783573988,1.0,21/80,4.80%,Prkce;Wasf1;Wipf3;Vav3;Nckap1;Baiap2;Abi2;Mapk1;Actr3;Ptk2;Arpc2;Cyfip1;Elmo2;Plcg2;Abi1;Plpp4;Cyfip2;Mapk3;Pik3cb;Arpc1a;Fyn
prerank,Inactivation Of CSF3 (G-CSF) Signaling R-HSA-9705462,-0.6579234192903654,-1.120505732190901,0.3503267973856209,1.0,1.0,6/23,16.65%,Stat5b;Csf3r;Hck;Socs1;Stat5a;Lyn
prerank,Complement Cascade R-HSA-166658,-0.6391346620903406,-1.119773407813213,0.3252032520325203,1.0,1.0,15/40,24.76%,Cfh;Vtn;Masp1;Ttf2;Clu;Cpne2;Cfhr4;Cd81;Cfb;Cd55;C5ar2;C5ar1;Cr2;C8a;C3
prerank,Role Of Nef In HIV-1 Replication And Disease Pathogenesis R-HSA-164952,-0.6599882998746276,-1.1179484954890082,0.3551532033426184,1.0,1.0,4/25,9.16%,Elmo1;Ap2b1;Hck;Dock2
prerank,Signaling By ERBB2 ECD Mutants R-HSA-9665348,-0.6846770069289217,-1.1172329348687784,0.36551724137931035,1.0,1.0,2/15,7.28%,Pik3r1;Egfr
prerank,Selenoamino Acid Metabolism R-HSA-2408522,0.5216055127772552,1.1147231315507646,0.2446351931330472,0.8962912331665127,1.0,30/99,12.24%,Rpl10a;Rplp1;Rpl15;Rpsa;Rplp0;Rpl3;Mrpl13;Rps28;Rpl36a;Rpl4;Rps8;Rpl8;Eefsec;Rps21;Uba52;Txnrd1;Rpl18a;Papss1;Rps3;Rpl30;Sephs2;Rpl38;Rsl24d1;Rpl41;Rps23;Rpl27a;Rpl9;Rps10;Rps13;Rps2
prerank,Activation Of IRF3/IRF7 Mediated By TBK1/IKK Epsilon R-HSA-936964,-0.6813009099657901,-1.114635755497085,0.3512396694214876,1.0,1.0,6/16,20.44%,Ikbke;Tlr4;Sarm1;Traf3;Ticam1;Irf7
prerank,Common Pathway Of Fibrin Clot Formation R-HSA-140875,-0.6724750638782534,-1.113773028305173,0.37006802721088433,1.0,1.0,2/19,8.75%,Serpine2;Ttf2
prerank,Activated NOTCH1 Transmits Signal To Nucleus R-HSA-2122948,-0.6525013911094213,-1.1131313777261918,0.3469387755102041,1.0,1.0,2/30,3.43%,Dner;Dlk1
prerank,Ca-dependent Events R-HSA-111996,0.5901731016773669,1.1129801456488024,0.36363636363636365,0.8966135679224426,1.0,10/34,1.92%,Nbea;Camk2a;Camk2b;Adcy1;Adcy2;Mapk1;Camkk1;Pde1b;Adcy9;Camk2g
prerank,Downstream Signaling Events Of B Cell Receptor (BCR) R-HSA-1168372,0.5317138191349805,1.109971208629654,0.29707112970711297,0.901276699228376,1.0,4/79,3.96%,Ppp3ca;Ppp3r1;Fbxw11;Calm1
prerank,Signaling By WNT In Cancer R-HSA-4791275,-0.6380729821302122,-1.10843754620694,0.3510204081632653,1.0,1.0,4/32,9.81%,Tcf7l2;Fzd4;Ppp2r5a;Fzd6
prerank,Nuclear Envelope Breakdown R-HSA-2980766,-0.6205218565991412,-1.1079411512324873,0.36820652173913043,1.0,1.0,2/49,1.56%,Prkcb;Vrk2
prerank,Aquaporin-mediated Transport R-HSA-445717,0.5708215015121103,1.107127416566736,0.3466666666666667,0.9045524837458571,1.0,6/42,2.14%,Adcy1;Adcy2;Myo5b;Adcy9;Gng7;Gng2
prerank,Nuclear Events Stimulated By ALK Signaling In Cancer R-HSA-9725371,-0.680341458888676,-1.105252586095516,0.37158469945355194,1.0,1.0,2/18,1.06%,Alk;Fn1
prerank,"Formation Of Ternary Complex, And Subsequently, 43S Complex R-HSA-72695",0.5623037563848063,1.1019691959405684,0.32950191570881227,0.9141816106234419,1.0,23/45,21.77%,Rpsa;Rps28;Rps8;Rps21;Rps3;Rps23;Rps10;Rps13;Rps2;Eif3b;Rps15;Eif3a;Eif3f;Eif3g;Eif3l;Eif3m;Rps19;Eif3k;Rps29;Fau;Rps16;Rps12;Eif3i
prerank,Metabolism Of Water-Soluble Vitamins And Cofactors R-HSA-196849,-0.5644768308408843,-1.0994610485239955,0.31666666666666665,1.0,1.0,16/113,13.84%,Enpp2;Parp4;Parp8;Enpp3;Aldh1l1;Aox1;Cyb5a;Ppcs;Ldlrap1;Tcn2;Cblif;Cd38;Tpk1;Abcc1;Sp8;Acp5
prerank,TCF Dependent Signaling In Response To WNT R-HSA-201681,-0.5423617973805228,-1.0993049274809537,0.3031055900621118,1.0,1.0,17/182,7.41%,Sox6;Rspo2;Tcf7l2;Tcf7l1;Cxxc4;Ccdc88c;Lef1;Lgr5;Fzd2;Cav1;Fzd4;Tle3;Tle2;Tcf7;Sox2;Ppp2r5a;Sox4
prerank,RAC1 GTPase Cycle R-HSA-9013149,0.46546463541357885,1.0990622008494955,0.26011560693641617,0.9178421499753218,1.0,27/175,3.19%,Dock10;Kalrn;Iqgap2;Tiam1;Wasf1;Abr;Wipf3;Vav3;Rasgrf2;Nckap1;Baiap2;Arhgap20;Dock4;Dock11;Arhgef4;Abi2;Arhgef25;Cdc42bpa;Arhgap15;Arhgap39;Arhgap21;Dock3;Cyfip1;Spata13;Abi1;Abl2;Nisch
prerank,Regulation Of Complement Cascade R-HSA-977606,-0.6380509184537919,-1.0989810718045732,0.37027027027027026,1.0,1.0,14/33,24.76%,Cfh;Vtn;Ttf2;Clu;Cpne2;Cfhr4;Cd81;Cfb;Cd55;C5ar2;C5ar1;Cr2;C8a;C3
prerank,TGF-beta Receptor Signaling In EMT (Epithelial To Mesenchymal Transition) R-HSA-2173791,0.6303192032159646,1.098078134703098,0.4,0.9158390786318691,1.0,2/16,1.05%,Pard3;Tgfbr1
prerank,Phototransduction Cascade R-HSA-2514856,-0.6359852389352736,-1.0971061420985324,0.3726541554959786,1.0,1.0,8/28,14.84%,Prkcq;Gucy2f;Camkmt;Pde6g;Slc24a1;Nmt2;Prkca;Pde6b
prerank,Cellular Response To Heat Stress R-HSA-3371556,0.5120897147637121,1.0956076749992614,0.30327868852459017,0.9187883097261802,1.0,10/92,5.12%,Camk2a;Camk2b;Mapk1;Camk2g;Bag4;Ywhae;Rptor;Mapk3;Eef1a1;Hspa2
prerank,Signaling By FGFR1 R-HSA-5654736,-0.6259483720091826,-1.0955971992244775,0.3736413043478261,1.0,1.0,4/46,2.21%,Flrt2;Pik3r1;Flrt1;Fgf1
prerank,GLI3 Is Processed To GLI3R By Proteasome R-HSA-5610785,-0.5956629255973075,-1.0930966285051185,0.3782722513089005,1.0,1.0,1/58,0.70%,Gli3
prerank,TAK1-dependent IKK And NF-kappa-B Activation R-HSA-445989,-0.6292256950799726,-1.0922670795170808,0.3537859007832898,1.0,1.0,9/41,19.68%,Alpk1;App;Irak2;Nlrc5;Nod2;Nkiras1;Usp14;Rela;Ager
prerank,Vasopressin Regulates Renal Water Homeostasis Via Aquaporins R-HSA-432040,0.5763373787861711,1.0918847251019537,0.35874439461883406,0.9241213407018963,1.0,6/38,2.14%,Adcy1;Adcy2;Myo5b;Adcy9;Gng7;Gng2
prerank,SARS-CoV Infections R-HSA-9679506,-0.5153349250825372,-1.091730968985884,0.3017543859649123,1.0,1.0,21/332,7.35%,Gpc6;Mgat4c;St6gal1;Gpc5;Atp1a2;Parp4;Gja1;S1pr1;Parp8;Cav1;Man2a1;Ikbke;Fxyd1;Mgat5;Hspg2;Trim25;Zdhhc2;Ap2b1;Atp1b3;Masp1;Gpc2
prerank,MicroRNA (miRNA) Biogenesis R-HSA-203927,0.5978429120987865,1.0915099593449404,0.3663003663003663,0.9204465753079503,1.0,7/24,12.87%,Ago1;Dicer1;Ago2;Dgcr8;Ago4;Polr2k;Polr2e
prerank,PI-3K cascade:FGFR2 R-HSA-5654695,-0.6652353622960339,-1.0911613062755854,0.3950617283950617,1.0,1.0,2/21,2.21%,Pik3r1;Fgf1
prerank,Synthesis Of PIPs At Early Endosome Membrane R-HSA-1660516,0.6528822767544966,1.0909032183742302,0.41509433962264153,0.9176408793112014,1.0,1/16,0.73%,Mtmr12
prerank,Synthesis Of Very Long-Chain Fatty acyl-CoAs R-HSA-75876,-0.6468673829814201,-1.0899740300530543,0.3793103448275862,1.0,1.0,9/24,23.00%,Acsbg1;Acsl3;Elovl7;Elovl6;Tecrl;Hsd17b12;Elovl2;Tecr;Elovl4
prerank,TRAF6 Mediated NF-kB Activation R-HSA-933542,-0.6530241321318269,-1.0897430796725007,0.38274932614555257,1.0,1.0,7/22,19.68%,App;Trim25;Ifih1;Nkiras1;Map3k1;Rela;Ager
prerank,Abortive Elongation Of HIV-1 Transcript In Absence Of Tat R-HSA-167242,0.585820757211695,1.086429850930604,0.3888888888888889,0.9266207887417991,1.0,6/21,13.61%,Gtf2f2;Ncbp1;Polr2k;Gtf2f1;Polr2e;Ctdp1
prerank,Collagen Degradation R-HSA-1442490,-0.6304185036149398,-1.0864215379292395,0.3792633015006821,1.0,1.0,9/34,9.39%,Col26a1;Col19a1;Col14a1;Mmp14;Col18a1;Col9a1;Mmp28;Mmp15;Col12a1
prerank,Gene Silencing By RNA R-HSA-211000,0.5166264567953718,1.0857196798887376,0.33755274261603374,0.923941530483985,1.0,11/92,7.67%,Tnrc6c;Ago1;Tnrc6b;Dicer1;Ago2;Ndc1;Ranbp2;Tsnax;H2az1;H2ax;Tsn
prerank,TRP Channels R-HSA-3295583,0.6146005035731974,1.0839638337015838,0.4043321299638989,0.9243871574103042,1.0,2/24,0.34%,Trpm3;Trpc6
prerank,CaM Pathway R-HSA-111997,0.5832602416800896,1.0839427731562514,0.3900414937759336,0.9197349059510519,1.0,9/32,1.92%,Nbea;Camk2a;Camk2b;Adcy1;Adcy2;Camkk1;Pde1b;Adcy9;Camk2g
prerank,Gluconeogenesis R-HSA-70263,-0.6377841433527135,-1.0819012221499562,0.4084124830393487,1.0,1.0,8/27,21.63%,Pck2;Slc25a13;G6pc3;Aldoc;Eno1;Mdh1;Slc37a2;Fbp1
prerank,SLC Transporter Disorders R-HSA-5619102,0.5010438683135808,1.0789508947095108,0.3217391304347826,0.9292132857047992,1.0,6/91,4.69%,Slc4a4;Slc1a1;Slc24a4;Slc9a9;Slc12a6;Slc9a7
prerank,Initiation Of Nuclear Envelope (NE) Reformation R-HSA-2995383,-0.6549264879742396,-1.0781887333382962,0.40555555555555556,1.0,1.0,1/19,1.56%,Vrk2
prerank,Signaling By FGFR R-HSA-190236,-0.5840757302493845,-1.0767041754717224,0.3767123287671233,1.0,1.0,5/80,2.36%,Flrt2;Pik3r1;Flrt1;Fgf1;Fgfr3
prerank,"BMAL1:CLOCK,NPAS2 Activates Circadian Gene Expression R-HSA-1368108",-0.6485376736353177,-1.0764319431029383,0.4,1.0,1.0,6/25,15.36%,Tbl1x;Npas2;Smarcd3;Ppara;Rxra;Klf15
prerank,PI-3K cascade:FGFR1 R-HSA-5654689,-0.6615649849875175,-1.0762672090118817,0.4236111111111111,1.0,1.0,2/19,2.21%,Pik3r1;Fgf1
prerank,Downstream Signaling Of Activated FGFR2 R-HSA-5654696,-0.642109479414375,-1.0761683911620197,0.41046831955922863,1.0,1.0,2/27,2.21%,Pik3r1;Fgf1
prerank,SARS-CoV-2 Modulates Host Translation Machinery R-HSA-9754678,0.5452653137918989,1.0758638358658812,0.3505535055350554,0.9334816260243742,1.0,23/44,21.32%,Rpsa;Rps28;Rps8;Rps21;Gemin8;Rps3;Snrpb;Snrpd3;Rps23;Rps10;Rps13;Rps2;Rps15;Gemin2;Snrpf;Gemin5;Rps19;Smn1;Gemin4;Rps29;Fau;Rps16;Rps12
prerank,Degradation Of Beta-Catenin By Destruction Complex R-HSA-195253,-0.5722771042917243,-1.0755142171165062,0.39113428943937417,1.0,1.0,7/84,6.72%,Tcf7l2;Tcf7l1;Lef1;Tle3;Tle2;Tcf7;Ppp2r5a
prerank,Meiotic Synapsis R-HSA-1221632,0.5514771689967436,1.075318989144745,0.3958333333333333,0.9303128398678014,1.0,11/46,11.12%,Syne1;Hspa2;H2az1;H2ax;Terf2;Smc1b;Dido1;Rec8;H2ac4;Stag2;H2ac6
prerank,Signaling By NODAL R-HSA-1181150,0.6046962459762554,1.0741878360250745,0.38549618320610685,0.9291920423329997,1.0,5/20,5.17%,Mapk1;Acvr2a;Smad3;Mapk3;Acvr1c
prerank,RAF Activation R-HSA-5673000,0.5862917353937411,1.07372938379552,0.3595505617977528,0.9258977925403893,1.0,8/30,3.96%,Camk2a;Camk2b;Map2k1;Ppp1cb;Camk2g;Ywhab;Ksr1;Calm1
prerank,SUMOylation Of Transcription Cofactors R-HSA-3899300,0.5566268629290828,1.0736884308268353,0.3553113553113553,0.921429484039948,1.0,13/40,8.50%,Mrtfa;Ddx5;Uhrf2;Phc2;Ncor2;Pias1;Sumo2;Crebbp;Ncoa1;Cbx4;Npm1;Phc3;Trim28
prerank,Interferon Gamma Signaling R-HSA-877300,0.5203340594301779,1.0731885154101137,0.3686440677966102,0.9183560204675305,1.0,7/64,2.43%,Camk2a;Camk2b;Bcl11b;Ncam1;Camk2g;Trim2;Trim46
prerank,Interferon Signaling R-HSA-913531,0.4614794028015401,1.072839304434136,0.3177570093457944,0.9149876207945042,1.0,11/153,3.67%,Camk2a;Camk2b;Bcl11b;Sgip1;Pdzd2;Ncam1;Camk2g;Trim2;Trim46;Nedd4;Eif4a2
prerank,Purine Catabolism R-HSA-74259,0.6307453721232064,1.0725577931509016,0.4083969465648855,0.9113198583914034,1.0,2/15,3.80%,Gda;Nt5c2
prerank,RUNX1 Interacts With Co-Factors Whose Precise Effect On RUNX1 Targets Is Not Known R-HSA-8939243,0.5670896655283278,1.0692199329657515,0.40540540540540543,0.9160139181799896,1.0,10/34,8.08%,Arid1b;Smarca2;Phc2;Smarcd2;Cbfb;Smarca4;Cbx6;Arid2;Cbx4;Phc3
prerank,ABC-family Proteins Mediated Transport R-HSA-382556,-0.5613069657905253,-1.0686703727987037,0.3680104031209363,1.0,1.0,10/97,13.48%,Abca9;Cftr;Abca6;Abcc2;Derl3;Abcc9;Abcb9;Psmb8;Abca7;Abcc1
prerank,Amino Acid Transport Across Plasma Membrane R-HSA-352230,-0.6145230852830796,-1.0670598877397441,0.3932885906040268,1.0,1.0,13/31,16.12%,Slc7a11;Slc7a2;Slc7a7;Slc38a3;Slc7a10;Slc36a1;Slc38a4;Slc7a1;Slc1a5;Slc38a2;Slc3a1;Slc38a1;Slc7a3
prerank,Sema3A PAK Dependent Axon Repulsion R-HSA-399954,0.6134518416955845,1.0670557096118656,0.38571428571428573,0.9179872111648063,1.0,2/16,0.70%,Plxna4;Nrp1
prerank,RAC2 GTPase Cycle R-HSA-9013404,0.48787322459662785,1.0652594711659513,0.3110236220472441,0.9190884798569899,1.0,12/86,2.88%,Dock10;Tiam1;Abr;Vav3;Nckap1;Dock4;Abi2;Arhgap39;Arhgap21;Dock3;Cyfip1;Abi1
prerank,Insulin Receptor Signaling Cascade R-HSA-74751,-0.6034071021077211,-1.0637046938149606,0.4100817438692098,1.0,1.0,5/48,2.53%,Gab2;Pik3r1;Fgf1;Fgfr3;Grb10
prerank,"Inactivation, Recovery And Regulation Of Phototransduction Cascade R-HSA-2514859",-0.6192262821845487,-1.0626540662717083,0.42914438502673796,1.0,1.0,7/27,14.84%,Prkcq;Gucy2f;Camkmt;Pde6g;Nmt2;Prkca;Pde6b
prerank,Formation Of Fibrin Clot (Clotting Cascade) R-HSA-140877,-0.6035710727848966,-1.062140090974425,0.41152815013404825,1.0,1.0,3/33,8.75%,Serpine2;F3;Ttf2
prerank,Transcriptional Regulation By TP53 R-HSA-3700989,0.4116487886192568,1.0619213669147398,0.24342105263157895,0.924406902914825,1.0,34/330,4.81%,Tnrc6c;Ppp1r13b;Pdzd2;Prkag2;Chd4;Map2k6;Akt3;Cnot2;Bcl6;Jun;Gtf2h2;Chd3;Usp2;Cnot6l;Gatad2b;Hdac1;Rragd;Ywhaz;Ago1;Tnrc6b;Cdk5r1;Ywhah;Ywhab;Cdk12;Mapk14;Ywhae;Gtf2h5;Steap3;Kmt5a;Rptor;Mta2;Gtf2f2;Ago2;Ccnh
prerank,Glucagon Signaling In Metabolic Regulation R-HSA-163359,0.5731230913205544,1.061711191972774,0.3991228070175439,0.9206450607613276,1.0,5/31,2.14%,Adcy1;Adcy2;Adcy9;Gng7;Gng2
prerank,Interleukin-17 Signaling R-HSA-448424,0.5122075051721044,1.06139029530013,0.3459715639810427,0.9171652064620326,1.0,21/68,8.92%,Mapk1;Map2k1;Map2k6;Jun;Rps6ka2;Mef2c;Tnip2;Fbxw11;Mapk14;Mapk3;Btrc;Map2k4;Mapk10;Irak1;Dusp4;Cul1;Uba52;Skp1;Mef2a;Nfkb1;Mapk7
prerank,Metabolism Of Amino Acids And Derivatives R-HSA-71291,-0.49278356811962537,-1.0579596618103597,0.3554006968641115,1.0,1.0,51/340,17.88%,Slc6a7;Dio2;Carns1;Ass1;Gadl1;Aspa;Gatm;Folh1;Ido2;Glul;Tyr;Aass;Dmgdh;Sdsl;Naalad2;Pcbd1;Acmsd;Arg2;Slc25a13;Tph2;Pipox;Gldc;Atat1;Smox;Bcat1;Hnmt;Dhtkd1;Slc6a11;Psmb8;Ckb;Otc;Sqor;Glud1;Serinc2;Bckdhb;Pah;Rpl3l;Ethe1;Agxt2;Ldhd;Slc38a1;Psat1;Aspg;Dct;Ftcd;Asrgl1;Heca;Psma8;Aldh6a1;Ckm;Duox1
prerank,Extracellular Matrix Organization R-HSA-1474244,-0.5040973747348538,-1.0567179278554333,0.3746958637469586,1.0,1.0,64/269,9.39%,Ltbp1;Adamts2;Scube1;Ntn4;Dmd;Itga9;Fn1;Adamts16;Col26a1;Nrxn1;Lama4;Col8a1;Bcan;Col27a1;Lrp4;P4ha3;Jam3;Jam2;Col4a5;Lama2;Col28a1;Bmp2;Itga2;Col19a1;Adam19;Col14a1;Mmp14;Vcan;Htra1;Col18a1;Col6a2;Lama1;Col1a2;Adam12;Hspg2;Capn2;Col6a5;Ttr;Col9a1;Efemp2;Ltbp3;Nid1;Ddr2;Col4a2;Adamts5;Timp2;Hapln1;Vtn;P3h2;Col6a1;Dcn;Col3a1;Tgfb3;Cd44;Mmp28;Bmp4;Tnn;Pcolce;Fbln5;Itgb5;Sdc4;Itgad;Mmp15;Col12a1
prerank,Regulation Of Cholesterol Biosynthesis By SREBP (SREBF) R-HSA-1655829,-0.5966406015689387,-1.0566548343628699,0.42971887550200805,1.0,1.0,12/53,14.80%,Tbl1x;Hmgcs1;Sqle;Hmgcr;Smarcd3;Fdft1;Elovl6;Ppara;Srebf2;Lmbr1;Rxra;Gpam
prerank,CD28 Dependent PI3K/Akt Signaling R-HSA-389357,-0.6281538363027321,-1.0565065895950312,0.42441054091539526,1.0,1.0,4/22,7.12%,Pik3r1;Prr5;Cd86;Cd80
prerank,Fatty acyl-CoA Biosynthesis R-HSA-75105,-0.6093008756385581,-1.056113745419673,0.44129554655870445,1.0,1.0,10/33,23.00%,Acsbg1;Acsl3;Elovl7;Elovl6;Tecrl;Hsd17b12;Elovl2;Tecr;Acaca;Elovl4
prerank,HDR Thru Homologous Recombination (HRR) R-HSA-5685942,-0.5762820467653561,-1.0535143846113948,0.42245989304812837,1.0,1.0,6/64,13.56%,Rbbp8;Brip1;Bard1;Top3a;Artn;Xrcc2
prerank,Aggrephagy R-HSA-9646399,-0.6215014322939908,-1.053330141699812,0.45125348189415043,1.0,1.0,1/23,1.72%,Cftr
prerank,NoRC Negatively Regulates rRNA Expression R-HSA-427413,0.5194425847976982,1.052017370422493,0.38114754098360654,0.9394862510695681,1.0,20/62,13.62%,Gtf2h2;Hdac1;Ubtf;Gtf2h5;Ccnh;H2az1;Baz2a;H2ax;Dnmt1;Smarca5;Polr1h;H2ac4;Hdac2;Mnat1;H2ac6;Suds3;Polr2k;Ercc2;Polr2e;Arid4b
prerank,Transcriptional Regulation By RUNX1 R-HSA-8878171,-0.5271895262312687,-1.0510763121504125,0.3811881188118812,1.0,1.0,6/184,2.57%,Ldb2;Prkcb;Tcf7l1;Prkcq;Esr1;Nr4a3
prerank,Diseases Of Glycosylation R-HSA-3781865,-0.5253469395025111,-1.050995448344527,0.3940520446096654,1.0,1.0,21/136,7.51%,Gpc6;Thsd4;Adamtsl1;Gpc5;Adamts2;Ext1;Adamts16;Bcan;B3glct;Lfng;Vcan;Prelp;Chst3;Hspg2;Cspg5;Adamts12;Adamts5;Notch3;Gpc2;Dcn;Adamts6
prerank,Nicotinate Metabolism R-HSA-196807,-0.6116767516095956,-1.0453194017892962,0.45616438356164385,1.0,1.0,2/30,2.98%,Parp4;Parp8
prerank,FCGR3A-mediated IL10 Synthesis R-HSA-9664323,0.5553002294251351,1.0441128316674508,0.4263565891472868,0.9569193016320705,1.0,11/32,7.58%,Adcy1;Adcy2;Adcy9;Plcg2;Calm1;Fyn;Itpr1;Src;Prkar1a;Prkacb;Prkar2b
prerank,Selective Autophagy R-HSA-9663891,-0.5677801972616832,-1.0436461135456463,0.4326424870466321,1.0,1.0,5/59,4.03%,Cftr;Mfn1;Prkaa2;Epas1;Prkab2
prerank,CRMPs In Sema3A Signaling R-HSA-399956,0.5864978356740674,1.0429829397425558,0.44074074074074077,0.9555883715001531,1.0,2/16,0.70%,Plxna4;Nrp1
prerank,Interleukin-4 And Interleukin-13 Signaling R-HSA-6785807,-0.542404336649911,-1.042928176998721,0.4167741935483871,1.0,1.0,31/95,21.34%,Bcl2;Fn1;Pik3r1;S1pr1;Nanos2;Col1a2;Oprd1;Sox2;Tnfrsf1b;Anxa1;Alox5;Socs1;Vegfa;Maoa;Icam1;Mmp2;Il17f;Itgb1;Il18;Rorc;Muc1;Ccnd1;Lama5;Itgam;Vcam1;Il1a;Il23a;Vim;Itgb2;Twist1;Oprm1
prerank,KSRP (KHSRP) Binds And Destabilizes mRNA R-HSA-450604,0.6066125067599373,1.0425202273678702,0.4524714828897338,0.9526359411875498,1.0,4/16,5.78%,Ywhaz;Mapk14;Khsrp;Exosc8
prerank,RAF/MAP Kinase Cascade R-HSA-5673001,0.4262957754721484,1.0421917917731782,0.3181818181818182,0.9491549134151507,1.0,47/257,5.79%,Lrrc7;Camk2a;Camk2b;Grin2b;Rasal2;Nrg3;Rasgrf1;Nrg2;Rasgrf2;Cnksr2;Gfra1;Sptb;Mapk1;Rapgef2;Ptpra;Ncam1;Map2k1;Tgfa;Ptk2;Ppp1cb;Sptbn1;Camk2g;Gfra2;Ptpn3;Sptbn4;Syngap1;Ksr2;Ywhab;Actn2;Flt3;Ksr1;Rasgef1a;Calm1;Mapk3;Pik3cb;Fyn;Kl;Irs1;Sptan1;Fgf5;Mras;Gprin1;Paqr3;Nefl;Mpp3;Abhd17c;Araf
prerank,PCP/CE Pathway R-HSA-4086400,-0.5535468140545647,-1.0420774335783232,0.42650918635170604,1.0,1.0,13/88,14.45%,Prkcb;Fzd2;Fzd4;Smurf1;Ap2b1;Prkcg;Fzd9;Wnt5a;Fzd6;Psmb8;Prkca;Wnt5b;Ncoa3
prerank,RND2 GTPase Cycle R-HSA-9696270,-0.5855186321777157,-1.0419005011423108,0.4276315789473684,1.0,1.0,6/41,7.44%,Pik3r1;Fam83b;Cav1;Prag1;Plxnd1;Kif14
prerank,MAPK1/MAPK3 Signaling R-HSA-5684996,0.42531662317546004,1.0417213364982334,0.3181818181818182,0.9462345638245887,1.0,47/262,5.79%,Lrrc7;Camk2a;Camk2b;Grin2b;Rasal2;Nrg3;Rasgrf1;Nrg2;Rasgrf2;Cnksr2;Gfra1;Sptb;Mapk1;Rapgef2;Ptpra;Ncam1;Map2k1;Tgfa;Ptk2;Ppp1cb;Sptbn1;Camk2g;Gfra2;Ptpn3;Sptbn4;Syngap1;Ksr2;Ywhab;Actn2;Flt3;Ksr1;Rasgef1a;Calm1;Mapk3;Pik3cb;Fyn;Kl;Irs1;Sptan1;Fgf5;Mras;Gprin1;Paqr3;Nefl;Mpp3;Abhd17c;Araf
prerank,Integration Of Energy Metabolism R-HSA-163685,0.4854926562893818,1.0399928114193975,0.3880597014925373,0.9466295703631232,1.0,14/102,2.54%,Cacna1e;Cacna1c;Cacnb2;Adcy1;Adcy2;Plcb1;Cacna1d;Prkag2;Gnaq;Adcy9;Gng7;Gng2;Kcng2;Abcc8
prerank,Negative Epigenetic Regulation Of rRNA Expression R-HSA-5250941,0.5138628542654705,1.0382794782800455,0.3949579831932773,0.9468409244148542,1.0,20/65,13.62%,Gtf2h2;Hdac1;Ubtf;Gtf2h5;Ccnh;H2az1;Baz2a;H2ax;Dnmt1;Smarca5;Polr1h;H2ac4;Hdac2;Mnat1;H2ac6;Suds3;Polr2k;Ercc2;Polr2e;Arid4b
prerank,SUMOylation Of DNA Damage Response And Repair Proteins R-HSA-3108214,0.509581095796213,1.0376690064063359,0.4,0.9443619560525078,1.0,15/71,12.68%,Herc2;Hdac7;Phc2;Pias1;Sumo2;Ndc1;Cbx4;Rad52;Ranbp2;Phc3;Nsmce4a;Stag2;Pom121;Nup93;Rnf2
prerank,Downstream Signal Transduction R-HSA-186763,-0.6143029425934557,-1.0375640622212834,0.4696969696969697,1.0,1.0,7/28,14.19%,Stat5b;Pik3r1;Pdgfra;Pdgfrb;Grb7;Stat5a;Pdgfb
prerank,O-linked Glycosylation Of Mucins R-HSA-913709,-0.572613286170427,-1.0366353352352229,0.4385245901639344,1.0,1.0,5/50,4.36%,Galntl6;St6gal1;Galnt6;Galnt9;B3gnt5
prerank,Formation Of beta-catenin:TCF Transactivating Complex R-HSA-201722,-0.5838721779985536,-1.0363806767410775,0.4550408719346049,1.0,1.0,6/47,6.01%,Tcf7l2;Tcf7l1;Lef1;Tle3;Tle2;Tcf7
prerank,Signaling By BRAF And RAF1 Fusions R-HSA-6802952,0.5191633559138639,1.0354270082183248,0.3614457831325301,0.9463820352455102,1.0,15/59,4.65%,Camk2a;Camk2b;Cnksr2;Ap3b1;Mapk1;Kdm7a;Map2k1;Camk2g;Ksr2;Mprip;Ywhab;Ksr1;Calm1;Mapk3;Fam114a2
prerank,RHOB GTPase Cycle R-HSA-9013026,-0.5624922922101474,-1.034339703484292,0.4426002766251729,1.0,1.0,9/68,4.57%,Dlc1;Pcdh7;Pik3r1;Arhgap26;Vav2;Cav1;Anln;Mcf2;Akap13
prerank,Post-translational Modification: Synthesis Of GPI-anchored Proteins R-HSA-163125,0.4878669476705193,1.0341624141060144,0.40082644628099173,0.9454775360526941,1.0,8/72,3.56%,Negr1;Cntn5;Lsamp;Nrn1;Ntng2;Rtn4rl1;Gpld1;Sprn
prerank,Biosynthesis Of N-glycan Precursor (Dolichol LLO) And Transfer To Protein R-HSA-446193,-0.549108631437654,-1.0332375296911926,0.4309677419354839,1.0,1.0,10/77,9.74%,St8sia5;St6gal1;St6gal2;St3gal6;Gfpt2;St8sia2;St8sia6;Alg14;Uap1;Renbp
prerank,Paracetamol ADME R-HSA-9753281,-0.6071986404555937,-1.0321035476157217,0.46195652173913043,1.0,1.0,5/21,15.82%,Slc38a3;Abcc2;Ggt5;Abcc1;Slc38a1
prerank,GPER1 Signaling R-HSA-9634597,0.5249559378946794,1.0315493219153202,0.3898305084745763,0.9488086495078176,1.0,5/41,2.14%,Adcy1;Adcy2;Adcy9;Gng7;Gng2
prerank,Opioid Signaling R-HSA-111885,0.4886869089507391,1.0308416533642843,0.3876651982378855,0.9465811961749415,1.0,18/86,2.17%,Ppp3ca;Nbea;Camk2a;Camk2b;Adcy1;Adcy2;Plcb1;Gnal;Mapk1;Gnaq;Camkk1;Pde1b;Ppp3r1;Adcy9;Gng7;Camk2g;Gng2;Pde4a
prerank,Antiviral Mechanism By IFN-stimulated Genes R-HSA-1169410,0.49554821179450975,1.0287523024313354,0.41923076923076924,0.9482528055194736,1.0,11/75,8.79%,Sgip1;Pdzd2;Nedd4;Eif4a2;Mapk3;Eif4g2;Ndc1;Ranbp2;Uba52;Abce1;Pde12
prerank,IRAK4 Deficiency (TLR2/4) R-HSA-5603041,-0.6342213140010176,-1.028514466486526,0.4675862068965517,1.0,1.0,7/17,23.96%,Irak4;Myd88;S100a1;Tlr1;Tlr4;Btk;Tlr6
prerank,Immunoregulatory Interactions Between A Lymphoid And A non-Lymphoid Cell R-HSA-198933,-0.5519832408411375,-1.0279619191177767,0.4487534626038781,1.0,1.0,25/73,21.78%,Kir3dl2;Colec12;Clec2d;Cxadr;Crtam;Cd200r1;Cd160;Lair1;Icam1;Fcgr2b;Cd81;Ifitm1;Nectin2;Cd96;Itgb1;Cd200;Cd300lg;Oscar;Vcam1;Raet1e;Itgal;Cd40;Itgb2;Treml4;Slamf7
prerank,Mitochondrial Fatty Acid Beta-Oxidation R-HSA-77289,-0.5876628453990023,-1.026704080118925,0.4671916010498688,1.0,1.0,7/34,20.81%,Acot11;Acsf2;Pctp;Decr1;Acot9;Acadl;Acsm3
prerank,Diseases Associated With TLR Signaling Cascade R-HSA-5602358,-0.6087900079442756,-1.0259015643121443,0.4891304347826087,1.0,1.0,12/29,23.96%,Irak4;Tlr3;Myd88;S100a1;Tlr1;Rela;Tlr4;Traf3;Tlr5;Ticam1;Btk;Tlr6
prerank,HSF1-dependent Transactivation R-HSA-3371571,0.554015974376114,1.0244868188170915,0.45714285714285713,0.9566107984287973,1.0,3/34,1.92%,Camk2a;Camk2b;Camk2g
prerank,Disassembly Of Destruction Complex And Recruitment Of AXIN To Membrane R-HSA-4641262,-0.6000955643355611,-1.0243371995876025,0.4748299319727891,1.0,1.0,3/28,6.72%,Fzd2;Cav1;Ppp2r5a
prerank,Signaling By Receptor Tyrosine Kinases R-HSA-9006934,0.3924418953427076,1.023697068217749,0.36363636363636365,0.954591589277959,1.0,72/478,5.04%,Prkce;Ntrk3;Gabrb3;Tiam1;Gabrb1;Ptk2b;Bcl11b;Grin2b;Wasf1;Nrg3;Vav3;Nrg2;Pcsk5;Nrp1;Nckap1;Ptprj;Gabrb2;Baiap2;Ntf3;Abi2;Mapk1;Gabrg2;Ptprk;Chd4;Map2k1;Tgfa;Adcyap1r1;Ptk2;Ncor1;Akt3;Nrp2;Dock3;Mef2d;Cyfip1;Ptpn3;Cbl;Lamc1;Atp6v1a;Tcf12;Rit2;Rps6ka2;Nck2;Elmo2;Hdac1;Mef2c;Sh3gl1;Syngap1;Abi1;Dnm1;Thbs3;Cdk5r1;Nedd4;Ywhab;Flt3;Cul5;Ctnnb1;Mapk14;Lamb1;Calm1;Cyfip2;Hnrnph1;Psen1;Mapk3;Pik3cb;Gtf2f2;Matk;Diaph1;Arhgef7;Fyn;Rock1;Rbfox2;Kl
prerank,FRS-mediated FGFR4 Signaling R-HSA-5654712,-0.6277456148489411,-1.023542410802072,0.5034387895460798,1.0,1.0,3/18,14.45%,Fgf1;Fgf16;Fgf17
prerank,Signaling By FGFR2 In Disease R-HSA-5655253,-0.5867057943860069,-1.0234143666153603,0.45379310344827584,1.0,1.0,2/40,2.21%,Pik3r1;Fgf1
prerank,Synthesis Of Substrates In N-glycan Biosythesis R-HSA-446219,-0.5566844240721409,-1.023380481488357,0.44152431011826543,1.0,1.0,6/63,5.60%,St8sia5;St6gal1;St6gal2;St3gal6;Gfpt2;St8sia2
prerank,SHC-mediated cascade:FGFR4 R-HSA-5654719,-0.6291666280847568,-1.020856224632488,0.4937062937062937,1.0,1.0,3/16,14.45%,Fgf1;Fgf16;Fgf17
prerank,Signaling By Nuclear Receptors R-HSA-9006931,-0.4956773164885308,-1.0205470625278412,0.44619105199516323,1.0,1.0,44/229,15.12%,Erbb4;Bcl2;Aldh1a1;Tbl1x;Esr2;Arl4c;Pik3r1;Esr1;Gng4;Cav1;Apoe;Kank1;Abca1;Gnai1;Tle3;Rara;Cpt1a;Nrip1;Kat2b;Kdm1b;Egfr;Kcnh8;Aldh1a3;Cyp26b1;Gnb4;Aldh8a1;Gnai2;H2ac20;Myb;Gng12;Greb1;Kdm3a;Gng3;H3c7;Rxrg;Nr1h2;Ncoa3;Pdk4;Rxra;Sphk1;Cav2;Gpam;Mmp2;Ldhd
prerank,Fc Epsilon Receptor (FCERI) Signaling R-HSA-2454202,0.4479329677677112,1.0205307067228424,0.38495575221238937,0.9595940846024902,1.0,13/127,4.92%,Ppp3ca;Vav3;Mapk1;Ppp3r1;Jun;Plcg2;Fbxw11;Calm1;Mapk3;Pik3cb;Fyn;Btrc;Map2k4
prerank,Signaling By NTRK3 (TRKC) R-HSA-9034015,0.5851483671716557,1.018698796121867,0.46691176470588236,0.960318756246279,1.0,2/16,1.00%,Ntrk3;Ntf3
prerank,Telomere Extension By Telomerase R-HSA-171319,-0.6026859331152281,-1.0146867808118325,0.49865951742627346,1.0,1.0,4/22,18.76%,Ankrd28;Cdk2;Pif1;Terf1
prerank,Regulation Of KIT Signaling R-HSA-1433559,-0.6250727643645946,-1.014431867726994,0.48840381991814463,1.0,1.0,1/15,0.80%,Kit
prerank,Chromatin Modifying Enzymes R-HSA-3247509,0.41976912527473004,1.01182112023031,0.35,0.9756791713382891,1.0,55/218,10.41%,Kat6b;Arid1b;Kdm7a;Chd4;Phf21a;Ncor1;Smarca2;Chd3;Gatad2b;Hdac1;Nsd1;Brwd1;Smarcd2;Dot1l;Smarca4;Ash1l;Kmt5a;Ncor2;Mta2;Rbbp5;Mta3;Crebbp;Ncoa1;Aebp2;Arid2;Ezh2;Hdac8;Elp2;Ehmt1;Setd2;H2az1;Setd7;Kmt2c;Kdm4a;H2ax;Rbbp7;Trrap;Kdm2b;Suz12;Zzz3;Setdb1;Nfkb1;Tada1;Rcor1;Kansl1;Brpf3;Smarcd1;Kat7;Wdr77;Msl1;Smyd2;Rbbp4;Eny2;H2ac4;Hdac2
prerank,Cargo Recognition For Clathrin-Mediated Endocytosis R-HSA-8856825,-0.5364167648652699,-1.0068713225353916,0.4891994917407878,1.0,1.0,16/94,8.64%,Syt9;Chrm2;Cftr;Eps15;Fzd4;Syt12;Dab2;Grk3;Sh3gl2;Ap2b1;Syt2;Egfr;Stam2;Tacr1;Ldlrap1;Wnt5a
prerank,Paradoxical Activation Of RAF Signaling By Kinase Inactive BRAF R-HSA-6802955,0.5258012578907362,1.0065499926263344,0.4575645756457565,0.9862979083715439,1.0,11/38,4.58%,Camk2a;Camk2b;Cnksr2;Mapk1;Map2k1;Camk2g;Ksr2;Ywhab;Ksr1;Calm1;Mapk3
prerank,LDL Clearance R-HSA-8964038,-0.6083447237716306,-1.0049123884941507,0.5132867132867133,1.0,1.0,3/16,11.03%,Ap2b1;Ldlrap1;Ldlr
prerank,Metabolism Of Cofactors R-HSA-8978934,-0.614176685105302,-1.0040750036415647,0.49719101123595505,1.0,1.0,5/19,16.43%,Prkg2;Tacr1;Pdss1;Dhfr;Coq3
prerank,Interleukin-2 Family Signaling R-HSA-451927,-0.5686865514436493,-1.003216912087868,0.5006821282401092,1.0,1.0,8/40,7.96%,Stat5b;Gab2;Pik3r1;Inppl1;Clstn1;Il15;Havcr2;Csf2rb
prerank,ERK/MAPK Targets R-HSA-198753,0.5400560761950995,1.0020128217891453,0.4449152542372881,0.9947083750346032,1.0,8/21,8.92%,Mapk1;Rps6ka2;Mef2c;Mapk14;Mapk3;Dusp4;Mef2a;Mapk7
prerank,Elevation Of Cytosolic Ca2+ Levels R-HSA-139853,-0.6151340171713628,-1.0001866461414592,0.5208613728129206,1.0,1.0,4/15,1.60%,P2rx7;Trpc3;Trpc7;Itpr2
prerank,Sialic Acid Metabolism R-HSA-4085001,-0.5805432221720855,-1.0001284625901443,0.5059760956175299,1.0,1.0,5/33,5.60%,St8sia5;St6gal1;St6gal2;St3gal6;St8sia2
prerank,Cellular Response To Chemical Stress R-HSA-9711123,-0.5038585344772327,-0.9997088523865928,0.4841463414634146,1.0,1.0,24/174,17.99%,Tbl1x;Slc7a11;Gpx7;Nox4;Brip1;Ncf2;Mafg;Smarcd3;Gpx8;Cox16;Ppara;Notch1;Psmb8;Abcc1;Stap2;Rxra;Glyat;Atp7a;Prkcd;Sod3;Psma8;Gpx2;Nlrp3;Txnip
prerank,TGF-beta Receptor Signaling Activates SMADs R-HSA-2173789,0.5282048563727644,0.9991377497900893,0.47307692307692306,0.9983852153336137,1.0,9/44,3.29%,Itga8;Nedd4l;Tgfbr1;Ppp1cb;Cbl;Smad3;Itgb8;Usp15;Tgfb2
prerank,MET Activates PTK2 Signaling R-HSA-8874081,-0.5983418093254598,-0.9979316993394359,0.5193075898801598,1.0,1.0,4/17,4.51%,Lama4;Lama2;Itga2;Lama1
prerank,Cellular Response To Starvation R-HSA-9711097,0.44347162338073054,0.9978709573746293,0.44052863436123346,0.9974197538346513,1.0,38/145,11.40%,Fnip2;Atp6v1a;Rragd;Rpl10a;Cebpb;Rptor;Rplp1;Rpl15;Rpsa;Rplp0;Gcn1;Rpl3;Mios;Mrpl13;Rps28;Rpl36a;Rpl4;Rps8;Rpl8;Kptn;Atp6v1c2;Rps21;Uba52;Atp6v0e2;Rpl18a;Castor2;Rps3;Rpl30;Rpl38;Atp6v1d;Rsl24d1;Rpl41;Rps23;Rpl27a;Slc38a9;Rpl9;Rps10;Rps13
prerank,RNA Polymerase I Promoter Escape R-HSA-73772,0.5117110638398372,0.9974743196827269,0.4669421487603306,0.9942736548707006,1.0,14/47,12.87%,Gtf2h2;Ubtf;Gtf2h5;Ccnh;Cbx3;H2az1;H2ax;Polr1h;H2ac4;Mnat1;H2ac6;Polr2k;Ercc2;Polr2e
prerank,Metabolism Of Nucleotides R-HSA-15869,0.470330634759355,0.9971631344598102,0.4541832669322709,0.9909795476400238,1.0,6/86,4.26%,Ak5;Dpyd;Gda;Adk;Nt5c2;Upp2
prerank,FGFR2 Ligand Binding And Activation R-HSA-190241,-0.6000007594470574,-0.9966278593721123,0.5075239398084815,1.0,1.0,3/17,14.45%,Fgf1;Fgf16;Fgf17
prerank,Metabolism Of Amine-Derived Hormones R-HSA-209776,-0.5999664373000131,-0.9928423261436133,0.524390243902439,1.0,1.0,2/18,7.86%,Dio2;Tph2
prerank,Resolution Of Abasic Sites (AP Sites) R-HSA-73933,-0.5673615839994587,-0.992380549017072,0.518005540166205,1.0,1.0,2/38,6.70%,Nthl1;Lrig1
prerank,Signaling By RAF1 Mutants R-HSA-9656223,0.5266268243861407,0.9914510570510572,0.4925925925925926,1.0,1.0,11/36,4.58%,Camk2a;Camk2b;Cnksr2;Mapk1;Map2k1;Camk2g;Ksr2;Ywhab;Ksr1;Calm1;Mapk3
prerank,Dual Incision In TC-NER R-HSA-6782135,0.4784051328984934,0.9911393709144294,0.4357976653696498,0.9993321235566053,1.0,11/63,12.87%,Gtf2h2;Gtf2h5;Ccnh;Ercc4;Uba52;Usp7;Mnat1;Tcea1;Polr2k;Ercc2;Polr2e
prerank,SHC1 Events In ERBB2 Signaling R-HSA-1250196,0.5682686275377401,0.9911127718893875,0.5119047619047619,0.995225807865674,1.0,3/20,0.66%,Prkce;Nrg3;Nrg2
prerank,MAPK Targets/ Nuclear Events Mediated By MAP Kinases R-HSA-450282,0.5309716123545984,0.9907167687972015,0.4469026548672566,0.9921767974134565,1.0,10/29,8.92%,Mapk1;Jun;Rps6ka2;Mef2c;Mapk14;Mapk3;Mapk10;Dusp4;Mef2a;Mapk7
prerank,Cell-Cell Communication R-HSA-1500931,0.4489794165921094,0.9905199856005682,0.41810344827586204,0.9884837784968741,1.0,22/111,5.27%,Cdh9;Kirrel3;Cadm2;Cdh8;Ptk2b;Magi2;Pard3;Cdh12;Ptk2;Sptbn1;Nck2;Actn2;Ctnnb1;Pals1;Nectin1;Pik3cb;Cd2ap;Fyn;Actn1;Actn4;Sptan1;Parvb
prerank,Diseases Of Metabolism R-HSA-5668914,-0.47532184801685357,-0.9898865829737061,0.4928909952606635,1.0,1.0,32/225,9.90%,Gpc6;Thsd4;Adamtsl1;Gpc5;Adamts2;Ext1;Adamts16;Bcan;Tbxas1;B3glct;Lfng;Vcan;Prelp;Chst3;Hspg2;Cyp27a1;Cspg5;Adamts12;Adamts5;Gusb;Notch3;Gpc2;Dcn;Adamts6;Csf2rb;Sdc4;Thsd7b;Alg14;Tcn2;Gys1;Cyp26b1;Cspg4
prerank,"TICAM1, RIP1-mediated IKK Complex Recruitment R-HSA-168927",-0.6030349984433657,-0.9888998589904144,0.5402455661664393,1.0,1.0,2/18,7.37%,Birc3;Tlr3
prerank,Sensory Processing Of Sound R-HSA-9659379,-0.524933857627041,-0.9883781482713336,0.507227332457293,1.0,1.0,11/73,7.48%,Pcdh15;Whrn;Epb41l3;Kcnn2;Myo1e;Cacna2d2;Stx1a;Xirp2;Ezr;Gsn;Slc26a5
prerank,Regulation Of Signaling By CBL R-HSA-912631,-0.5956964577895395,-0.9870773676415524,0.5366528354080221,1.0,1.0,4/18,8.81%,Pik3r1;Clstn1;Vav1;Hck
prerank,ZBP1(DAI) Mediated Induction Of Type I IFNs R-HSA-1606322,-0.6024185137046476,-0.9869100152183395,0.5418918918918919,1.0,1.0,6/20,19.20%,Tlr3;Myd88;Dtx4;Nkiras1;Rela;Ticam1
prerank,Chaperone Mediated Autophagy R-HSA-9613829,-0.5887703254576516,-0.9854356548046681,0.5415512465373962,1.0,1.0,2/19,10.18%,Cftr;Plin2
prerank,Signaling By ERBB2 In Cancer R-HSA-1227990,-0.5902641657714829,-0.9847670183775209,0.5295735900962861,1.0,1.0,4/24,3.73%,Erbb4;Nrg1;Pik3r1;Erbb3
prerank,Activated Point Mutants Of FGFR2 R-HSA-2033519,-0.6049365847742596,-0.9845015325352547,0.5333333333333333,1.0,1.0,3/15,14.45%,Fgf1;Fgf16;Fgf17
prerank,Phospholipase C-mediated Cascade; FGFR2 R-HSA-5654221,-0.6041354298704475,-0.9838734705989777,0.5310344827586206,1.0,1.0,3/16,14.45%,Fgf1;Fgf16;Fgf17
prerank,Semaphorin Interactions R-HSA-373755,0.49747588697998374,0.9817171739613265,0.46987951807228917,1.0,1.0,4/64,1.28%,Plxna4;Sema5a;Nrp1;Sema6d
prerank,RNA Polymerase II Transcribes snRNA Genes R-HSA-6807505,0.47696493006169444,0.981414026603628,0.47580645161290325,1.0,1.0,26/71,15.53%,Rprd1a;Ints6;Gtf2f2;Pou2f2;Ints2;Rprd1b;Ncbp1;Ccnt2;Pou2f1;Cdk9;Rprd2;Nabp1;Ints11;Gtf2a1;Polr2k;Phax;Ints10;Gtf2f1;Ccnt1;Polr2e;Ints14;Ints1;Taf6;Pcf11;Ice2;Ccnk
prerank,Signaling By ERBB2 KD Mutants R-HSA-9664565,-0.5905403326040205,-0.9814038721125068,0.5247252747252747,1.0,1.0,4/23,3.73%,Erbb4;Nrg1;Pik3r1;Erbb3
prerank,Influenza Infection R-HSA-168255,0.43056337334662736,0.9812631652342659,0.4434389140271493,1.0,1.0,38/146,13.26%,Rpl10a;Rplp1;Gtf2f2;Rpl15;Rpsa;Rplp0;Rpl3;Ndc1;Mrpl13;Rps28;Rpl36a;Rpl4;Rps8;Ranbp2;Pabpn1;Rpl8;Rps21;Uba52;Rpl18a;Rps3;Rpl30;Rpl38;Xpo1;Rsl24d1;Rpl41;Rps23;Rpl27a;Rpl9;Rps10;Rps13;Polr2k;Pom121;Rps2;Nup93;Gtf2f1;Kpna1;Polr2e;Rps15
prerank,Asparagine N-linked Glycosylation R-HSA-446203,-0.4658025376575029,-0.9795670904555379,0.526071842410197,1.0,1.0,14/273,5.80%,Ank1;Mgat4c;Chst8;St8sia5;St6gal1;Ankrd28;St6gal2;Man2a1;St3gal6;Gfpt2;Mgat5;Edem1;St8sia2;Fuca1
prerank,Processing Of DNA Double-Strand Break Ends R-HSA-5693607,-0.5362910941509603,-0.9776470794649736,0.5463087248322148,1.0,1.0,7/68,12.19%,Rbbp8;Brip1;Bard1;Nsd2;Top3a;Cdk2;Artn
prerank,Activation Of Pre-Replicative Complex R-HSA-68962,-0.5681565948291475,-0.9769065298178974,0.5301204819277109,1.0,1.0,4/31,14.23%,Mcm10;Cdk2;Mcm3;Cdt1
prerank,Regulation Of Actin Dynamics For Phagocytic Cup Formation R-HSA-2029482,0.4922062165515646,0.9764858854995995,0.4817813765182186,1.0,1.0,16/55,4.63%,Wasf1;Wipf3;Vav3;Nckap1;Baiap2;Abi2;Mapk1;Actr3;Ptk2;Arpc2;Cyfip1;Elmo2;Abi1;Cyfip2;Mapk3;Arpc1a
prerank,Signaling By ERBB2 R-HSA-1227986,0.4985280568724974,0.9762477380227087,0.4679245283018868,1.0,1.0,4/48,1.85%,Prkce;Nrg3;Nrg2;Akt3
prerank,FCGR3A-mediated Phagocytosis R-HSA-9664422,0.48572473427215274,0.9751381820879723,0.502127659574468,1.0,1.0,17/55,4.80%,Wasf1;Wipf3;Vav3;Nckap1;Baiap2;Abi2;Mapk1;Actr3;Ptk2;Arpc2;Cyfip1;Elmo2;Abi1;Cyfip2;Mapk3;Arpc1a;Fyn
prerank,G Alpha (I) Signaling Events R-HSA-418594,-0.4708444019373841,-0.9740545505091336,0.5368171021377672,1.0,1.0,35/246,5.87%,Plcb4;Htr1f;Pde4b;Camk2d;Rgs20;Grm3;Camk4;Grm8;Pde4d;Chrm2;Pde1a;Itpr2;Rgs12;Lpar1;Rgs6;Rgs3;Opn3;Ptger3;Pde1c;Gpr37l1;Gng4;Rgsl1;Ccl28;Oprk1;Gpr17;Grm4;Gnas;App;Prkar1b;Gnai1;Adcy8;Rgs16;Ppp3cc;Oprd1;Plcb2
prerank,FOXO-mediated Transcription Of Cell Cycle Genes R-HSA-9617828,0.5516695691161398,0.9732787985574218,0.5335968379446641,1.0,1.0,3/17,3.20%,Foxo1;Smad3;Btg1
prerank,CDC42 GTPase Cycle R-HSA-9013148,-0.489280331725777,-0.9714761592509642,0.5384615384615384,1.0,1.0,24/144,5.04%,Fnbp1l;Cpne8;Dlc1;Arhgef26;Srgap1;Plekhg1;Arhgap22;Farp1;Arap2;Arhgap31;Cdc42ep3;Pik3r1;Arhgap26;Vav2;Cav1;Dock6;Arhgef19;Arhgap45;Mcf2;Srgap2;Syde1;Arhgef6;Arhgap42;Iqgap1
prerank,RIP-mediated NFkB Activation Via ZBP1 R-HSA-1810476,-0.595342773585866,-0.9709661006314828,0.5462962962962963,1.0,1.0,5/17,19.20%,Tlr3;Myd88;Nkiras1;Rela;Ticam1
prerank,Regulation Of RUNX2 Expression And Activity R-HSA-8939902,-0.5247531980357547,-0.9706519196695671,0.5418918918918919,1.0,1.0,7/71,11.81%,Esr1;Bmp2;Dlx5;Smurf1;Ppargc1a;Dlx6;Psmb8
prerank,Signaling By TGF-beta Receptor Complex R-HSA-170834,0.4582327299978663,0.970643305209118,0.49586776859504134,1.0,1.0,16/91,4.58%,Itga8;Nedd4l;Pard3;Tgfbr1;Mapk1;Ncor1;Ppp1cb;Cbl;Smad3;Hdac1;Itgb8;Usp15;Tgfb2;Ski;Ncor2;Mapk3
prerank,Signaling By WNT R-HSA-195721,0.3809767559233208,0.9689277362497263,0.4742857142857143,1.0,1.0,18/277,3.01%,Ppp3ca;Prkg1;Pip5k1b;Camk2a;Tnrc6c;Hecw1;Plcb1;Prickle1;Znrf3;Tle1;Ppp3r1;Gng7;Gng2;Zranb1;Hdac1;Ywhaz;Ago1;Tnrc6b
prerank,Metalloprotease DUBs R-HSA-5689901,-0.5679671794496297,-0.9684284026068352,0.5592747559274756,1.0,1.0,5/27,10.86%,Bard1;Kat2b;Stambpl1;H2ac21;H2ac20
prerank,Nuclear Events Mediated By NFE2L2 R-HSA-9759194,-0.518916158916812,-0.9675815312596707,0.53125,1.0,1.0,5/77,11.81%,Slc7a11;Brip1;Mafg;Notch1;Psmb8
prerank,FCERI Mediated MAPK Activation R-HSA-2871796,0.5419573139165629,0.9670494719268685,0.5314685314685315,1.0,1.0,6/28,4.92%,Vav3;Mapk1;Jun;Plcg2;Mapk3;Map2k4
prerank,RHOG GTPase Cycle R-HSA-9013408,0.4687958155880538,0.9666818830695432,0.484375,1.0,1.0,10/72,2.58%,Kalrn;Iqgap2;Vav3;Dock4;Itsn1;Arhgap39;Arhgap21;Dock3;Cyfip1;Elmo2
prerank,RHOC GTPase Cycle R-HSA-9013106,-0.5185340009889312,-0.9651042387787815,0.5284015852047557,1.0,1.0,11/72,5.04%,Dlc1;Pik3r1;Arhgap26;Vav2;Arhgap18;Cav1;Anln;Mcf2;Ccdc187;Akap13;Iqgap1
prerank,PI3K Events In ERBB2 Signaling R-HSA-1963642,-0.5990864799755492,-0.9647431535453465,0.5574866310160428,1.0,1.0,4/15,3.73%,Erbb4;Nrg1;Pik3r1;Erbb3
prerank,G-protein Mediated Events R-HSA-112040,0.49505452028865915,0.964709562842774,0.5443037974683544,1.0,1.0,13/51,1.92%,Nbea;Camk2a;Camk2b;Adcy1;Adcy2;Plcb1;Gnal;Mapk1;Gnaq;Camkk1;Pde1b;Adcy9;Camk2g
prerank,UCH Proteinases R-HSA-5689603,0.4480020333898746,0.9636850792559383,0.48221343873517786,1.0,1.0,4/90,3.13%,Mbd5;Tgfbr1;Foxk1;Usp15
prerank,Oncogenic MAPK Signaling R-HSA-6802957,0.46491397038873666,0.9632347505790666,0.5234042553191489,1.0,1.0,16/74,4.65%,Camk2a;Camk2b;Cnksr2;Ap3b1;Mapk1;Kdm7a;Map2k1;Ppp1cb;Camk2g;Ksr2;Mprip;Ywhab;Ksr1;Calm1;Mapk3;Fam114a2
prerank,SMAD2/SMAD3:SMAD4 Heterotrimer Regulates Transcription R-HSA-2173796,-0.5585931667825632,-0.9630170377444972,0.5643835616438356,1.0,1.0,3/36,5.18%,Wwtr1;Col1a2;Smad2
prerank,Activation Of HOX Genes During Differentiation R-HSA-5619507,-0.5179371358767894,-0.9615691458803169,0.545822102425876,1.0,1.0,9/69,14.53%,Meis1;Pbx1;Rara;Pcgf2;H2ac20;H3c7;Mafb;Ncoa3;Rxra
prerank,CD28 Co-Stimulation R-HSA-389356,-0.5443951241196473,-0.9614717361801489,0.54421768707483,1.0,1.0,9/33,16.75%,Pik3r1;Prr5;Cd86;Cd80;Vav1;Trib3;Lyn;Grap2;Pkn2
prerank,Nuclear Receptor Transcription Pathway R-HSA-383280,-0.539802439277837,-0.961162716565792,0.5748987854251012,1.0,1.0,7/51,2.59%,Rorb;Nr4a1;Thrb;Esr2;Esr1;Nr4a3;Nr4a2
prerank,Synthesis Of Bile Acids And Bile Salts Via 7Alpha-Hydroxycholesterol R-HSA-193368,0.5534287109456616,0.9610992333072536,0.48031496062992124,1.0,1.0,1/18,0.63%,Cyp7b1
prerank,Transport To Golgi And Subsequent Modification R-HSA-948021,-0.4833023840085402,-0.9600431173442608,0.5660847880299252,1.0,1.0,9/156,5.80%,Ank1;Mgat4c;Chst8;St6gal1;Ankrd28;Man2a1;Mgat5;St8sia2;Fuca1
prerank,Transcriptional Regulation Of White Adipocyte Differentiation R-HSA-381340,-0.5164025077442254,-0.9596974578567964,0.5720053835800808,1.0,1.0,14/80,15.56%,Tbl1x;Klf5;Nr2f2;Smarcd3;Ppargc1a;Ppara;Ebf1;Pparg;Angptl4;Srebf2;Ccnd3;Ncoa3;Rxra;Lpl
prerank,RHOD GTPase Cycle R-HSA-9013405,-0.533350538651976,-0.9559403197957629,0.5652759084791387,1.0,1.0,9/49,8.27%,Cpne8;Vrk2;Pik3r1;Arhgap26;Plxna1;Cav1;Akap12;Mcam;Stbd1
prerank,L1CAM Interactions R-HSA-373760,-0.5003240212689861,-0.9551799374688885,0.5634920634920635,1.0,1.0,15/95,6.18%,Ank1;Cntn6;Gap43;Itga9;Dcx;Vav2;Itga2;Cntn2;Scn5a;Alcam;Lama1;Sh3gl2;L1cam;Ezr;Ap2b1
prerank,Signaling By Insulin Receptor R-HSA-74752,-0.5212913866389003,-0.9546144503751415,0.561141304347826,1.0,1.0,5/70,2.53%,Gab2;Pik3r1;Fgf1;Fgfr3;Grb10
prerank,PIP3 Activates AKT Signaling R-HSA-1257604,0.39041621645501107,0.9544142221851167,0.5555555555555556,1.0,1.0,37/257,5.27%,Il1rap;Pip5k1b;Tnrc6c;Nrg3;Nrg2;Foxo1;Mapk1;Chd4;Tgfa;Akt3;Jun;Chd3;Cnot6l;Gatad2b;Hdac1;Rragd;Ago1;Tnrc6b;Nedd4;Flt3;Hdac7;Phc2;Cbx6;Prex2;Strn;Pip5k1a;Rptor;Mapk3;Mta2;Pik3cb;Ago2;Fyn;Mta3;Kl;Irs1;Tnks;Fgf5
prerank,Class B/2 (Secretin Family Receptors) R-HSA-373080,-0.509352797952126,-0.9531064385986225,0.5734720416124838,1.0,1.0,30/82,19.56%,Gng4;Fzd2;Vipr2;Fzd4;Wnt2;Gnas;Shh;Crhbp;Fzd9;C1qtnf1;Wnt5a;Crh;Wnt10a;Fzd6;Gnb4;Smox;Gng12;Gng3;Crhr1;Wnt3a;Calcb;Adgre1;Fzd10;Ucn;Cd55;Cysltr2;Gng8;Adm;Calcrl;Ghrh
prerank,PLC Beta Mediated Events R-HSA-112043,0.491963085688169,0.9527644609922097,0.5416666666666666,1.0,1.0,12/46,1.92%,Nbea;Camk2a;Camk2b;Adcy1;Adcy2;Plcb1;Mapk1;Gnaq;Camkk1;Pde1b;Adcy9;Camk2g
prerank,Plasma Lipoprotein Clearance R-HSA-8964043,-0.5533208267802673,-0.9503894941974007,0.5882352941176471,1.0,1.0,5/33,13.65%,Apoe;Ap2b1;Ldlrap1;Ldlr;Nr1h2
prerank,G Alpha (Z) Signaling Events R-HSA-418597,0.4833609402822017,0.9501843862660838,0.4817813765182186,1.0,1.0,6/46,2.14%,Prkce;Adcy1;Adcy2;Adcy9;Gng7;Gng2
prerank,TRAF6-mediated Induction Of TAK1 Complex Within TLR4 Complex R-HSA-937072,-0.5847929115870183,-0.9496183950761883,0.5876840696117804,1.0,1.0,4/15,19.20%,Irak2;Tlr4;Sarm1;Ticam1
prerank,Sensory Processing Of Sound By Inner Hair Cells Of Cochlea R-HSA-9662360,-0.5108773046619843,-0.9495046641762914,0.5752330226364847,1.0,1.0,7/65,4.07%,Pcdh15;Whrn;Epb41l3;Myo1e;Cacna2d2;Stx1a;Xirp2
prerank,SARS-CoV-1 Infection R-HSA-9678108,-0.5205909046508354,-0.9453581862242649,0.584573748308525,1.0,1.0,4/50,3.07%,St6gal1;Parp4;Parp8;Cav1
prerank,PINK1-PRKN Mediated Mitophagy R-HSA-5205685,-0.5629946484342432,-0.9451642291671843,0.5834445927903872,1.0,1.0,1/21,3.37%,Mfn1
prerank,Metabolism Of Steroids R-HSA-8957322,-0.48110573903523524,-0.9451502993305575,0.5800256081946222,1.0,1.0,30/136,17.77%,Tbl1x;Osbpl1a;Msmo1;Hmgcs1;Sqle;Cyp27a1;Lgmn;Hmgcr;Smarcd3;Ldlrap1;Fdft1;Elovl6;Osbpl9;Baat;Ppara;Dhcr24;Hsd17b2;Slc27a5;Srebf2;Osbpl3;Lmbr1;Stard4;Rxra;Gpam;Nr1h4;Hsd17b12;Osbpl6;Hsd11b1;Idi2;Ch25h
prerank,Degradation Of Extracellular Matrix R-HSA-1474228,0.43531684124082126,0.9448904482334646,0.5468164794007491,1.0,1.0,10/95,3.89%,Erc2;Mmp16;Spock3;Col25a1;Mmp17;Lamc1;Bmp1;Capn3;Adamts1;Lamb1
prerank,Metabolism Of Folate And Pterines R-HSA-196757,-0.5820087011853521,-0.9440626316544666,0.5904628330995793,1.0,1.0,4/15,21.98%,Aldh1l1;Dhfr;Mthfd1l;Folr2
prerank,RHO GTPases Activate Formins R-HSA-5663220,0.4226974358748297,0.9437191741331477,0.5465587044534413,1.0,1.0,9/114,4.81%,Diaph2;Mrtfa;Cenpp;Fmnl2;Taok1;Dync1i2;Fmnl1;Diaph1;Rhob
prerank,Signaling By B Cell Receptor (BCR) R-HSA-983705,0.43133092854212585,0.9433685397906028,0.5614035087719298,1.0,1.0,8/108,4.85%,Ppp3ca;Orai2;Ppp3r1;Plcg2;Fbxw11;Calm1;Fyn;Btrc
prerank,Myogenesis R-HSA-525793,-0.5604419476986269,-0.9430780853851752,0.5697050938337802,1.0,1.0,4/26,4.17%,Tcf7l2;Cdh4;Tcf7l1;Ctnna1
prerank,Iron Uptake And Transport R-HSA-917937,-0.5201677858453023,-0.9429806701698651,0.5930851063829787,1.0,1.0,7/54,9.85%,Steap2;Cybrd1;Heph;Cp;Atp6v1b1;Tcirg1;Hfe
prerank,Cytoprotection By HMOX1 R-HSA-9707564,-0.5344673162406255,-0.9424322587169588,0.5897097625329816,1.0,1.0,10/54,17.99%,Tbl1x;Brip1;Smarcd3;Cox16;Ppara;Abcc1;Stap2;Rxra;Nlrp3;Txnip
prerank,HIV Infection R-HSA-162906,0.3966782658308145,0.9422318768373699,0.536144578313253,1.0,1.0,25/214,8.40%,Nedd4l;Sgip1;Gtf2h2;Nmt1;Vps37b;Cul5;Gtf2h5;Gtf2f2;Fyn;Ccnh;Btrc;Ap1s2;Psmd13;Ndc1;Ap1g1;Slc25a5;Psip1;Ranbp2;Ncbp1;Npm1;Ccnt2;Ssrp1;Uba52;Cdk9;Skp1
prerank,PKMTs Methylate Histone Lysines R-HSA-3214841,0.4848948420131645,0.9421566182162582,0.5096525096525096,1.0,1.0,21/46,13.37%,Nsd1;Dot1l;Ash1l;Kmt5a;Rbbp5;Aebp2;Ezh2;Ehmt1;Setd2;Setd7;Kmt2c;Rbbp7;Suz12;Setdb1;Nfkb1;Smyd2;Rbbp4;Kmt2a;Kmt5b;Kmt2b;Dpy30
prerank,Kinesins R-HSA-983189,-0.5373070890327173,-0.9418275434270594,0.5764075067024129,1.0,1.0,9/36,12.92%,Kif21b;Kif6;Kif26a;Kif23;Kif5a;Kif16b;Kif9;Kif13b;Kif11
prerank,Synthesis Of PA R-HSA-1483166,-0.5448767439580204,-0.941395899713593,0.6034712950600801,1.0,1.0,12/37,23.62%,Pla2g5;Gpat3;Pla2g4a;Gpat2;Gpam;Pla2r1;Pla2g10;Pld6;Ddhd1;Lclat1;Pld2;Miga1
prerank,B-WICH Complex Positively Regulates rRNA Expression R-HSA-5250924,-0.5321464515879872,-0.9410145259330621,0.5785234899328859,1.0,1.0,4/46,12.69%,Myo1e;Kat2b;H2ac20;H3c7
prerank,Extension Of Telomeres R-HSA-180786,-0.5269044723323131,-0.9400077286858681,0.5888594164456233,1.0,1.0,6/49,18.76%,Ankrd28;Lrig1;Chtf18;Cdk2;Pif1;Terf1
prerank,RHO GTPase Cycle R-HSA-9012999,-0.4339675721275898,-0.9387220779430485,0.64,1.0,1.0,72/426,8.52%,Fnbp1l;Dock1;Cpne8;Dlc1;Arhgef26;Pcdh7;Sh3rf1;Srgap1;Plekhg1;Arhgap22;Farp1;Arap2;Arhgap31;Vrk2;Cdc42ep3;Cftr;Rhoj;Pik3r1;Peak1;Stmn2;Arhgap26;Vav2;Homer2;Plxna1;Gja1;Fam83b;Fgd5;Swap70;Arhgap18;Pde5a;Cav1;Dock6;Anln;Arhgef19;Prag1;Myo6;Arhgap45;Plxnd1;Rnd3;Mcf2;Ccdc187;Dock5;Srgap2;Nhs;Arhgap6;Akap13;Garre1;Syde1;Arhgap23;Arhgef6;Arhgap42;Iqgap1;Arhgap28;Ncf2;Akap12;Msi2;Rhoq;Rhobtb1;Cdc42ep5;Baiap2l2;Rhoh;Kif14;Wwp2;Dock8;Wipf1;Stam2;Arhgap30;Mcam;Stbd1;Uaca;Vav1;Plekhg2
prerank,TNFs Bind Their Physiological Receptors R-HSA-5669034,-0.5460611867248956,-0.9370403898545473,0.5782792665726375,1.0,1.0,8/25,20.35%,Edaradd;Tnfrsf1b;Tnfrsf11b;Tnfrsf13b;Edar;Lta;Tnfsf4;Eda2r
prerank,Regulation Of MECP2 Expression And Activity R-HSA-9022692,0.5133969559898375,0.9358353022416553,0.5523012552301255,1.0,1.0,11/31,4.75%,Camk2a;Camk2b;Tnrc6c;Ncor1;Camk2g;Hdac1;Ago1;Tnrc6b;Calm1;Ncor2;Ago2
prerank,Processive Synthesis On Lagging Strand R-HSA-69183,-0.580098840908672,-0.9347303284978885,0.5978407557354926,1.0,1.0,1/15,6.70%,Lrig1
prerank,Translation Of Structural Proteins R-HSA-9683701,-0.5447968276939764,-0.9344386562067616,0.5953678474114441,1.0,1.0,3/29,2.98%,St6gal1;Parp4;Parp8
prerank,Constitutive Signaling By Ligand-Responsive EGFR Cancer Variants R-HSA-1236382,-0.5646082497465995,-0.933942730792994,0.5913528591352859,1.0,1.0,2/18,7.28%,Pik3r1;Egfr
prerank,Na+/Cl- Dependent Neurotransmitter Transporters R-HSA-442660,-0.563513959777409,-0.9336038010911583,0.596,1.0,1.0,5/17,11.27%,Slc6a7;Slc18a1;Slc6a9;Slc22a1;Slc6a11
prerank,"Platelet Activation, Signaling And Aggregation R-HSA-76002",0.3810833847828597,0.9303427755829794,0.6081871345029239,1.0,1.0,28/241,4.98%,Dgkh;Prkce;Dgki;Trpc6;Vav3;Dgkg;Mapk1;Gnaq;Ptk2;Gng7;Gng2;Dagla;Dgkd;Plcg2;Ywhaz;Tgfb2;Cap1;Actn2;Fam3c;Mapk14;Calm1;Lhfpl2;Mapk3;Pik3cb;Fyn;Rhob;Actn1;Actn4
prerank,Intra-Golgi Traffic R-HSA-6811438,0.4986734217395945,0.93003425533887,0.5411764705882353,1.0,1.0,3/35,3.33%,Nsf;Cyth1;Ric1
prerank,SUMOylation Of RNA Binding Proteins R-HSA-4570464,0.48042196123694514,0.9300199276279117,0.5412186379928315,1.0,1.0,12/42,12.68%,Phc2;Sumo2;Hnrnpc;Ndc1;Cbx4;Ranbp2;Nop58;Phc3;Hnrnpk;Pom121;Nup93;Rnf2
prerank,RND3 GTPase Cycle R-HSA-9696264,0.4931286590529545,0.9298072681042256,0.5532786885245902,1.0,1.0,7/40,4.94%,Plekhg5;Rasal2;Arhgap21;Pkp4;Nisch;Ccdc88a;Rock1
prerank,Activation Of ATR In Response To Replication Stress R-HSA-176187,-0.5354621730139072,-0.9298065728421749,0.6050531914893617,1.0,1.0,7/35,22.53%,Mcm10;Cdk2;Mcm3;Rrad;Orc5;Rfc2;Slc25a2
prerank,Platelet Calcium Homeostasis R-HSA-418360,-0.5496037880609792,-0.9296973891406172,0.6033057851239669,1.0,1.0,5/26,1.60%,P2rx7;Trpc3;Slc8a1;Trpc7;Itpr2
prerank,Extra-nuclear Estrogen Signaling R-HSA-9009391,-0.5039477242673388,-0.9294967591556313,0.6005188067444877,1.0,1.0,13/69,11.83%,Bcl2;Esr2;Pik3r1;Esr1;Gng4;Cav1;Gnai1;Egfr;Kcnh8;Gnb4;Gnai2;Gng12;Gng3
prerank,MyD88 Deficiency (TLR2/4) R-HSA-5602498,-0.5733909864804497,-0.9289622369334624,0.6205479452054794,1.0,1.0,6/16,23.96%,Myd88;S100a1;Tlr1;Tlr4;Btk;Tlr6
prerank,Antigen Processing: Ubiquitination And Proteasome Degradation R-HSA-983168,0.3685304936917663,0.9277841506923714,0.6402877697841727,1.0,1.0,36/298,6.45%,Lmo7;Ube2e2;Nedd4l;Cblb;Hace1;Trim9;Herc2;Rnf19a;Zbtb16;Hectd2;Fbxl7;Fbxo11;Klhl2;Fbxo41;Nedd4;Ube2w;Rnf182;Huwe1;Klhl3;Fbxw11;Cul5;Ube2k;Znrf2;Herc3;Rnf217;Btrc;Ube2e3;Mex3c;Ube2b;Ube2g2;Pja2;Spsb1;Ubr1;Ube2d3;Psmd13;Ube2d1
prerank,Signaling By ERBB2 TMD/JMD Mutants R-HSA-9665686,-0.5601268825041058,-0.9275294674590702,0.6205962059620597,1.0,1.0,3/20,3.73%,Erbb4;Nrg1;Erbb3
prerank,RHOU GTPase Cycle R-HSA-9013420,-0.5317386099358409,-0.9270261113537035,0.6008230452674898,1.0,1.0,10/39,7.94%,Arhgap31;Pik3r1;Peak1;Myo6;Srgap2;Arhgef6;Iqgap1;Wwp2;Stam2;Arhgap30
prerank,Apoptosis R-HSA-109581,0.39637532893717975,0.9262082976799876,0.6116071428571429,1.0,1.0,26/161,7.31%,Dapk1;Ppp1r13b;Mapk1;Ppp3r1;Ptk2;Akt3;Unc5a;Ocln;Nmt1;Ywhaz;Dcc;Ywhah;Ywhab;Ctnnb1;Stk26;Ywhae;Mapk3;Rock1;Sptan1;Dsg2;Psmd13;Appl1;Bcl2l1;Tjp1;Dnm1l;Maged1
prerank,Dual Incision In GG-NER R-HSA-5696400,0.4866635353734178,0.9258528212843834,0.528957528957529,1.0,1.0,4/41,8.25%,Gtf2h2;Gtf2h5;Ercc4;Uba52
prerank,Activation Of NF-kappaB In B Cells R-HSA-1169091,-0.5019617266922262,-0.9251635012722208,0.6063408190224571,1.0,1.0,7/66,17.12%,Prkcb;Psmb8;Rel;Nfkbie;Bcl10;Psma8;Rela
prerank,Signaling By ALK Fusions And Activated Point Mutants R-HSA-9725370,-0.5118563619149249,-0.9232989376354356,0.6238159675236806,1.0,1.0,7/53,6.47%,Alk;Fn1;Pik3r1;Rrbp1;Vcl;Hip1;Atic
prerank,Retrograde Transport At Trans-Golgi-Network R-HSA-6811440,0.472047857603236,0.9232980433879289,0.55859375,1.0,1.0,2/44,3.33%,Nsf;Ric1
prerank,Signaling By ERBB4 R-HSA-1236394,0.4660074231747933,0.9229420567688205,0.5813953488372093,1.0,1.0,7/56,1.80%,Gabrb3;Gabrb1;Nrg3;Nrg2;Gabrb2;Gabrg2;Ncor1
prerank,mRNA Splicing - Major Pathway R-HSA-72163,-0.4589732260629002,-0.9229396499237926,0.6296758104738155,1.0,1.0,2/180,3.10%,Elavl2;Colec12
prerank,Amyloid Fiber Formation R-HSA-977225,0.45954117462362626,0.9226423740459073,0.6067415730337079,1.0,1.0,6/58,3.13%,Snca;Calb1;Sorl1;Tspan5;Tspan33;Sncaip
prerank,RNA Polymerase III Transcription Initiation From Type 1 Promoter R-HSA-76061,0.5178138706843523,0.9220447971518407,0.5555555555555556,1.0,1.0,9/27,17.11%,Gtf3c1;Gtf3c4;Gtf3c2;Polr2k;Polr2e;Brf1;Bdp1;Tbp;Gtf3a
prerank,Transport Of Inorganic Cations/Anions And Amino Acids/Oligopeptides R-HSA-425393,0.4224280875364755,0.9217906916584842,0.6147186147186147,1.0,1.0,15/102,4.69%,Ahcyl2;Slc4a4;Slc8a2;Slc4a7;Slc16a10;Slc6a15;Slc17a7;Slc1a1;Slc24a4;Slc4a10;Calm1;Slc9a9;Slc6a6;Slc12a6;Slc9a7
prerank,TNFR2 Non-Canonical NF-kB Pathway R-HSA-5668541,-0.47737685667295976,-0.9213714026051085,0.6013513513513513,1.0,1.0,18/96,20.60%,Edaradd;Birc3;Tnfsf12;Tnfrsf1b;Ltbr;Tnfrsf11b;Tnfrsf13b;Psmb8;Tnfrsf11a;Relb;Edar;Psma8;Traf3;Cd40;Lta;Tnfsf4;Eda2r;Uba3
prerank,MET Promotes Cell Motility R-HSA-8875878,-0.5409562730650865,-0.9211486035900033,0.6109589041095891,1.0,1.0,4/28,4.51%,Lama4;Lama2;Itga2;Lama1
prerank,mRNA Splicing R-HSA-72172,-0.45446145969852964,-0.9198789471249682,0.6389578163771712,1.0,1.0,2/188,3.10%,Elavl2;Colec12
prerank,Regulation Of Insulin Secretion R-HSA-422356,0.44780673979836577,0.9196424579492972,0.5497835497835498,1.0,1.0,10/74,2.54%,Cacna1e;Cacna1c;Cacnb2;Plcb1;Cacna1d;Gnaq;Gng7;Gng2;Kcng2;Abcc8
prerank,Transcriptional Regulation By E2F6 R-HSA-8953750,-0.5340025665864454,-0.91939406774387,0.6137566137566137,1.0,1.0,1/33,1.16%,Rbbp8
prerank,Diseases Associated With O-glycosylation Of Proteins R-HSA-3906995,0.4412592687176275,0.9192954610992825,0.5703125,1.0,1.0,8/63,2.82%,Sema5a;Thsd7a;Adamts17;Spon1;Adamts3;Notch2;Sema5b;Large1
prerank,Class I MHC Mediated Antigen Processing And Presentation R-HSA-983169,0.35713210412671864,0.9167477060234563,0.6837606837606838,1.0,1.0,39/357,6.45%,Lmo7;Ube2e2;Nedd4l;Cblb;Hace1;Trim9;Herc2;Rnf19a;Sec24d;Zbtb16;Hectd2;Fbxl7;Fbxo11;Sec14l2;Klhl2;Fbxo41;Nedd4;Ube2w;Rnf182;Huwe1;Klhl3;Fbxw11;Cul5;Ube2k;Znrf2;Herc3;Rnf217;Btrc;Ube2e3;Sec23a;Mex3c;Ube2b;Ube2g2;Pja2;Spsb1;Ubr1;Ube2d3;Psmd13;Ube2d1
prerank,SLC-mediated Transmembrane Transport R-HSA-425407,0.37333515732739014,0.9157533775896951,0.6787878787878788,1.0,1.0,16/227,2.33%,Ahcyl2;Slc4a4;Slc44a5;Slc2a13;Slc8a2;Slc29a4;Slc4a7;Slc39a6;Slc16a7;Slc16a10;Slc16a2;Slc6a15;Slc30a3;Slc17a7;Slc1a1;Slc24a4
prerank,Epigenetic Regulation Of Gene Expression R-HSA-212165,0.4174059693176465,0.9145886595657966,0.6081632653061224,1.0,1.0,32/102,11.18%,Chd4;Gtf2h2;Chd3;Gatad2b;Hdac1;Baz1b;Ubtf;Gtf2h5;Mta2;Ccnh;Mta3;Mtf2;Cbx3;Aebp2;Ezh2;H2az1;Baz2a;Dek;H2ax;Rbbp7;Suz12;Sf3b1;Dnmt1;Ddx56;Smarca5;Polr1h;Rbbp4;H2ac4;Hdac2;Mnat1;H2ac6;Suds3
prerank,Antimicrobial Peptides R-HSA-6803157,-0.5350711638720498,-0.9143971357233183,0.626358695652174,1.0,1.0,23/33,39.98%,Clu;Slc11a1;Atp7a;Tlr1;Defb1;Trim21;Chga;S100a7a;Pglyrp1;Ro60;Bpifb1;Rnase6;Ltf;Ccr2;Leap2;Tlr2;Ccr6;Lcn2;Cd4;Pglyrp3;Bpifa1;Bpifb2;Bpifb4
prerank,Glyoxylate Metabolism And Glycine Degradation R-HSA-389661,-0.5268024376828179,-0.9133687410242436,0.6022253129346314,1.0,1.0,9/29,26.46%,Gldc;Dhtkd1;Bckdhb;Agxt2;Ldhd;Dao;Dlat;Prodh2;Pxmp2
prerank,Signaling By FGFR3 R-HSA-5654741,-0.5322525110131198,-0.9131607375287933,0.6296809986130375,1.0,1.0,3/37,2.36%,Pik3r1;Fgf1;Fgfr3
prerank,Transcriptional Regulation By RUNX3 R-HSA-8878159,0.42138292556328694,0.9127388223640969,0.6106870229007634,1.0,1.0,7/93,3.92%,Maml2;Maml3;Tead1;Smad3;Ctnnb1;Itga4;Cbfb
prerank,Heme Signaling R-HSA-9707616,-0.5240404999208861,-0.9095990611450016,0.6358620689655172,1.0,1.0,6/42,7.20%,Tbl1x;Npas2;Brip1;Smarcd3;Nrip1;Ppargc1a
prerank,EGFR Downregulation R-HSA-182971,0.4836025682572332,0.9092422803929597,0.5437262357414449,1.0,1.0,10/30,8.25%,Ptprk;Tgfa;Ptpn3;Cbl;Sh3gl1;Arhgef7;Sh3kbp1;Grb2;Epn1;Uba52
prerank,Antigen Activates B Cell Receptor Leading To Second Messenger Generation R-HSA-983695,-0.5287371391666431,-0.9092288137275256,0.6091794158553546,1.0,1.0,5/30,8.78%,Itpr2;Pik3r1;Clstn1;Vav1;Pik3ap1
prerank,RNA Polymerase III Transcription Initiation From Type 2 Promoter R-HSA-76066,0.5107112367019855,0.9089640639917572,0.5686274509803921,1.0,1.0,8/26,16.98%,Gtf3c1;Gtf3c4;Gtf3c2;Polr2k;Polr2e;Brf1;Bdp1;Tbp
prerank,Drug ADME R-HSA-9748784,-0.49961165896543225,-0.9082706254693049,0.6329284750337382,1.0,1.0,15/55,15.82%,Slc22a3;Vav2;Slco2b1;Slc38a3;Abcc2;Vav1;Slc22a7;Slc22a1;Ggt5;Slc28a3;Slc16a1;Abcc1;Slc28a2;Glyat;Slc38a1
prerank,Transport Of Mature mRNA Derived From An Intron-Containing Transcript R-HSA-159236,0.44799974626136935,0.9075679768104409,0.572,1.0,1.0,28/70,20.13%,Cdc40;Srsf1;Srsf9;Thoc2;Ndc1;Srsf7;Srsf2;Ranbp2;Ncbp1;Srsf11;Srsf6;Pom121;Thoc3;Nup93;Fyttd1;Upf3b;Nup155;Srsf3;Nxt1;Srsf4;U2af1l4;Nup54;Alyref;Sarnp;Nup210;U2af1;Slu7;Thoc7
prerank,Constitutive Signaling By AKT1 E17K In Cancer R-HSA-5674400,-0.5335930239839035,-0.9074022874074321,0.6193724420190996,1.0,1.0,2/26,3.95%,Nr4a1;Prr5
prerank,HCMV Early Events R-HSA-9609690,-0.4789072535195398,-0.9072121381573021,0.6321989528795812,1.0,1.0,7/80,12.69%,Tbl1x;Pcsk1;Egfr;Kcnh8;H2ac21;H2ac20;H3c7
prerank,RHO GTPases Activate PKNs R-HSA-5625740,0.4690464831536142,0.9062621062745622,0.5934959349593496,1.0,1.0,10/49,7.40%,Ppp1cb;Ppp1r12b;Ywhaz;Ywhah;Ywhab;Ywhae;Rhob;Myh9;H2az1;H2ax
prerank,Sulfur Amino Acid Metabolism R-HSA-1614635,-0.537555446047363,-0.906231023083199,0.6103723404255319,1.0,1.0,4/25,18.35%,Gadl1;Sqor;Ethe1;Cdo1
prerank,O-glycosylation Of TSR Domain-Containing Proteins R-HSA-5173214,0.4669950220855103,0.9051837059359988,0.6079136690647482,1.0,1.0,6/38,2.21%,Sema5a;Thsd7a;Adamts17;Spon1;Adamts3;Sema5b
prerank,Defective CFTR Causes Cystic Fibrosis R-HSA-5678895,-0.49655679782784007,-0.9038898906110451,0.6319261213720316,1.0,1.0,5/60,18.03%,Cftr;Derl3;Psmb8;Psma8;Sel1l
prerank,Defective B3GALTL Causes PpS R-HSA-5083635,0.46700508567822097,0.9032896875063332,0.597864768683274,1.0,1.0,6/37,2.21%,Sema5a;Thsd7a;Adamts17;Spon1;Adamts3;Sema5b
prerank,RMTs Methylate Histone Arginines R-HSA-3214858,0.4542751560308191,0.9030022696107497,0.5976095617529881,1.0,1.0,12/43,11.12%,Arid1b;Smarca2;Smarcd2;Smarca4;Arid2;H2az1;H2ax;Rbbp7;Smarcd1;Wdr77;H2ac4;H2ac6
prerank,Triglyceride Metabolism R-HSA-8979227,-0.5364567640158842,-0.9024765098720303,0.6401062416998672,1.0,1.0,7/30,14.92%,Agmo;Cav1;Prkca;Fabp7;Gpat2;Gpam;Mogat1
prerank,Regulation Of TP53 Activity Thru Phosphorylation R-HSA-6804756,-0.48090533092745613,-0.9012966140342714,0.6421052631578947,1.0,1.0,11/83,12.19%,Rbbp8;Prkaa2;Prkab2;Brip1;Bard1;Dyrk2;Nuak1;Mapk11;Top3a;Cdk2;Artn
prerank,Nuclear Signaling By ERBB4 R-HSA-1251985,-0.5251769078236108,-0.9005754507544467,0.6310160427807486,1.0,1.0,4/31,3.17%,Erbb4;Nrg1;Esr1;Apoe
prerank,Regulation Of IGF Transport And Uptake By IGFBPs R-HSA-381426,-0.4666191235300635,-0.9000939694848978,0.6407894736842106,1.0,1.0,19/111,8.78%,Ltbp1;Fam20a;Fn1;Igfbp7;Apoe;Sgpp2;Eva1a;Igf1;Vcan;Vgf;App;Mfge8;Cst3;Cp;Wfs1;Bmp4;Serpina10;Ttf2;Scg3
prerank,HDACs Deacetylate Histones R-HSA-3214815,0.4562491957391685,0.8990635372624107,0.6102941176470589,1.0,1.0,9/48,4.89%,Chd4;Phf21a;Ncor1;Chd3;Gatad2b;Hdac1;Ncor2;Mta2;Mta3
prerank,Late Endosomal Microautophagy R-HSA-9615710,-0.5261807727734976,-0.8990063816642034,0.6433470507544582,1.0,1.0,2/29,10.18%,Cftr;Plin2
prerank,RHO GTPases Activate ROCKs R-HSA-5627117,0.5193124401369452,0.898690312661444,0.5613382899628253,1.0,1.0,6/19,8.02%,Ppp1cb;Ppp1r12b;Rhob;Rock1;Myh9;Limk2
prerank,Costimulation By CD28 Family R-HSA-388841,-0.49276170667384456,-0.898690041740843,0.6476964769647696,1.0,1.0,10/56,16.75%,Pik3r1;Prr5;Cd86;Ppp2r5a;Cd80;Vav1;Trib3;Lyn;Grap2;Pkn2
prerank,Diseases Of Signal Transduction By Growth Factor Receptors And Second Messengers R-HSA-5663202,-0.4181254879686879,-0.8978082938463923,0.7164009111617312,1.0,1.0,44/409,7.28%,Camk2d;Erbb4;Alk;Kit;Tcf7l2;Nr4a1;Fn1;Stat5b;Tbl1x;Esr2;Nrg1;Gab2;Pik3r1;Dusp10;Rrbp1;Fgf1;Cux1;Fgfr3;Esr1;Etv6;Nox4;Pdgfra;Clstn1;Zc3hav1;Erbb3;Fzd4;Vcl;Prr5;Kank1;Hdac4;Iqgap1;Smad2;Dusp16;Hip1;Dusp6;Cd86;Qki;Shh;Atic;Ppp2r5a;Spred1;Kat2b;Cd80;Egfr
prerank,Potassium Channels R-HSA-1296071,0.4142506894171764,0.8961155896000501,0.6571428571428571,1.0,1.0,22/99,4.16%,Kcnd2;Kcnj6;Kcnj3;Kcnab1;Kcnh1;Kcnc3;Gabbr2;Kcnd3;Kcnq3;Gng7;Gng2;Kcng2;Kcnk10;Kcnc4;Abcc8;Kcng1;Kcnk1;Kcng3;Kcnmb4;Kcna1;Kcnab2;Kcns2
prerank,Signaling By Hedgehog R-HSA-5358351,-0.45531696288547047,-0.8959469775975929,0.6579925650557621,1.0,1.0,12/134,6.11%,Gpc5;Gli3;Gli2;Dzip1;Gpr161;Gnas;Prkar1b;Hhip;Adcy8;Intu;Smurf1;Shh
prerank,Acyl Chain Remodelling Of PG R-HSA-1482925,-0.5542751022761123,-0.8958808867870476,0.6498002663115846,1.0,1.0,5/17,18.20%,Pla2g5;Pla2g4a;Pla2r1;Pla2g10;Lpgat1
prerank,Translocation Of SLC2A4 (GLUT4) To Plasma Membrane R-HSA-1445148,0.4636316571560969,0.8957800456815286,0.6196078431372549,1.0,1.0,12/50,6.62%,Ralgapa2;Prkag2;Exoc4;Ywhaz;Ywhah;Ywhab;Calm1;Ywhae;Stxbp3;Myh9;Exoc6;C2cd5
prerank,SHC-mediated cascade:FGFR2 R-HSA-5654699,-0.5378663519608252,-0.8955375696094025,0.6326530612244898,1.0,1.0,3/20,14.45%,Fgf1;Fgf16;Fgf17
prerank,FRS-mediated FGFR2 Signaling R-HSA-5654700,-0.5367582730108914,-0.8927155055948911,0.652232746955345,1.0,1.0,3/22,14.45%,Fgf1;Fgf16;Fgf17
prerank,Peroxisomal Protein Import R-HSA-9033241,-0.49373214047321684,-0.8924625115795776,0.6635761589403973,1.0,1.0,16/58,26.78%,Nanos2;Crot;Pipox;Baat;Crat;Phyh;Glyat;Pex7;Ephx2;Nudt7;Dao;Pex13;Ide;Paox;Pex12;Sycp2
prerank,RET Signaling R-HSA-8853659,-0.5111520165369148,-0.8914529836150437,0.6376021798365122,1.0,1.0,11/39,12.19%,Shc3;Gab2;Pik3r1;Grb10;Clstn1;Ret;Gfra3;Nrtn;Grb7;Prkca;Artn
prerank,TP53 Regulates Transcription Of Additional Cell Cycle Genes With Uncertain Roles In P53 Pathway R-HSA-6804115,0.4959604849934983,0.8898387054037679,0.5802047781569966,1.0,1.0,6/20,8.24%,Cnot2;Cnot6l;Cnot1;Npm1;Btg2;Cnot4
prerank,Nucleotide Salvage R-HSA-8956321,0.5031864308262435,0.8880151083598202,0.575,1.0,1.0,6/21,10.44%,Adk;Upp2;Upp1;Ampd2;Adal;Dguok
prerank,Transcriptional Activation Of Mitochondrial Biogenesis R-HSA-2151201,-0.5029784252090872,-0.8876519269046824,0.6732542819499341,1.0,1.0,8/49,12.70%,Camk4;Tbl1x;Smarcd3;Ppargc1a;Ppara;Idh2;Glud1;Perm1
prerank,Downregulation Of ERBB2 Signaling R-HSA-8863795,-0.5197508984136374,-0.8854794478357904,0.6839237057220708,1.0,1.0,3/28,3.73%,Erbb4;Nrg1;Erbb3
prerank,NOD1/2 Signaling Pathway R-HSA-168638,-0.5219127697089218,-0.8848312943515411,0.6701986754966888,1.0,1.0,7/32,14.07%,Casp1;Birc3;Mapk11;Irak2;Mapk13;Casp4;Nod2
prerank,Estrogen-dependent Gene Expression R-HSA-9018519,-0.46399850036815493,-0.884823239976699,0.6653386454183267,1.0,1.0,7/103,6.90%,Erbb4;Bcl2;Esr1;Kank1;Tle3;Nrip1;Kat2b
prerank,Downstream TCR Signaling R-HSA-202424,-0.46701992999140557,-0.8833927240737925,0.6538952745849298,1.0,1.0,2/83,1.85%,Prkcq;Pik3r1
prerank,Macroautophagy R-HSA-1632852,-0.455172715359432,-0.8827468362793736,0.6805736636245111,1.0,1.0,5/110,4.03%,Cftr;Mfn1;Prkaa2;Epas1;Prkab2
prerank,ROS And RNS Production In Phagocytes R-HSA-1222556,-0.511936231578167,-0.8821354764308872,0.6789617486338798,1.0,1.0,6/34,13.48%,Nanos2;Ncf2;Atp6v1b1;Tcirg1;Hvcn1;Slc11a1
prerank,PI Metabolism R-HSA-1483255,0.4198888749382021,0.8808314607918557,0.6352941176470588,1.0,1.0,5/81,1.56%,Pip5k1b;Mtmr12;Plekha5;Sbf1;Plekha2
prerank,Regulation Of TLR By Endogenous Ligand R-HSA-5686938,-0.5438219081179306,-0.8804297589059317,0.6792452830188679,1.0,1.0,5/17,23.96%,S100a1;Gsdmd;Tlr1;Tlr4;Tlr6
prerank,SHC-mediated cascade:FGFR1 R-HSA-5654688,-0.5368483239465484,-0.8803427536758045,0.6596638655462185,1.0,1.0,3/18,14.45%,Fgf1;Fgfr1;Fgf17
prerank,Signaling By VEGF R-HSA-194138,0.40318872870008676,0.8802191405948526,0.6764705882352942,1.0,1.0,23/100,4.94%,Ptk2b;Wasf1;Vav3;Nrp1;Nckap1;Baiap2;Abi2;Ptk2;Akt3;Nrp2;Cyfip1;Nck2;Elmo2;Syngap1;Abi1;Ctnnb1;Mapk14;Calm1;Cyfip2;Pik3cb;Arhgef7;Fyn;Rock1
prerank,Regulated Necrosis R-HSA-5218859,-0.48862991710938297,-0.8794250804710966,0.6621438263229308,1.0,1.0,7/49,12.88%,Casp1;Birc3;Flot1;Casp4;Gsdmd;Tnfsf10;Irf2
prerank,Post-translational Protein Phosphorylation R-HSA-8957275,-0.46326703212331616,-0.8784744710966288,0.6857523302263648,1.0,1.0,17/99,8.78%,Ltbp1;Fam20a;Fn1;Igfbp7;Apoe;Sgpp2;Eva1a;Vcan;Vgf;App;Mfge8;Cst3;Cp;Wfs1;Bmp4;Serpina10;Scg3
prerank,Citric Acid Cycle (TCA Cycle) R-HSA-71403,-0.5214454140924365,-0.8779321114764891,0.6470588235294118,1.0,1.0,3/21,15.12%,Ldlr;Idh2;Ldhd
prerank,Tie2 Signaling R-HSA-210993,-0.5330055294988717,-0.8778113034005067,0.6586345381526104,1.0,1.0,2/17,2.99%,Pik3r1;Angpt1
prerank,FRS-mediated FGFR1 Signaling R-HSA-5654693,-0.5357516593396623,-0.8778026093931519,0.6731571627260083,1.0,1.0,3/20,14.45%,Fgf1;Fgfr1;Fgf17
prerank,NOTCH3 Activation And Transmission Of Signal To Nucleus R-HSA-9013507,-0.5243917556859005,-0.8768580228230324,0.662568306010929,1.0,1.0,4/24,11.31%,Notch3;Egfr;Wwp2;Jag2
prerank,Downregulation Of SMAD2/3:SMAD4 Transcriptional Activity R-HSA-2173795,0.47234393400760377,0.8767919494247935,0.6129032258064516,1.0,1.0,10/31,6.45%,Nedd4l;Mapk1;Ncor1;Smad3;Hdac1;Ski;Ncor2;Mapk3;Ube2d3;Ube2d1
prerank,ABC Transporter Disorders R-HSA-5619084,-0.474292750432988,-0.8762367806187455,0.6911764705882353,1.0,1.0,6/77,11.81%,Cftr;Abca1;Abcc2;Derl3;Abcc9;Psmb8
prerank,mRNA 3-End Processing R-HSA-72187,0.45061027641140705,0.8762279256428835,0.6653061224489796,1.0,1.0,20/58,13.23%,Cdc40;Papola;Srsf1;Srsf9;Nudt21;Cstf3;Thoc2;Cpsf6;Srsf7;Srsf2;Pabpn1;Ncbp1;Cstf2t;Srsf11;Wdr33;Cpsf7;Srsf6;Thoc3;Fyttd1;Upf3b
prerank,Intraflagellar Transport R-HSA-5620924,0.4571828992460851,0.8746135391266836,0.6232394366197183,1.0,1.0,11/39,13.00%,Dync2h1;Hspb11;Cluap1;Dynlt2b;Ttc26;Ift122;Ift57;Kif3c;Ift22;Tnpo1;Ift80
prerank,Mismatch Repair R-HSA-5358508,-0.5444476578198263,-0.8741111642055145,0.677027027027027,1.0,1.0,1/15,6.70%,Lrig1
prerank,Integrin Cell Surface Interactions R-HSA-216083,-0.47709575952217176,-0.8727813939736152,0.6897018970189702,1.0,1.0,15/64,11.32%,Itga9;Fn1;Jam3;Jam2;Itga2;Col18a1;Hspg2;Col9a1;Col4a2;Vtn;Cd44;Itgb5;Itgad;Col4a1;Itga6
prerank,RND1 GTPase Cycle R-HSA-9696273,0.449744606941037,0.8708139360639245,0.5899581589958159,1.0,1.0,4/41,2.11%,Plekhg5;Rasal2;Rras2;Pkp4
prerank,Regulation Of TP53 Activity R-HSA-5633007,0.3742422816132152,0.867155645562516,0.7649769585253456,1.0,1.0,14/143,4.59%,Ppp1r13b;Pdzd2;Prkag2;Chd4;Map2k6;Akt3;Chd3;Usp2;Gatad2b;Hdac1;Cdk5r1;Mapk14;Kmt5a;Mta2
prerank,Phospholipid Metabolism R-HSA-1483257,0.3587707321200652,0.8670701678866586,0.8031088082901554,1.0,1.0,15/203,4.61%,Pip5k1b;Slc44a5;Pitpnm2;Mtmr12;Plekha5;Sbf1;Plekha2;Pla2g4e;Dgat2;Cpne6;Slc44a1;Arf3;Pip5k1a;Mtmr1;Pik3cb
prerank,InlB-mediated Entry Of Listeria Monocytogenes Into Host Cell R-HSA-8875360,-0.530107148276026,-0.8655977835353713,0.6836461126005362,1.0,1.0,3/15,7.81%,Eps15;Sh3gl2;Stam2
prerank,Organelle Biogenesis And Maintenance R-HSA-1852241,-0.4118438468165768,-0.8649472411811676,0.7580071174377224,1.0,1.0,23/256,12.70%,Asap1;Camk4;Tbl1x;Bbs2;Prkaa2;Sclt1;Prkab2;Nde1;Smarcd3;Cep83;Plk4;Ppargc1a;Alms1;Mapk11;Atat1;Smox;Ppara;Tubb4a;Idh2;Prkca;Chchd6;Glud1;Perm1
prerank,ESR-mediated Signaling R-HSA-8939211,-0.43340277648298203,-0.863588810905084,0.7315521628498728,1.0,1.0,21/168,11.83%,Erbb4;Bcl2;Esr2;Pik3r1;Esr1;Gng4;Cav1;Kank1;Gnai1;Tle3;Nrip1;Kat2b;Egfr;Kcnh8;Gnb4;Gnai2;H2ac20;Myb;Gng12;Greb1;Gng3
prerank,Interaction Between L1 And Ankyrins R-HSA-445095,0.46656118114245804,0.8635434401315146,0.6259842519685039,1.0,1.0,10/29,2.66%,Ank3;Scn3a;Nrcam;Sptb;Scn8a;Scn3b;Kcnq3;Sptbn1;Sptbn4;Scn2a
prerank,ECM Proteoglycans R-HSA-3000178,-0.48246224251927705,-0.8635392843403504,0.6998654104979811,1.0,1.0,16/54,8.54%,Itga9;Lama4;Bcan;Lrp4;Lama2;Itga2;Vcan;Lama1;Hspg2;Col9a1;Hapln1;Vtn;Dcn;Tgfb3;Tnn;Itgb5
prerank,IKK Complex Recruitment Mediated By RIP1 R-HSA-937041,-0.5149304399035588,-0.8634923406014182,0.6849865951742627,1.0,1.0,4/21,19.20%,Birc3;Tlr4;Sarm1;Ticam1
prerank,G Alpha (S) Signaling Events R-HSA-418555,-0.44355938374381904,-0.8616491788790964,0.7433962264150943,1.0,1.0,34/133,12.12%,Pde3a;Pde4d;Pde11a;Rxfp1;Pde1a;Htr7;Gng4;Vipr2;Npsr1;Adrb3;Tshr;Lhcgr;Grk3;Gnas;Prkar1b;Gnai1;Adcy8;Mc5r;Rxfp2;Hrh2;Pde10a;C1qtnf1;Adora2b;Pde8a;Crh;Gnb4;Pde2a;Adcy7;Gnai2;Pde4c;Gng12;Gng3;Prkca;Crhr1
prerank,DARPP-32 Events R-HSA-180024,0.48056925801750233,0.8602190856473496,0.6078431372549019,1.0,1.0,3/23,2.17%,Ppp3ca;Ppp3r1;Pde4a
prerank,Processing Of Capped Intron-Containing Pre-mRNA R-HSA-72203,-0.4158555270087273,-0.8599549079158629,0.7466827503015682,1.0,1.0,2/237,3.10%,Elavl2;Colec12
prerank,RHOA GTPase Cycle R-HSA-8980692,-0.436744302809629,-0.8591159595499175,0.7287705956907478,1.0,1.0,22/144,5.26%,Dlc1;Pcdh7;Srgap1;Arhgap22;Farp1;Arap2;Arhgap31;Pik3r1;Arhgap26;Vav2;Arhgap18;Cav1;Anln;Arhgef19;Arhgap45;Mcf2;Arhgap6;Akap13;Arhgap23;Arhgap42;Iqgap1;Arhgap28
prerank,Transport Of Mature Transcript To Cytoplasm R-HSA-72202,0.41200933537073336,0.856722667925861,0.6861924686192469,1.0,1.0,25/79,17.53%,Cdc40;Srsf1;Srsf9;Thoc2;Ndc1;Srsf7;Srsf2;Ranbp2;Ncbp1;Srsf11;Wdr33;Eif4e;Srsf6;Pom121;Thoc3;Nup93;Fyttd1;Upf3b;Nup155;Srsf3;Nxt1;Srsf4;U2af1l4;Nup54;Alyref
prerank,RHOBTB1 GTPase Cycle R-HSA-9013422,-0.51277269374504,-0.8561236288938079,0.6962864721485411,1.0,1.0,3/23,6.21%,Pde5a;Myo6;Rhobtb1
prerank,Intra-Golgi And Retrograde Golgi-to-ER Traffic R-HSA-6811442,-0.423089940602456,-0.855442373320763,0.7407862407862408,1.0,1.0,9/164,3.51%,Kif21b;Akr1b10;Kif6;Kif26a;Cux1;Kif23;Usp6nl;Man2a1;Golim4
prerank,rRNA Modification In Nucleus And Cytosol R-HSA-6790901,0.4358903059425112,0.8549474641731095,0.7022058823529411,1.0,1.0,28/59,22.53%,Rcl1;Nop58;Utp4;Sppl2a;Heatr1;Wdr43;Ddx47;Fbl;Rps2;Utp15;Dkc1;Nop2;Nol6;Krr1;Wdr36;Wdr3;Tbl3;Rrp9;Emg1;Utp6;Dcaf13;Dhx37;Nop56;Bud23;Thumpd1;Tsr3;Mphosph10;Bms1
prerank,Mitochondrial Biogenesis R-HSA-1592230,-0.4641632409479587,-0.8549407871761857,0.7313237221494102,1.0,1.0,12/73,12.70%,Camk4;Tbl1x;Prkaa2;Prkab2;Smarcd3;Ppargc1a;Mapk11;Ppara;Idh2;Chchd6;Glud1;Perm1
prerank,SUMO E3 Ligases SUMOylate Target Proteins R-HSA-3108232,-0.42927736509947884,-0.8549108950359754,0.7325581395348837,1.0,1.0,14/157,10.86%,Satb2;Thrb;Esr1;Nr4a2;Ikbke;Hdac4;Rara;Nrip1;Ppargc1a;Satb1;Top2a;Ppara;Pparg;Pcgf2
prerank,Signaling By MET R-HSA-6806834,-0.47181350774190095,-0.8541641657832547,0.7047872340425532,1.0,1.0,9/63,7.81%,Lama4;Pik3r1;Lama2;Eps15;Itga2;Lama1;Sh3gl2;Lrig1;Stam2
prerank,Regulation Of Expression Of SLITs And ROBOs R-HSA-9010553,-0.4267473765662722,-0.8536301190320676,0.756926952141058,1.0,1.0,3/161,3.65%,Ldb2;Col4a5;Robo1
prerank,Disorders Of Transmembrane Transporters R-HSA-5619115,0.366539700425904,0.8534380407110518,0.7980295566502463,1.0,1.0,12/168,6.95%,Slc4a4;Slc1a1;Slc24a4;Abcc8;Slc9a9;Slc12a6;Slc9a7;Derl1;Psmd13;Ndc1;Ranbp2;Kcnj11
prerank,MTOR Signaling R-HSA-165159,0.44567477190515836,0.8516009228629507,0.6867924528301886,1.0,1.0,6/41,5.67%,Prkag2;Rragd;Ywhab;Rptor;Strada;Eif4b
prerank,RUNX1 Regulates Genes Involved In Megakaryocyte Differentiation And Platelet Function R-HSA-8936459,0.4202377378417873,0.8498777171968525,0.6852589641434262,1.0,1.0,10/54,7.40%,Tnrc6c;Hdac1;Ago1;Tnrc6b;Cbfb;Rbbp5;Mov10;H2az1;Kmt2c;H2ax
prerank,tRNA Processing R-HSA-72306,-0.4481374585316665,-0.8497103740447775,0.7067567567567568,1.0,1.0,2/96,3.10%,Trmt9b;Colec12
prerank,Thrombin Signaling Thru Proteinase Activated Receptors (PARs) R-HSA-456926,0.4552758571472005,0.8496053209952514,0.6547085201793722,1.0,1.0,5/31,4.58%,Mapk1;Gnaq;Gng7;Gng2;Mapk3
prerank,Chaperonin-mediated Protein Folding R-HSA-390466,-0.4515292736744079,-0.8494366901617771,0.73046875,1.0,1.0,11/81,11.83%,Fkbp9;Rgs6;Gng4;Kif13a;Tubb3;Gna15;Gnb4;Arfgef2;Gng12;Tubb4a;Gng3
prerank,Platelet Homeostasis R-HSA-418346,-0.45344396175751667,-0.8487809692090358,0.7292517006802721,1.0,1.0,17/82,8.30%,P2rx7;Trpc3;Slc8a1;Pde11a;Trpc7;Pde1a;Itpr2;Gng4;Pde5a;Nanos2;Prkg2;Gnas;Irag1;P2rx6;Ppp2r5a;Pde10a;P2rx4
prerank,Aberrant Regulation Of Mitotic G1/S Transition In Cancer Due To RB1 Defects R-HSA-9659787,-0.508403996957452,-0.8483411177470955,0.6921017402945113,1.0,1.0,5/17,17.92%,Cdkn1c;Cdk2;Ccnd3;E2f1;Ccnd1
prerank,Butyrate Response Factor 1 Binds And Destabilizes mRNA R-HSA-450385,-0.5215976994069715,-0.8482050017580449,0.7031463748290013,1.0,1.0,1/16,3.57%,Zfp36l1
prerank,G Alpha (Q) Signaling Events R-HSA-416476,-0.4174699491378278,-0.8481593612497166,0.753441802252816,1.0,1.0,31/193,6.36%,Plcb4;Htr2c;Chrm3;Htr2a;Adra1b;Trpc3;Rasgrp1;Trpc7;Adra1a;Itpr2;Qrfpr;Prkcq;Lpar1;Nmbr;Tacr3;Pik3r1;Rgs3;Cckbr;Rasgrp2;Gng4;Rgsl1;Npsr1;Gpr17;App;Gnrh1;Ednrb;Rgs16;Plcb2;Dgkk;Ntsr2;Grpr
prerank,SUMOylation R-HSA-2990846,-0.4260184543728329,-0.8480525019659869,0.7542483660130719,1.0,1.0,14/163,10.86%,Satb2;Thrb;Esr1;Nr4a2;Ikbke;Hdac4;Rara;Nrip1;Ppargc1a;Satb1;Top2a;Ppara;Pparg;Pcgf2
prerank,Transcriptional Activity Of SMAD2/SMAD3:SMAD4 Heterotrimer R-HSA-2173793,0.4229611002530141,0.8477776356740367,0.6819923371647509,1.0,1.0,11/51,6.45%,Nedd4l;Mapk1;Ncor1;Smad3;Hdac1;Ski;Ncor2;Mapk3;Cdk8;Ube2d3;Ube2d1
prerank,Nucleotide Catabolism R-HSA-8956319,0.45468091812142397,0.8475185928607912,0.6507352941176471,1.0,1.0,4/30,4.26%,Dpyd;Gda;Nt5c2;Upp2
prerank,Mitophagy R-HSA-5205647,-0.49609399281985167,-0.8472626497065552,0.7144754316069057,1.0,1.0,1/27,3.37%,Mfn1
prerank,Azathioprine ADME R-HSA-9748787,0.4783507373276225,0.8464286159331852,0.6373626373626373,1.0,1.0,1/19,0.64%,Vav3
prerank,Programmed Cell Death R-HSA-5357801,0.36018009928750727,0.8460580643290089,0.8564102564102564,1.0,1.0,28/188,7.31%,Dapk1;Ppp1r13b;Mapk1;Ppp3r1;Ptk2;Akt3;Unc5a;Sdcbp;Ocln;Nmt1;Ywhaz;Dcc;Ywhah;Ywhab;Peli1;Ctnnb1;Stk26;Ywhae;Mapk3;Rock1;Sptan1;Dsg2;Psmd13;Appl1;Bcl2l1;Tjp1;Dnm1l;Maged1
prerank,Signaling By ROBO Receptors R-HSA-376176,-0.4148013072727804,-0.845566277124403,0.7781908302354399,1.0,1.0,6/201,4.13%,Ldb2;Srgap1;Ntn1;Col4a5;Robo1;Srgap2
prerank,Presynaptic Function Of Kainate Receptors R-HSA-500657,0.4814715400737212,0.8453051207901074,0.6557377049180327,1.0,1.0,3/20,2.14%,Plcb1;Gng7;Gng2
prerank,Recycling Of Bile Acids And Salts R-HSA-159418,-0.5261078325570551,-0.8450108290989073,0.7186206896551725,1.0,1.0,6/15,21.77%,Baat;Slc27a5;Rxra;Nr1h4;Slc51a;Abcb11
prerank,COPI-mediated Anterograde Transport R-HSA-6807878,-0.45411793934942446,-0.8445643819257475,0.7367741935483871,1.0,1.0,1/76,0.04%,Ank1
prerank,PIWI-interacting RNA (piRNA) Biogenesis R-HSA-5601884,-0.4904878211494057,-0.8438314666274883,0.7027397260273973,1.0,1.0,4/29,18.69%,Tdrd6;Piwil1;Pld6;Tdrd9
prerank,Protein Folding R-HSA-391251,-0.4453984783316388,-0.8437955430771131,0.7353324641460235,1.0,1.0,11/87,11.83%,Fkbp9;Rgs6;Gng4;Kif13a;Tubb3;Gna15;Gnb4;Arfgef2;Gng12;Tubb4a;Gng3
prerank,MHC Class II Antigen Presentation R-HSA-2132295,-0.44880263020467487,-0.8423586291881061,0.7253886010362695,1.0,1.0,13/85,13.52%,Osbpl1a;Kif26a;Kif23;Sh3gl2;Lgmn;Ap2b1;Kif5a;Ctso;Ctsh;Cd74;Kif11;Ctsc;Lag3
prerank,Interleukin-6 Family Signaling R-HSA-6783589,0.4759421205448706,0.8421195046588292,0.6775510204081633,1.0,1.0,2/22,2.30%,Crlf1;Cbl
prerank,Cell Junction Organization R-HSA-446728,-0.45600172814963025,-0.8414256179305477,0.728494623655914,1.0,1.0,12/81,4.79%,Cdh18;Cdh6;Cdh10;Nectin3;Cdh4;Cdh19;Lama4;Sdk1;Cldn1;Ctnna1;Lims1;Arhgef6
prerank,Pyruvate Metabolism And Citric Acid (TCA) Cycle R-HSA-71406,-0.464193813962172,-0.8406222902257111,0.7440318302387268,1.0,1.0,10/52,19.01%,Adhfe1;Ldhal6b;Ldlr;Idh2;Slc16a1;Pdk4;Rxra;Ldhd;Ldha;Ldhb
prerank,MyD88 Cascade Initiated On Plasma Membrane R-HSA-975871,0.3860662660232916,0.8404905018672686,0.7397959183673469,1.0,1.0,23/90,8.92%,Mapk1;Map2k1;Map2k6;Jun;Rps6ka2;Mef2c;Tnip2;Peli1;Fbxw11;Mapk14;Peli2;Mapk3;Btrc;Map2k4;Mapk10;Irak1;Dusp4;Cul1;Uba52;Skp1;Mef2a;Nfkb1;Mapk7
prerank,G Beta:Gamma Signaling Thru PLC Beta R-HSA-418217,0.48221739153081716,0.8401651459086515,0.65748031496063,1.0,1.0,3/19,2.14%,Plcb1;Gng7;Gng2
prerank,RNA Polymerase II Transcription Termination R-HSA-73856,0.4205204184569937,0.83932576974768,0.7362204724409449,1.0,1.0,18/66,10.22%,Cdc40;Papola;Srsf1;Srsf9;Nudt21;Cstf3;Thoc2;Cpsf6;Srsf7;Srsf2;Pabpn1;Ncbp1;Cstf2t;Srsf11;Snrpb;Snrpd3;Wdr33;Cpsf7
prerank,RAF-independent MAPK1/3 Activation R-HSA-112409,-0.5069558605444452,-0.8392205433467831,0.7158469945355191,1.0,1.0,5/21,8.97%,Dusp10;Dusp5;Dusp16;Dusp6;Dusp2
prerank,Peroxisomal Lipid Metabolism R-HSA-390918,-0.5015120427975106,-0.8391775298319972,0.717032967032967,1.0,1.0,8/27,27.58%,Crot;Crat;Phyh;Nudt7;Abcd1;Acbd4;Sycp2;Aldh3a2
prerank,"PI5P, PP2A And IER3 Regulate PI3K/AKT Signaling R-HSA-6811558",-0.4422992658186749,-0.8377683127897639,0.7366310160427807,1.0,1.0,21/99,9.18%,Erbb4;Kit;Esr2;Nrg1;Gab2;Pik3r1;Fgf1;Fgfr3;Esr1;Pdgfra;Clstn1;Erbb3;Irak4;Cd86;Ppp2r5a;Cd80;Egfr;Vav1;Pdgfrb;Pik3ap1;Myd88
prerank,Regulation Of PLK1 Activity At G2/M Transition R-HSA-2565942,-0.4370307920957111,-0.8374598229773221,0.7409879839786382,1.0,1.0,6/86,11.84%,Optn;Nde1;Plk4;Alms1;Tubb4a;Prkca
prerank,Global Genome Nucleotide Excision Repair (GG-NER) R-HSA-5696399,0.3996716234523114,0.8370989250137282,0.7015503875968992,1.0,1.0,13/81,10.89%,Gtf2h2;Gtf2h5;Ccnh;Pias1;Ino80d;Sumo2;Ercc4;Uba52;Nfrkb;Gps1;Mnat1;Ino80e;Cops2
prerank,Cell-extracellular Matrix Interactions R-HSA-446353,-0.5226977508963822,-0.8355595436213196,0.7222982216142271,1.0,1.0,5/16,21.26%,Lims1;Arhgef6;Itgb1;Flnc;Vasp
prerank,Keratan Sulfate Biosynthesis R-HSA-2022854,0.4280447525703604,0.8352618232048699,0.6612903225806451,1.0,1.0,10/27,8.21%,B4galt1;Chst1;B4galt5;B3gnt2;B4galt4;B4galt6;St3gal3;B4gat1;Ogn;St3gal1
prerank,Voltage Gated Potassium Channels R-HSA-1296072,0.4381043997536548,0.8337587746463548,0.6931407942238267,1.0,1.0,13/43,4.16%,Kcnd2;Kcnab1;Kcnh1;Kcnc3;Kcnd3;Kcnq3;Kcng2;Kcnc4;Kcng1;Kcng3;Kcna1;Kcnab2;Kcns2
prerank,Toll Like Receptor 9 (TLR9) Cascade R-HSA-168138,0.37856369035058673,0.8325688454120121,0.743455497382199,1.0,1.0,25/100,8.92%,Mapk1;Map2k1;Map2k6;Jun;Rps6ka2;Mef2c;Tnip2;Peli1;Fbxw11;Mapk14;Peli2;Mapk3;Btrc;Map2k4;Mapk10;Irak1;Dusp4;Cul1;Rbsn;Uba52;Skp1;Mef2a;Nfkb1;Eea1;Mapk7
prerank,TRAF6 Mediated Induction Of NFkB And MAP Kinases Upon TLR7/8 Or 9 Activation R-HSA-975138,0.3777944989802917,0.8321354413787292,0.7329842931937173,1.0,1.0,23/95,8.92%,Mapk1;Map2k1;Map2k6;Jun;Rps6ka2;Mef2c;Tnip2;Peli1;Fbxw11;Mapk14;Peli2;Mapk3;Btrc;Map2k4;Mapk10;Irak1;Dusp4;Cul1;Uba52;Skp1;Mef2a;Nfkb1;Mapk7
prerank,HDR Thru Homologous Recombination (HRR) Or Single Strand Annealing (SSA) R-HSA-5693567,-0.4398596023791965,-0.8320099565601895,0.7576158940397351,1.0,1.0,8/101,13.56%,Rbbp8;Brip1;Bard1;Nsd2;Top3a;Cdk2;Artn;Xrcc2
prerank,PCNA-Dependent Long Patch Base Excision Repair R-HSA-5651801,-0.49283868298921774,-0.8311694417921517,0.7160326086956522,1.0,1.0,5/21,35.04%,Lrig1;Rfc2;Pold4;Rfc3;Rpa3
prerank,Glucose Metabolism R-HSA-70326,-0.4484154874562424,-0.8309723897724279,0.7549933422103862,1.0,1.0,15/79,21.63%,Pfkp;Pfkfb3;Pck2;Slc25a13;Map4k2;Prkca;G6pc3;Aldoc;Pfkfb4;Eno1;Mdh1;Hook2;Nup205;Slc37a2;Fbp1
prerank,RHOBTB GTPase Cycle R-HSA-9706574,-0.4841099269412771,-0.8302013324515733,0.7308707124010554,1.0,1.0,4/35,6.21%,Pde5a;Myo6;Msi2;Rhobtb1
prerank,Degradation Of GLI2 By Proteasome R-HSA-5610783,-0.4562240479008447,-0.8299460872785577,0.7387862796833773,1.0,1.0,3/58,11.84%,Gli2;Psmb8;Prkca
prerank,Positive Epigenetic Regulation Of rRNA Expression R-HSA-5250913,0.40496635139096615,0.8294376275190347,0.74,1.0,1.0,19/60,10.41%,Chd4;Chd3;Gatad2b;Hdac1;Baz1b;Mta2;Mta3;Cbx3;H2az1;Dek;H2ax;Rbbp7;Sf3b1;Ddx56;Smarca5;Polr1h;Rbbp4;H2ac4;Hdac2
prerank,Homology Directed Repair R-HSA-5693538,-0.43499244308700186,-0.82926944233691,0.7711640211640212,1.0,1.0,8/106,13.56%,Rbbp8;Brip1;Bard1;Nsd2;Top3a;Cdk2;Artn;Xrcc2
prerank,G2/M Checkpoints R-HSA-69481,-0.424086334143774,-0.8290041195680836,0.7554140127388536,1.0,1.0,10/135,12.19%,Rbbp8;Mcm10;Brip1;Bard1;Nsd2;Top3a;Cdk2;Mcm3;Psmb8;Artn
prerank,Molecules Associated With Elastic Fibres R-HSA-2129379,-0.4899335077360288,-0.8288969262267031,0.7236315086782377,1.0,1.0,9/27,8.54%,Ltbp1;Bmp2;Efemp2;Ltbp3;Vtn;Tgfb3;Bmp4;Fbln5;Itgb5
prerank,O-linked Glycosylation R-HSA-5173105,-0.4324144361338271,-0.8273079254383988,0.7638522427440633,1.0,1.0,10/98,4.36%,Galntl6;Thsd4;St6gal1;Adamtsl1;Adamts2;Adamts16;B3glct;Galnt6;Galnt9;B3gnt5
prerank,COPI-dependent Golgi-to-ER Retrograde Traffic R-HSA-6811434,0.38833776700277206,0.8264742094899149,0.7625,1.0,1.0,2/72,0.57%,Nsf;Kif26b
prerank,Activation Of SMO R-HSA-5635838,0.4632670227928114,0.8259756182056693,0.694980694980695,1.0,1.0,5/18,7.52%,Cdon;Efcab7;Csnk1a1;Ptch1;Grk2
prerank,Golgi-to-ER Retrograde Transport R-HSA-8856688,0.3701050156852597,0.8241129371699935,0.8009478672985783,1.0,1.0,10/105,6.27%,Nsf;Kif26b;Dync1i2;Capza2;Arf3;Dctn1;Kif5c;Capzb;Kif5b;Arf5
prerank,MyD88 Dependent Cascade Initiated On Endosome R-HSA-975155,0.37420431260223447,0.823771444473408,0.7566137566137566,1.0,1.0,23/96,8.92%,Mapk1;Map2k1;Map2k6;Jun;Rps6ka2;Mef2c;Tnip2;Peli1;Fbxw11;Mapk14;Peli2;Mapk3;Btrc;Map2k4;Mapk10;Irak1;Dusp4;Cul1;Uba52;Skp1;Mef2a;Nfkb1;Mapk7
prerank,Toll Like Receptor 7/8 (TLR7/8) Cascade R-HSA-168181,0.3736249843235425,0.822943031640391,0.7684210526315789,1.0,1.0,23/97,8.92%,Mapk1;Map2k1;Map2k6;Jun;Rps6ka2;Mef2c;Tnip2;Peli1;Fbxw11;Mapk14;Peli2;Mapk3;Btrc;Map2k4;Mapk10;Irak1;Dusp4;Cul1;Uba52;Skp1;Mef2a;Nfkb1;Mapk7
prerank,Negative Regulation Of PI3K/AKT Network R-HSA-199418,-0.4323853199205102,-0.8226958274748931,0.7730307076101469,1.0,1.0,21/106,9.18%,Erbb4;Kit;Esr2;Nrg1;Gab2;Pik3r1;Fgf1;Fgfr3;Esr1;Pdgfra;Clstn1;Erbb3;Irak4;Cd86;Ppp2r5a;Cd80;Egfr;Vav1;Pdgfrb;Pik3ap1;Myd88
prerank,G-protein Beta:Gamma Signaling R-HSA-397795,0.42806766865223717,0.822651282491172,0.7076923076923077,1.0,1.0,4/31,2.14%,Plcb1;Akt3;Gng7;Gng2
prerank,mRNA Decay By 3 To 5 Exoribonuclease R-HSA-429958,0.47119812408479517,0.8223765184874942,0.6642066420664207,1.0,1.0,8/15,25.05%,Exosc8;Nt5c3b;Hbs1l;Skic2;Exosc1;Dcps;Skic8;Dis3
prerank,Negative Regulation Of MET Activity R-HSA-6807004,0.45140389188621144,0.8213289127873072,0.6513409961685823,1.0,1.0,3/21,2.69%,Ptprj;Cbl;Sh3gl1
prerank,Smooth Muscle Contraction R-HSA-445355,0.426782186900344,0.8212183035603079,0.720754716981132,1.0,1.0,6/40,4.85%,Sorbs1;Cacna1h;Cald1;Anxa6;Calm1;Gucy1b1
prerank,Regulation Of Pyruvate Dehydrogenase (PDH) Complex R-HSA-204174,-0.5105216430993511,-0.8210747350693142,0.7449392712550608,1.0,1.0,4/15,22.62%,Pdk4;Rxra;Ldhd;Dlat
prerank,Cooperation Of PDCL (PhLP1) And TRiC/CCT In G-protein Beta Folding R-HSA-6814122,0.4328882622085723,0.8188281028898001,0.7196652719665272,1.0,1.0,4/36,2.14%,Rgs7;Gnaq;Gng7;Gng2
prerank,Oxygen-dependent Proline Hydroxylation Of Hypoxia-inducible Factor Alpha R-HSA-1234176,-0.44570954040860733,-0.8182824387439092,0.7547169811320755,1.0,1.0,4/63,12.39%,Egln3;Epas1;Psmb8;Limd1
prerank,Transferrin Endocytosis And Recycling R-HSA-917977,-0.4768763137460019,-0.8181085674452362,0.7158469945355191,1.0,1.0,4/28,9.85%,Steap2;Atp6v1b1;Tcirg1;Hfe
prerank,Lewis Blood Group Biosynthesis R-HSA-9037629,0.45133424350319545,0.8167185656569643,0.66015625,1.0,1.0,4/15,6.09%,B3galt5;B3galt1;St3gal3;Fut10
prerank,FGFR2 Mutant Receptor Activation R-HSA-1839126,-0.47639960171574924,-0.8162146034433232,0.7653478854024557,1.0,1.0,3/31,14.45%,Fgf1;Fgf16;Fgf17
prerank,Regulation Of PTEN Stability And Activity R-HSA-8948751,0.39968118820145804,0.8157836178683581,0.7403100775193798,1.0,1.0,19/67,17.85%,Akt3;Nedd4;Prex2;Tnks;Psmd13;Uba52;Stub1;Otud3;Psmc1;Psmd3;Psmd2;Psmc5;Psmb6;Tnks2;Psmb4;Pten;Psmd8;Usp13;Psmb3
prerank,tRNA Modification In Nucleus And Cytosol R-HSA-6782315,-0.47270684371622096,-0.8156104871048944,0.7595108695652174,1.0,1.0,1/39,2.74%,Trmt9b
prerank,HCMV Infection R-HSA-9609646,-0.4226524762793282,-0.8146490067520894,0.7947368421052632,1.0,1.0,8/104,12.69%,Tbl1x;Pcsk1;Egfr;Kcnh8;H2ac21;H2ac20;Vps25;H3c7
prerank,RAB GEFs Exchange GTP For GDP On RABs R-HSA-8876198,0.37061950772185276,0.8131008638288354,0.8230088495575221,1.0,1.0,15/84,8.84%,Sbf1;Akt3;Dennd1b;Rab27a;Dennd1a;Rab3ip;Dennd2b;Ric1;Ywhae;Rin1;Madd;Rab14;Sbf2;Trappc8;Rab10
prerank,Signaling By Interleukins R-HSA-449147,-0.3788775304431709,-0.8129446858995436,0.8836944127708096,1.0,1.0,72/407,15.05%,Socs2;Bcl2;Il34;Fn1;Stat5b;Ptpn14;Gab2;Pik3r1;Alpk1;Inppl1;S1pr1;Casp1;Stx1a;Clstn1;Nanos2;Csf3r;Irak4;App;Il15;Col1a2;Il17re;Il7;Dusp6;Cd86;Oprd1;Ptpn9;Sox2;Ptpn20;Tnfrsf1b;Irak3;Osmr;Cd80;Havcr2;Ifnlr1;Cish;Csf2rb;Il1rl2;Ptpn5;Vav1;Kcnh8;Hck;Ebi3;Mapk11;Myd88;Ptpn4;Irak2;Il17ra;Anxa1;Ccr5;Alox5;Nlrc5;Socs1;Vegfa;Gsdmd;Psmb8;Prkca;Maoa;Icam1;Mapk8;H3c7;Inpp5d;Rala;Ctf1;Rap1b;Rps6ka5;Stat5a;Nod2;Il7r;Ptpn13;Mmp2;Csf1r;Il17f
prerank,"Transport Of Vitamins, Nucleosides, And Related Molecules R-HSA-425397",-0.4720513724840947,-0.8108250685502584,0.7534435261707989,1.0,1.0,13/35,20.74%,Slco1c1;Slco2b1;Slco4a1;Slc28a3;Slc35d2;Slc29a3;Slc28a2;Apod;Nlrp3;Slc27a4;Arl2bp;Slc28a1;Slc27a6
prerank,Signaling By High-Kinase Activity BRAF Mutants R-HSA-6802948,0.4404867556165082,0.8108021719084478,0.6875,1.0,1.0,9/31,6.36%,Cnksr2;Mapk1;Map2k1;Ksr2;Ywhab;Ksr1;Mapk3;Araf;Src
prerank,Keratan Sulfate/Keratin Metabolism R-HSA-1638074,0.4167577305551303,0.8100837421940333,0.6859504132231405,1.0,1.0,10/32,8.21%,B4galt1;Chst1;B4galt5;B3gnt2;B4galt4;B4galt6;St3gal3;B4gat1;Ogn;St3gal1
prerank,Nucleotide Excision Repair R-HSA-5696398,0.3711469650666813,0.8092224176850401,0.8085106382978723,1.0,1.0,19/105,13.10%,Gtf2h2;Gtf2h5;Ccnh;Pias1;Ino80d;Sumo2;Ercc4;Uba52;Usp7;Nfrkb;Gps1;Mnat1;Ino80e;Cops2;Tcea1;Polr2k;Ercc2;Polr2e;Cops7a
prerank,E3 Ubiquitin Ligases Ubiquitinate Target Proteins R-HSA-8866654,-0.4520982106109681,-0.8086763744456426,0.7686062246278755,1.0,1.0,1/48,1.51%,Rnf152
prerank,Metabolism Of Nitric Oxide: NOS3 Activation And Regulation R-HSA-202131,-0.49153079274416556,-0.8086646720934626,0.7442489851150202,1.0,1.0,3/15,7.86%,Ddah1;Cav1;Tacr1
prerank,Synthesis Of PIPs At Plasma Membrane R-HSA-1660499,0.41110281455470554,0.8083350575689406,0.7296296296296296,1.0,1.0,3/51,1.56%,Pip5k1b;Plekha5;Plekha2
prerank,Elastic Fibre Formation R-HSA-1566948,-0.47157585134738467,-0.8075738094532842,0.771505376344086,1.0,1.0,9/37,8.54%,Ltbp1;Bmp2;Efemp2;Ltbp3;Vtn;Tgfb3;Bmp4;Fbln5;Itgb5
prerank,Cell-cell Junction Organization R-HSA-421270,-0.45180426075661806,-0.8064323182471981,0.7622282608695652,1.0,1.0,8/56,2.25%,Cdh18;Cdh6;Cdh10;Nectin3;Cdh4;Cdh19;Sdk1;Cldn1
prerank,ADP Signaling Thru P2Y Purinoceptor 12 R-HSA-392170,-0.49145824046139924,-0.8050273520930813,0.7631578947368421,1.0,1.0,6/21,11.83%,Gng4;Gnai1;Gnb4;Gnai2;Gng12;Gng3
prerank,Signaling To ERKs R-HSA-187687,0.44468542978739845,0.804651916489481,0.7518796992481203,1.0,1.0,7/33,4.58%,Bcl11b;Mapk1;Map2k1;Rit2;Ywhab;Mapk14;Mapk3
prerank,Signaling By NTRK1 (TRKA) R-HSA-187037,0.35963273447023886,0.804419387118571,0.808695652173913,1.0,1.0,17/112,5.13%,Bcl11b;Mapk1;Chd4;Map2k1;Adcyap1r1;Mef2d;Tcf12;Rit2;Rps6ka2;Mef2c;Dnm1;Cdk5r1;Ywhab;Mapk14;Mapk3;Pik3cb;Irs1
prerank,Signal Transduction By L1 R-HSA-445144,0.44555906414717805,0.8034182029571699,0.6879699248120301,1.0,1.0,4/20,1.66%,Nrp1;Mapk1;Ncam1;Map2k1
prerank,GAB1 Signalosome R-HSA-180292,-0.4946107378926418,-0.8030194504659433,0.7414030261348006,1.0,1.0,2/16,7.28%,Pik3r1;Egfr
prerank,Lysosome Vesicle Biogenesis R-HSA-432720,0.42644409712380604,0.8027712090658778,0.6958333333333333,1.0,1.0,8/32,11.15%,Clvs2;Ap1s2;Ap1g1;Clvs1;Ap4e1;Ap4m1;Ap1m1;Ap1s3
prerank,Regulation Of RAS By GAPs R-HSA-5658442,0.3931166891973424,0.8008827100378757,0.724,1.0,1.0,2/65,2.72%,Rasal2;Syngap1
prerank,Transcription-Coupled Nucleotide Excision Repair (TC-NER) R-HSA-6781827,0.37668204161676233,0.7997646380361744,0.7782101167315175,1.0,1.0,14/75,13.10%,Gtf2h2;Gtf2h5;Ccnh;Ercc4;Uba52;Usp7;Gps1;Mnat1;Cops2;Tcea1;Polr2k;Ercc2;Polr2e;Cops7a
prerank,Rab Regulation Of Trafficking R-HSA-9007101,-0.4211439420139868,-0.799645909715347,0.8219354838709677,1.0,1.0,8/115,9.63%,Optn;Rab31;Als2cl;Dennd3;Dennd5b;Rab32;Dennd1c;Tbc1d10c
prerank,MAP2K And MAPK Activation R-HSA-5674135,0.43624138434746784,0.7992775563463772,0.7316176470588235,1.0,1.0,9/35,6.36%,Cnksr2;Mapk1;Map2k1;Ksr2;Ywhab;Ksr1;Mapk3;Araf;Src
prerank,Energy Dependent Regulation Of mTOR By LKB1-AMPK R-HSA-380972,0.42790760277761075,0.7985229878578637,0.753731343283582,1.0,1.0,4/29,4.64%,Prkag2;Rragd;Rptor;Strada
prerank,DNA Double-Strand Break Repair R-HSA-5693532,-0.409947211570355,-0.7984758819776933,0.8190104166666666,1.0,1.0,11/135,13.56%,Rbbp8;Brip1;Bard1;Cnksr3;Nsd2;Top3a;Cdk2;Eya4;Artn;Mapk8;Xrcc2
prerank,Autophagy R-HSA-9612973,-0.406284951270394,-0.7953058573050379,0.8212435233160622,1.0,1.0,5/124,4.03%,Cftr;Mfn1;Prkaa2;Epas1;Prkab2
prerank,"Cell Cycle, Mitotic R-HSA-69278",-0.3627081522370807,-0.794767466573781,0.9342984409799554,1.0,1.0,47/487,17.05%,Optn;Prkcb;Vrk2;Cdc14a;Mcm10;Kif23;Nde1;Phlda1;Spdl1;Cenpn;Knl1;Tubb3;Lrig1;Ppp2r5a;Plk4;Cdkn1c;Cenpf;Ndc80;Alms1;Ncaph;Espl1;Top2a;Cdk2;H2ac20;Hmmr;Mcm3;Tubb4a;Psmb8;Prkca;H3c7;Ccnd3;Cks1b;E2f1;Cdt1;Phf8;Cdc25b;Nedd1;Sgo1;Cenpk;Cdkn2c;Foxm1;Dhfr;Bub1;Cnep1r1;Lyn;Spc25;Psma8
prerank,HATs Acetylate Histones R-HSA-3214847,0.37462752696412444,0.79443829201869,0.8362068965517241,1.0,1.0,17/92,11.28%,Kat6b;Crebbp;Ncoa1;Elp2;Rbbp7;Trrap;Zzz3;Tada1;Kansl1;Brpf3;Kat7;Msl1;Eny2;H2ac4;Epc1;H2ac6;Dr1
prerank,Adherens Junctions Interactions R-HSA-418990,-0.46825366400773155,-0.7925430856154152,0.7845528455284553,1.0,1.0,6/29,1.28%,Cdh18;Cdh6;Cdh10;Nectin3;Cdh4;Cdh19
prerank,HDMs Demethylate Histones R-HSA-3214842,-0.47577630437108737,-0.7916481396009605,0.7524071526822559,1.0,1.0,5/21,14.57%,Kdm4d;Kdm1b;Kdm3a;H3c7;Phf8
prerank,G2/M DNA Damage Checkpoint R-HSA-69473,-0.4404690355307462,-0.7905232902416462,0.7945578231292517,1.0,1.0,7/64,13.92%,Rbbp8;Brip1;Bard1;Nsd2;Top3a;Artn;Ywhaq
prerank,Nuclear Envelope (NE) Reassembly R-HSA-2995410,-0.42943127115946483,-0.7899399934572044,0.7718579234972678,1.0,1.0,3/65,11.36%,Vrk2;Tubb3;Tubb4a
prerank,Pyruvate Metabolism R-HSA-70268,-0.4626136197392112,-0.7893385321352319,0.7983761840324763,1.0,1.0,8/29,22.62%,Ldhal6b;Slc16a1;Pdk4;Rxra;Ldhd;Ldha;Ldhb;Dlat
prerank,VEGFA-VEGFR2 Pathway R-HSA-4420097,-0.4169887864799666,-0.7893292477966277,0.8252299605781866,1.0,1.0,12/91,6.45%,Dock1;Prkcb;Elmo1;Itpr2;Pik3r1;Vav2;Cav1;Axl;Prr5;Ctnna1;Ncf2;Cdh5
prerank,VLDLR Internalisation And Degradation R-HSA-8866427,-0.4861230775634122,-0.7890250652392058,0.7647058823529411,1.0,1.0,2/16,13.65%,Ap2b1;Nr1h2
prerank,Intrinsic Pathway For Apoptosis R-HSA-109606,0.40332434299614245,0.7886737718061433,0.7721518987341772,1.0,1.0,10/49,4.58%,Ppp1r13b;Mapk1;Ppp3r1;Akt3;Nmt1;Ywhaz;Ywhah;Ywhab;Ywhae;Mapk3
prerank,Metabolism Of Non-Coding RNA R-HSA-194441,0.4145734389470309,0.7883587867857977,0.7518518518518519,1.0,1.0,18/48,17.72%,Ndc1;Ranbp2;Ncbp1;Clns1a;Gemin8;Snrpb;Snrpd3;Wdr77;Phax;Pom121;Nup93;Gemin2;Snrpf;Nup155;Gemin5;Smn1;Nup54;Gemin4
prerank,Ion Transport By P-type ATPases R-HSA-936837,-0.44202830313161384,-0.7881314839893641,0.7803921568627451,1.0,1.0,8/51,4.47%,Camk2d;Atp10a;Atp13a4;Atp1a2;Atp8b1;Atp2c2;Fxyd1;Atp13a5
prerank,RNA Polymerase III Transcription Initiation R-HSA-76046,0.42647311663865567,0.7870566572521783,0.72,1.0,1.0,10/34,17.11%,Gtf3c1;Pou2f1;Gtf3c4;Gtf3c2;Polr2k;Polr2e;Brf1;Bdp1;Tbp;Gtf3a
prerank,Blood Group Systems Biosynthesis R-HSA-9033658,0.4366132767936255,0.786901835887856,0.7003891050583657,1.0,1.0,4/18,6.09%,B3galt5;B3galt1;St3gal3;Fut10
prerank,Polo-like Kinase Mediated Events R-HSA-156711,-0.47450392510961437,-0.7868946215235286,0.759493670886076,1.0,1.0,2/16,16.26%,Cenpf;Foxm1
prerank,Nuclear Events (Kinase And Transcription Factor Activation) R-HSA-198725,0.38361733379294616,0.7857398034508496,0.7838983050847458,1.0,1.0,9/59,4.58%,Mapk1;Chd4;Mef2d;Tcf12;Rps6ka2;Mef2c;Cdk5r1;Mapk14;Mapk3
prerank,Leishmania Infection R-HSA-9658195,-0.38399195888234916,-0.7857100708464211,0.8809523809523809,1.0,1.0,42/216,12.12%,Dock1;P2rx7;Elmo1;Rxfp1;Myo1e;Itpr2;Entpd1;Htr7;Vav2;Gng4;Casp1;Vipr2;Npsr1;Adrb3;Tshr;Lhcgr;Gnas;Prkar1b;Gnai1;Adcy8;Mc5r;Rxfp2;Hrh2;Plk2;Wipf1;C1qtnf1;P2rx4;Adora2b;Vav1;Wnt5a;Hck;Crh;Myo10;Gnb4;Ggt5;Adcy7;Gnai2;Gng12;Gsdmd;Gng3;Prkca;Crhr1
prerank,Potential Therapeutics For SARS R-HSA-9679191,0.36036645395349776,0.7834425680638905,0.8381742738589212,1.0,1.0,19/91,8.51%,Il1r1;Chd4;Phf21a;Chd3;Gatad2b;Hdac1;Plcg2;Atp1b1;Itga4;Mta2;Mta3;Rock1;Sh3kbp1;Grb2;Tyk2;Rbbp7;Fkbp1a;Brd4;Cul3
prerank,Neddylation R-HSA-8951664,0.31773413913489357,0.7833981117754705,0.9757575757575757,1.0,1.0,36/231,9.65%,Lmo7;Zbtb16;Fbxl7;Fbxo11;Klhl2;Fbxo41;Cul9;Klhl3;Fbxw11;Dcaf6;Cul5;Rbbp5;Btrc;Spsb1;Ube2d3;Psmd13;Ube2d1;Asb18;Fbxo31;Dcaf8;Rbbp7;Pum2;Cul1;Dcaf5;Obsl1;Fbxw10;Asb11;Uba52;Skp1;Cul3;Klhl5;Dcaf7;Klhl22;Fem1b;Commd9;Gps1
prerank,Protein Localization R-HSA-9609507,-0.3917241883834999,-0.7818227171699298,0.8591194968553459,1.0,1.0,16/151,16.80%,Stx1a;Nanos2;App;Cyb5a;Crot;Slc25a13;Pipox;Baat;Otc;Crat;Phyh;Glyat;Ldhd;Pex7;Ephx2;Nudt7
prerank,Cilium Assembly R-HSA-5617833,-0.3814221748369821,-0.7806182306024628,0.85785536159601,1.0,1.0,11/183,11.84%,Asap1;Bbs2;Sclt1;Nde1;Cep83;Plk4;Alms1;Atat1;Smox;Tubb4a;Prkca
prerank,Mitotic G2-G2/M Phases R-HSA-453274,-0.3820517380078667,-0.7803342579810068,0.8607277289836889,1.0,1.0,19/178,18.30%,Optn;Nde1;Phlda1;Plk4;Cenpf;Alms1;Cdk2;Hmmr;Tubb4a;Psmb8;Prkca;E2f1;Cdc25b;Nedd1;Foxm1;Psma8;Gtse1;Cep164;Ccp110
prerank,Chemokine Receptors Bind Chemokines R-HSA-380108,-0.451988785576103,-0.7799009061941109,0.7928669410150891,1.0,1.0,15/35,33.50%,Ccl28;Ccr5;Cxcr4;Ackr2;Cxcr2;Cxcl16;Ccr1;Xcr1;Ccr2;Cxcl5;Ccl19;Cxcl11;Ccrl2;Ccl4;Ccl1
prerank,Diseases Of Carbohydrate Metabolism R-HSA-5663084,0.4168256461308014,0.7798384320724898,0.7673611111111112,1.0,1.0,3/29,2.87%,Lct;Arsb;Galns
prerank,RHOF GTPase Cycle R-HSA-9035034,-0.4444525874803036,-0.7795137857378962,0.7896825396825397,1.0,1.0,8/39,8.18%,Farp1;Pik3r1;Cav1;Srgap2;Syde1;Akap12;Baiap2l2;Mcam
prerank,Cytochrome P450 - Arranged By Substrate Type R-HSA-211897,-0.4592764837440539,-0.7794281295236943,0.7978142076502732,1.0,1.0,8/33,15.88%,Arnt2;Tbxas1;Cyp27a1;Cyp26b1;Ahr;Rxra;Nr1h4;Cyp4b1
prerank,Termination Of O-glycan Biosynthesis R-HSA-977068,-0.466308199083601,-0.7792463154196189,0.7792732166890982,1.0,1.0,1/19,0.48%,St6gal1
prerank,SUMOylation Of DNA Methylation Proteins R-HSA-4655427,0.4581864101293959,0.7790890640543017,0.7346153846153847,1.0,1.0,5/15,12.68%,Phc2;Cbx4;Phc3;Dnmt1;Rnf2
prerank,SUMOylation Of Intracellular Receptors R-HSA-4090294,0.42606074774487906,0.7789923744717702,0.7428571428571429,1.0,1.0,1/29,0.18%,Nr3c2
prerank,Netrin-1 Signaling R-HSA-373752,-0.4378850407645486,-0.7784209700500448,0.8119079837618404,1.0,1.0,13/47,5.98%,Dock1;Ntn4;Trpc3;Unc5d;Trpc7;Ntn1;Prkcq;Rgma;Unc5c;Robo1;Unc5b;Slit2;Ezr
prerank,Activation Of BAD And Translocation To Mitochondria R-HSA-111447,-0.4811997204427927,-0.7762025438197981,0.7838196286472149,1.0,1.0,2/15,5.76%,Bcl2;Ppp3cc
prerank,DNA Repair R-HSA-73894,-0.36733414629699335,-0.7755637165064282,0.9112149532710281,1.0,1.0,19/288,12.59%,Rbbp8;Mgmt;Nthl1;Brip1;Bard1;Trim25;Usp43;Lrig1;Cnksr3;Dtl;Nsd2;Top3a;Cdk2;Eya4;H2ac20;Fancc;Isg15;Artn;Mapk8
prerank,Negative Regulation Of FGFR1 Signaling R-HSA-5654726,0.4219218673458662,0.7753902404211999,0.7631578947368421,1.0,1.0,9/30,8.63%,Mapk1;Cbl;Mapk3;Kl;Fgf5;Src;Grb2;Uba52;Frs2
prerank,G2/M Transition R-HSA-69275,-0.37882901033486127,-0.774791425374503,0.8775,1.0,1.0,11/176,11.84%,Optn;Nde1;Phlda1;Plk4;Cenpf;Alms1;Cdk2;Hmmr;Tubb4a;Psmb8;Prkca
prerank,Cellular Response To Hypoxia R-HSA-1234174,-0.41648693013705984,-0.7747824304807176,0.8031914893617021,1.0,1.0,5/71,12.39%,Egln3;Epas1;Vegfa;Psmb8;Limd1
prerank,Asymmetric Localization Of PCP Proteins R-HSA-4608870,-0.4250652579213062,-0.7743160990732055,0.8143631436314364,1.0,1.0,6/62,11.81%,Fzd2;Fzd4;Smurf1;Fzd9;Wnt5a;Psmb8
prerank,RHO GTPases Activate CIT R-HSA-5625900,0.44773080736788573,0.7742691300761743,0.7385159010600707,1.0,1.0,4/19,5.58%,Ppp1cb;Ppp1r12b;Rhob;Myh9
prerank,Lagging Strand Synthesis R-HSA-69186,-0.4667428381916251,-0.7723011955162996,0.7743243243243243,1.0,1.0,5/20,35.04%,Lrig1;Rfc2;Pold4;Rfc3;Rpa3
prerank,Activation Of BH3-only Proteins R-HSA-114452,0.42162389173687703,0.7713395592836806,0.7676348547717843,1.0,1.0,7/26,4.09%,Ppp1r13b;Ppp3r1;Akt3;Ywhaz;Ywhah;Ywhab;Ywhae
prerank,Signaling By FGFR4 R-HSA-5654743,-0.4484705608701979,-0.771223961263351,0.7895460797799174,1.0,1.0,2/37,2.21%,Pik3r1;Fgf1
prerank,Transcription Of E2F Targets Under Negative Control By P107 (RBL1) And P130 (RBL2) In Complex With HDAC1 R-HSA-1362300,0.44278336099856214,0.7711362792367001,0.7167235494880546,1.0,1.0,3/16,10.04%,Hdac1;Rbl2;Rbbp4
prerank,G Beta:Gamma Signaling Thru CDC42 R-HSA-8964616,-0.471102352806016,-0.7700940125726942,0.7908232118758435,1.0,1.0,5/19,11.83%,Gng4;Arhgef6;Gnb4;Gng12;Gng3
prerank,tRNA Processing In Nucleus R-HSA-6784531,-0.43025962325352474,-0.7693221913492642,0.8209366391184573,1.0,1.0,1/51,3.10%,Colec12
prerank,Cell Cycle Checkpoints R-HSA-69620,-0.37101021949034185,-0.7692199364834261,0.901840490797546,1.0,1.0,17/252,12.19%,Rbbp8;Mcm10;Nde1;Brip1;Bard1;Spdl1;Cenpn;Knl1;Ppp2r5a;Cenpf;Ndc80;Nsd2;Top3a;Cdk2;Mcm3;Psmb8;Artn
prerank,Signaling By TGFB Family Members R-HSA-9006936,-0.39794601286767894,-0.7679945378086567,0.8728923476005188,1.0,1.0,13/116,7.50%,Ltbp1;Wwtr1;Bmpr1b;Bmp2;Cgn;Amhr2;Col1a2;Smad2;Smurf1;Smad6;Ltbp3;Smad9;Tgfb3
prerank,Mitotic Prophase R-HSA-68875,-0.41065985181559317,-0.767432697830249,0.8562005277044855,1.0,1.0,2/95,1.56%,Prkcb;Vrk2
prerank,cGMP Effects R-HSA-418457,0.4503680059120515,0.7670151828582195,0.7022058823529411,1.0,1.0,3/15,3.44%,Prkg1;Pde1b;Kcnmb4
prerank,G-protein Activation R-HSA-202040,0.4275747680138398,0.7658011266827027,0.768595041322314,1.0,1.0,4/23,3.77%,Gnaq;Gng7;Gng2;Pdyn
prerank,"Transport Of Bile Salts And Organic Acids, Metal Ions And Amine Compounds R-HSA-425366",0.37006709447781155,0.7654822499643713,0.8803418803418803,1.0,1.0,6/80,2.22%,Slc44a5;Slc2a13;Slc39a6;Slc16a7;Slc6a15;Slc30a3
prerank,Prostacyclin Signaling Thru Prostacyclin Receptor R-HSA-392851,-0.4744490595751865,-0.7654223552838273,0.8108465608465608,1.0,1.0,5/18,11.83%,Gng4;Gnas;Gnb4;Gng12;Gng3
prerank,Post-chaperonin Tubulin Folding Pathway R-HSA-389977,-0.4684895241193716,-0.7651094493546741,0.784370477568741,1.0,1.0,2/17,11.36%,Tubb3;Tubb4a
prerank,Nuclear Pore Complex (NPC) Disassembly R-HSA-3301854,0.4125759131470948,0.7645747863000409,0.7717391304347826,1.0,1.0,6/32,12.52%,Nek6;Ndc1;Ranbp2;Nek7;Pom121;Nup93
prerank,Listeria Monocytogenes Entry Into Host Cells R-HSA-8876384,-0.46428277636049536,-0.7642521838361017,0.79702300405954,1.0,1.0,3/19,7.81%,Eps15;Sh3gl2;Stam2
prerank,Regulation Of HSF1-mediated Heat Shock Response R-HSA-3371453,0.36787414357982323,0.7618934945939452,0.8410041841004184,1.0,1.0,15/74,12.70%,Mapk1;Bag4;Ywhae;Mapk3;Hspa2;Ndc1;Ranbp2;Dnajb6;Tnfrsf21;Mapkapk2;Dnajc7;Hspa4;Pom121;Nup93;Hspa9
prerank,NR1H2 And NR1H3-mediated Signaling R-HSA-9024446,-0.4307717305443484,-0.7611317227578841,0.8171896316507503,1.0,1.0,6/41,7.02%,Tbl1x;Arl4c;Apoe;Abca1;Nrip1;Kdm1b
prerank,Sphingolipid De Novo Biosynthesis R-HSA-1660661,-0.43358832869426545,-0.7608043517200801,0.8149171270718232,1.0,1.0,5/44,5.40%,Prkd3;Plpp3;Sgpp2;Cers3;Fa2h
prerank,Signaling By EGFR R-HSA-177929,-0.4299096002261115,-0.7581750950240519,0.8292349726775956,1.0,1.0,7/48,7.81%,Pik3r1;Eps15;Sh3gl2;Adam12;Lrig1;Egfr;Stam2
prerank,HCMV Late Events R-HSA-9610379,-0.40889068636259174,-0.7575538747120519,0.8527443105756358,1.0,1.0,5/74,12.69%,Pcsk1;H2ac21;H2ac20;Vps25;H3c7
prerank,ER Quality Control Compartment (ERQC) R-HSA-901032,-0.45061180898951886,-0.7575399215055169,0.7983761840324763,1.0,1.0,5/21,23.00%,Edem1;Uggt2;Sel1l;Rnf103;Man1b1
prerank,Activation Of Kainate Receptors Upon Glutamate Binding R-HSA-451326,0.4004328852067786,0.7517514449949579,0.7546468401486989,1.0,1.0,5/28,2.14%,Grik4;Plcb1;Ncald;Gng7;Gng2
prerank,Formation Of Cornified Envelope R-HSA-6809371,-0.435120201391512,-0.7507764933949624,0.8207934336525308,1.0,1.0,11/33,21.41%,Kazn;Dsc3;Prss8;Klk12;Pcsk6;Rcan1;Lipm;St14;Tgm5;Lipk;Klk13
prerank,Amino Acids Regulate mTORC1 R-HSA-9639288,0.3735345691923853,0.7488995223863936,0.8415492957746479,1.0,1.0,9/53,8.65%,Fnip2;Atp6v1a;Rragd;Rptor;Mios;Kptn;Atp6v1c2;Atp6v0e2;Castor2
prerank,Negative Regulation Of MAPK Pathway R-HSA-5675221,-0.4185744613144531,-0.7475090460047727,0.8134228187919463,1.0,1.0,6/40,8.97%,Dusp10;Dusp5;Dusp16;Dusp6;Ppp2r5a;Dusp2
prerank,Resolution Of AP Sites Via Multiple-Nucleotide Patch Replacement Pathway R-HSA-110373,-0.44159425156061155,-0.7467739561870911,0.8179347826086957,1.0,1.0,5/25,35.04%,Lrig1;Rfc2;Pold4;Rfc3;Rpa3
prerank,MyD88:MAL(TIRAP) Cascade Initiated On Plasma Membrane R-HSA-166058,0.33682277310180214,0.7459158020902864,0.9259259259259259,1.0,1.0,23/106,8.92%,Mapk1;Map2k1;Map2k6;Jun;Rps6ka2;Mef2c;Tnip2;Peli1;Fbxw11;Mapk14;Peli2;Mapk3;Btrc;Map2k4;Mapk10;Irak1;Dusp4;Cul1;Uba52;Skp1;Mef2a;Nfkb1;Mapk7
prerank,Pre-NOTCH Processing In Golgi R-HSA-1912420,-0.46184270280484524,-0.7451954230018024,0.8205128205128205,1.0,1.0,5/18,11.43%,Lfng;St3gal6;Notch3;Atp2a3;Notch1
prerank,KEAP1-NFE2L2 Pathway R-HSA-9755511,-0.3927078555926483,-0.7451441619708689,0.8856041131105399,1.0,1.0,5/99,11.81%,Slc7a11;Brip1;Mafg;Notch1;Psmb8
prerank,TP53 Regulates Transcription Of Cell Death Genes R-HSA-5633008,-0.4356648944389487,-0.744430086151923,0.8191632928475033,1.0,1.0,2/32,2.96%,Cradd;Casp1
prerank,RHO GTPases Activate NADPH Oxidases R-HSA-5668599,-0.4419192282372551,-0.7440841294490009,0.8227334235453315,1.0,1.0,5/23,11.84%,Prkcb;Ncf2;Mapk11;Nox3;Prkca
prerank,Anti-inflammatory Response Favoring Leishmania Infection R-HSA-9662851,-0.37845720283730744,-0.7439477557777805,0.8946716232961586,1.0,1.0,29/139,12.12%,Rxfp1;Itpr2;Htr7;Gng4;Vipr2;Npsr1;Adrb3;Tshr;Lhcgr;Gnas;Prkar1b;Gnai1;Adcy8;Mc5r;Rxfp2;Hrh2;Plk2;C1qtnf1;Adora2b;Hck;Crh;Gnb4;Ggt5;Adcy7;Gnai2;Gng12;Gng3;Prkca;Crhr1
prerank,Keratinization R-HSA-6805567,-0.401877302986559,-0.7435906655385655,0.8548387096774194,1.0,1.0,18/60,24.61%,Kazn;Dsc3;Prss8;Klk12;Pcsk6;Rcan1;Krt25;Lipm;Krt26;Krt79;St14;Tgm5;Lipk;Krt77;Klk13;Krt24;Krt80;Perp
prerank,Acyl Chain Remodelling Of PS R-HSA-1482801,-0.44953008969293073,-0.7435529356306595,0.8145695364238411,1.0,1.0,8/21,18.07%,Pla2g5;Osbpl10;Mboat1;Pla2g4a;Osbpl8;Pla2r1;Pla1a;Pla2g10
prerank,Termination Of Translesion DNA Synthesis R-HSA-5656169,-0.4244999826756774,-0.7434682163571662,0.8348868175765646,1.0,1.0,3/32,12.06%,Trim25;Usp43;Isg15
prerank,Sealing Of Nuclear Envelope (NE) By ESCRT-III R-HSA-9668328,-0.4454671209101917,-0.7427436869178095,0.8255977496483825,1.0,1.0,2/22,11.36%,Tubb3;Tubb4a
prerank,Thromboxane Signaling Thru TP Receptor R-HSA-428930,0.41382621453052454,0.7413178326892672,0.8049792531120332,1.0,1.0,3/23,2.14%,Gnaq;Gng7;Gng2
prerank,Metal Ion SLC Transporters R-HSA-425410,0.4024465762575095,0.7410460398423394,0.7765151515151515,1.0,1.0,3/26,5.45%,Slc39a6;Slc30a3;Slc39a14
prerank,Circadian Clock R-HSA-400253,-0.40831142093174694,-0.7402005581125316,0.8736559139784946,1.0,1.0,6/65,7.20%,Tbl1x;Npas2;Cpt1a;Smarcd3;Nrip1;Ppargc1a
prerank,Negative Regulation Of FGFR3 Signaling R-HSA-5654732,-0.44237460674527296,-0.7401181639550045,0.8285322359396433,1.0,1.0,2/27,2.36%,Fgf1;Fgfr3
prerank,DNA Damage Recognition In GG-NER R-HSA-5696394,0.3936462832064402,0.7397492344004507,0.8037735849056604,1.0,1.0,11/36,16.88%,Ino80d;Uba52;Nfrkb;Gps1;Ino80e;Cops2;Cops7a;Actl6a;Ino80b;Cops8;Mcrs1
prerank,Estrogen-dependent Nuclear Events Downstream Of ESR-membrane Signaling R-HSA-9634638,0.40548876224253083,0.7396560033749247,0.7845528455284553,1.0,1.0,4/23,1.85%,Mapk1;Tgfa;Ptk2;Akt3
prerank,Initial Triggering Of Complement R-HSA-166663,-0.45100501834972373,-0.7386186848280093,0.820979020979021,1.0,1.0,2/15,15.01%,Masp1;Cfb
prerank,Regulation Of mRNA Stability By Proteins That Bind AU-rich Elements R-HSA-450531,-0.39245049563134166,-0.7385978996897746,0.8791500664010624,1.0,1.0,5/87,11.84%,Enpp2;Zfp36l1;Mapk11;Psmb8;Prkca
prerank,Apoptotic Cleavage Of Cellular Proteins R-HSA-111465,-0.42367012084012323,-0.7385188658980576,0.841897233201581,1.0,1.0,5/36,8.81%,Prkcq;Casp7;Gsn;Gas2;Satb1
prerank,Regulation Of NF-kappa B Signaling R-HSA-9758274,-0.4441801107952498,-0.738305847558634,0.8262032085561497,1.0,1.0,2/17,15.86%,Nlrc5;Usp14
prerank,trans-Golgi Network Vesicle Budding R-HSA-199992,0.3556770556474984,0.7380528472948217,0.8362831858407079,1.0,1.0,10/66,6.72%,Clvs2;Ap3b1;Tbc1d8b;Tpd52l1;Sort1;Pum1;Ap1s2;Picalm;Ap1g1;Clvs1
prerank,"GABA Synthesis, Release, Reuptake And Degradation R-HSA-888590",0.42324955871733566,0.7361518521706601,0.8081180811808119,1.0,1.0,1/19,0.38%,Rims1
prerank,Chromosome Maintenance R-HSA-73886,-0.3864029302448798,-0.7350219663023864,0.888030888030888,1.0,1.0,8/103,10.86%,Ankrd28;Hjurp;Cenpn;Knl1;Lrig1;Chtf18;Cdk2;H2ac20
prerank,Deubiquitination R-HSA-5688426,0.2971321102356734,0.7348708995472111,1.0,1.0,1.0,29/246,8.69%,Mbd5;Tgfbr1;Zranb1;Usp2;Otud7a;Smad3;Tnip2;Foxk1;Usp47;Usp15;Usp32;Mysm1;Rnf128;Ino80d;Tnks;Usp34;Otub2;Psmd13;Babam2;Ube2d1;Usp12;Axin2;Trrap;Brcc3;Otud5;Uba52;Usp7;Otub1;Tomm20
prerank,COPI-independent Golgi-to-ER Retrograde Traffic R-HSA-6811436,0.38996284515562896,0.7343615510168261,0.8,1.0,1.0,4/33,5.60%,Dync1i2;Capza2;Dctn1;Capzb
prerank,Hyaluronan Metabolism R-HSA-2142845,0.4292476425745451,0.7338458133073976,0.7811320754716982,1.0,1.0,1/15,1.05%,Cemip
prerank,NR1H3 And NR1H2 Regulate Gene Expression Linked To Cholesterol Transport And Efflux R-HSA-9029569,-0.41929086187617615,-0.7332191067691227,0.8365650969529086,1.0,1.0,5/34,7.02%,Tbl1x;Arl4c;Apoe;Abca1;Kdm1b
prerank,Hedgehog Off State R-HSA-5610787,-0.38095526135859187,-0.7325193854023524,0.8888888888888888,1.0,1.0,7/97,5.33%,Gli3;Gli2;Gpr161;Gnas;Prkar1b;Adcy8;Intu
prerank,VEGFR2 Mediated Vascular Permeability R-HSA-5218920,-0.4289784457561698,-0.7322185783562837,0.8283378746594006,1.0,1.0,6/26,8.38%,Vav2;Cav1;Prr5;Ctnna1;Cdh5;Vav1
prerank,FBXL7 Down-Regulates AURKA During Mitotic Entry And In Early Mitosis R-HSA-8854050,0.36196030984312577,0.7318479230499327,0.824,1.0,1.0,14/54,17.85%,Fbxl7;Psmd13;Cul1;Uba52;Skp1;Psmc1;Fbxl18;Psmd3;Psmd2;Psmc5;Psmb6;Psmb4;Psmd8;Psmb3
prerank,Miscellaneous Transport And Binding Events R-HSA-5223345,0.41154254101934146,0.7317919201051375,0.7668918918918919,1.0,1.0,1/21,0.95%,Add2
prerank,Negative Regulation Of FGFR2 Signaling R-HSA-5654727,0.38996878163121185,0.7317486924841854,0.8106060606060606,1.0,1.0,8/32,8.63%,Mapk1;Cbl;Mapk3;Fgf5;Src;Grb2;Uba52;Frs2
prerank,Activated TAK1 Mediates P38 MAPK Activation R-HSA-450302,0.41949605124323486,0.7308329781124329,0.786046511627907,1.0,1.0,6/19,11.70%,Map2k6;Mapk14;Irak1;Mapkapk2;Ripk2;Tab2
prerank,MyD88-independent TLR4 Cascade R-HSA-166166,0.3362442744311849,0.7306382941580002,0.9444444444444444,1.0,1.0,23/100,8.92%,Mapk1;Map2k1;Map2k6;Jun;Rps6ka2;Mef2c;Tnip2;Fbxw11;Mapk14;Mapk3;Btrc;Map2k4;Ube2d3;Mapk10;Ube2d1;Irak1;Dusp4;Cul1;Uba52;Skp1;Mef2a;Nfkb1;Mapk7
prerank,Nitric Oxide Stimulates Guanylate Cyclase R-HSA-392154,0.41450637174898014,0.7304601019785288,0.7635135135135135,1.0,1.0,3/21,3.44%,Prkg1;Pde1b;Kcnmb4
prerank,Ephrin Signaling R-HSA-3928664,0.40722713966464863,0.7296073684111445,0.7874564459930313,1.0,1.0,7/18,6.99%,Sdcbp;Nck2;Efnb3;Arhgef7;Fyn;Src;Ephb2
prerank,Telomere Maintenance R-HSA-157579,-0.3930363700747777,-0.7285914359845848,0.8727034120734908,1.0,1.0,5/78,10.86%,Ankrd28;Lrig1;Chtf18;Cdk2;H2ac20
prerank,Gap-filling DNA Repair Synthesis And Ligation In TC-NER R-HSA-6782210,0.35445594045130285,0.7239601137386388,0.8876404494382022,1.0,1.0,10/62,12.87%,Gtf2h2;Gtf2h5;Ccnh;Uba52;Usp7;Mnat1;Tcea1;Polr2k;Ercc2;Polr2e
prerank,Cleavage Of Damaged Pyrimidine R-HSA-110329,-0.42477903583851817,-0.7233603720887065,0.8284574468085106,1.0,1.0,4/29,22.29%,Nthl1;H2ac20;Terf1;H2bc3
prerank,Unattached Kinetochores Signal Amplification Via A MAD2 Inhibitory Signal R-HSA-141444,-0.38503858738766994,-0.7230976049495056,0.896978021978022,1.0,1.0,11/89,16.81%,Nde1;Spdl1;Cenpn;Knl1;Ppp2r5a;Cenpf;Ndc80;Sgo1;Cenpk;Bub1;Spc25
prerank,Toll Like Receptor 3 (TLR3) Cascade R-HSA-168164,0.3303525999803805,0.7209654000360082,0.9408866995073891,1.0,1.0,23/97,8.92%,Mapk1;Map2k1;Map2k6;Jun;Rps6ka2;Mef2c;Tnip2;Fbxw11;Mapk14;Mapk3;Btrc;Map2k4;Ube2d3;Mapk10;Ube2d1;Irak1;Dusp4;Cul1;Uba52;Skp1;Mef2a;Nfkb1;Mapk7
prerank,Metabolic Disorders Of Biological Oxidation Enzymes R-HSA-5579029,0.3948989732580775,0.7161836526013544,0.8117647058823529,1.0,1.0,1/28,0.63%,Cyp7b1
prerank,Glycolysis R-HSA-70171,-0.3943282629403244,-0.7158333113473424,0.8773584905660378,1.0,1.0,7/62,17.04%,Pfkp;Pfkfb3;Map4k2;Prkca;Aldoc;Pfkfb4;Eno1
prerank,Telomere C-strand (Lagging Strand) Synthesis R-HSA-174417,-0.41860693259809256,-0.7155550963507449,0.8605577689243028,1.0,1.0,4/32,22.09%,Lrig1;Chtf18;Terf1;Rfc2
prerank,Mitochondrial tRNA Aminoacylation R-HSA-379726,0.40200574435287406,0.7153451686591636,0.803030303030303,1.0,1.0,2/18,4.21%,Dtd1;Fars2
prerank,Regulation Of TP53 Activity Thru Methylation R-HSA-6804760,0.40920184547869815,0.713984782227988,0.792156862745098,1.0,1.0,7/17,16.23%,Kmt5a;Ehmt1;Uba52;Smyd2;Chek2;Atm;Ttc5
prerank,Viral Messenger RNA Synthesis R-HSA-168325,0.37028153453278556,0.7130908359895745,0.8764044943820225,1.0,1.0,12/43,17.18%,Gtf2f2;Ndc1;Ranbp2;Polr2k;Pom121;Nup93;Gtf2f1;Polr2e;Gnl3;Nup155;Bloc1s6;Nup54
prerank,CTLA4 Inhibitory Signaling R-HSA-389513,-0.42419757645591305,-0.7122891147746384,0.8367071524966262,1.0,1.0,3/21,7.12%,Cd86;Ppp2r5a;Cd80
prerank,ADORA2B Mediated Anti-Inflammatory Cytokine Production R-HSA-9660821,-0.37273403101641267,-0.7113177675723376,0.9245524296675192,1.0,1.0,25/111,12.12%,Rxfp1;Htr7;Gng4;Vipr2;Npsr1;Adrb3;Tshr;Lhcgr;Gnas;Prkar1b;Gnai1;Adcy8;Mc5r;Rxfp2;Hrh2;C1qtnf1;Adora2b;Crh;Gnb4;Adcy7;Gnai2;Gng12;Gng3;Prkca;Crhr1
prerank,Apoptotic Execution Phase R-HSA-75153,-0.3993558979519394,-0.7086964290950744,0.8797814207650273,1.0,1.0,5/44,8.81%,Prkcq;Casp7;Gsn;Gas2;Satb1
prerank,RHOH GTPase Cycle R-HSA-9013407,0.38150550053866467,0.7085681938605018,0.8426966292134831,1.0,1.0,5/34,4.94%,Slc4a7;Dbn1;Ralgapa1;Wdr11;Rock1
prerank,Phase II - Conjugation Of Compounds R-HSA-156580,-0.38425863000856275,-0.707193207222301,0.9057591623036649,1.0,1.0,19/74,30.83%,Ugp2;Slc38a3;Ggt5;Gstt2;Glyat;Slc38a1;Podxl2;Gsta2;Gstm2;Gclc;Ugdh;Gstt1;Slc35b3;Mat1a;Slc26a2;Mgst3;Gclm;Ggt1;As3mt
prerank,"Base-Excision Repair, AP Site Formation R-HSA-73929",-0.41258091574902567,-0.7066487301548601,0.8475935828877005,1.0,1.0,2/31,10.86%,Nthl1;H2ac20
prerank,BBSome-mediated Cargo-Targeting To Cilium R-HSA-5620922,-0.41823490921279305,-0.704300531514481,0.8383311603650587,1.0,1.0,2/23,9.94%,Bbs2;Smox
prerank,Negative Regulation Of FGFR4 Signaling R-HSA-5654733,0.38889131962654544,0.704159335199992,0.8544776119402985,1.0,1.0,7/28,8.63%,Mapk1;Cbl;Mapk3;Src;Grb2;Uba52;Frs2
prerank,Senescence-Associated Secretory Phenotype (SASP) R-HSA-2559582,0.3476466306322303,0.7036152917783163,0.9230769230769231,1.0,1.0,14/66,8.92%,Mapk1;Jun;Rps6ka2;Cebpb;Mapk3;Ube2d1;Cdk6;Ehmt1;H2az1;H2ax;Uba52;Cdc27;Nfkb1;Mapk7
prerank,Signaling By EGFR In Cancer R-HSA-1643713,-0.4133603975513598,-0.701674978015019,0.8655692729766804,1.0,1.0,2/23,7.28%,Pik3r1;Egfr
prerank,Glucagon-type Ligand Receptors R-HSA-420092,-0.4157852585705813,-0.7004681926408212,0.8796895213454075,1.0,1.0,7/29,11.83%,Gng4;Vipr2;Gnas;C1qtnf1;Gnb4;Gng12;Gng3
prerank,DNA Damage/Telomere Stress Induced Senescence R-HSA-2559586,-0.400081149246226,-0.7002408455573081,0.8672922252010724,1.0,1.0,7/40,23.29%,Hmga2;Cdk2;H2ac20;Artn;Terf1;H2bc3;Lmnb1
prerank,Meiosis R-HSA-1500620,0.3334253662060562,0.6998085549749992,0.9267241379310345,1.0,1.0,1/72,0.45%,Syne1
prerank,Translesion Synthesis By POLI R-HSA-5656121,0.40644556641638474,0.6985637254140158,0.7816091954022989,1.0,1.0,2/17,8.25%,Rev1;Uba52
prerank,SARS-CoV-2 Activates/Modulates Innate And Adaptive Immune Responses R-HSA-9705671,-0.36613987618050814,-0.6985577012856226,0.9192708333333334,1.0,1.0,17/94,24.37%,Ikbke;Trim25;Masp1;Irak2;Il17ra;Isg15;Ifih1;Nod2;Il17f;Tlr1;Nlrp3;Traf3;Irf7;Nup205;Nod1;Sec24a;Kpna2
prerank,Inhibition Of DNA Recombination At Telomere R-HSA-9670095,0.3647522819782548,0.6984651222179751,0.90234375,1.0,1.0,9/34,13.57%,Atrx;H2az1;H2ax;Terf2;H2ac4;H2ac6;Polr2k;Polr2e;Terf2ip
prerank,Processive Synthesis On C-strand Of Telomere R-HSA-174414,-0.4290535159944857,-0.6982985625727607,0.8651535380507344,1.0,1.0,2/18,18.76%,Lrig1;Terf1
prerank,Regulation Of TP53 Degradation R-HSA-6804757,0.3603305546094009,0.6977309054144489,0.8210116731517509,1.0,1.0,2/35,2.39%,Akt3;Usp2
prerank,Sphingolipid Metabolism R-HSA-428157,-0.3721145179504926,-0.6959238729349665,0.9094540612516645,1.0,1.0,16/80,15.44%,Prkd3;Plpp3;Sgpp2;Cers3;Fa2h;Asah1;Gltp;Cerk;Neu4;Sptssa;Arsa;Arsg;Sphk1;Plpp2;Asah2;Sptlc2
prerank,ADP Signaling Thru P2Y Purinoceptor 1 R-HSA-418592,0.3831618177289762,0.695660483880438,0.8458333333333333,1.0,1.0,4/24,3.88%,Gnaq;Gng7;Gng2;Mapk14
prerank,DAP12 Signaling R-HSA-2424491,0.3882445063100637,0.6954648375783673,0.8098591549295775,1.0,1.0,4/26,4.80%,Vav3;Plcg2;Pik3cb;Fyn
prerank,Translesion Synthesis By REV1 R-HSA-110312,0.4093180223024483,0.6947102232468058,0.784,1.0,1.0,2/16,8.25%,Rev1;Uba52
prerank,Base Excision Repair R-HSA-73884,-0.3845999062714748,-0.6943821073396544,0.8918558077436582,1.0,1.0,3/59,10.86%,Nthl1;Lrig1;H2ac20
prerank,tRNA Aminoacylation R-HSA-379724,0.3797961360388557,0.6936330762785868,0.828125,1.0,1.0,3/26,6.42%,Dtd1;Fars2;Farsa
prerank,Neutrophil Degranulation R-HSA-6798695,-0.32158987797680477,-0.6935584027268861,0.9954853273137697,1.0,1.0,59/395,15.17%,Dlc1;Padi2;Rab31;Rab37;Ghdc;Arhgap45;Ptprn2;Vcl;Plppr3;Iqgap1;Frmpd3;Trpm2;Qpct;Ttr;Fuca1;Cd93;Gusb;Manba;Timp2;Tnfrsf1b;Gsn;Cst3;Ptprb;Asah1;Cd44;Mmp28;Plekho2;Cd63;Stbd1;Tcirg1;Bst2;Dock2;Tbc1d10c;Abca13;Hebp2;Ctsh;Syngr1;Anpep;Alox5;Tmem63a;Gsdmd;Tarm1;Dnajc13;Lair1;Mcemp1;Rcan1;Tnfaip6;Hvcn1;Ctsc;Slc11a1;Rap1b;Tmbim1;Ostf1;Crispld2;Arsa;Aldoc;Glyat;Pgm2;Dera
prerank,Gap-filling DNA Repair Synthesis And Ligation In GG-NER R-HSA-5696397,-0.40943957110829265,-0.6929813121809735,0.8795669824086604,1.0,1.0,6/25,35.04%,Lrig1;Rfc2;Pold4;Rfc3;Lrig3;Rpa3
prerank,Unfolded Protein Response (UPR) R-HSA-381119,0.32192978878096346,0.691825919046143,0.9555555555555556,1.0,1.0,9/85,5.78%,Atf6;Mbtps2;Extl2;Pdia5;Khsrp;Dctn1;Cebpb;Ssr1;Exosc8
prerank,Negative Regulation Of NOTCH4 Signaling R-HSA-9604323,0.34902865432153285,0.6908562525469237,0.9015748031496063,1.0,1.0,14/53,17.85%,Ywhaz;Psmd13;Cul1;Uba52;Skp1;Psmc1;Psmd3;Psmd2;Psmc5;Psmb6;Psmb4;Psmd8;Notch4;Psmb3
prerank,Translesion Synthesis By POLK R-HSA-5655862,0.399179028956056,0.6886923885816952,0.7817460317460317,1.0,1.0,2/17,8.25%,Rev1;Uba52
prerank,"Plasma Lipoprotein Assembly, Remodeling, And Clearance R-HSA-174824",-0.3774502339660307,-0.6880209193516111,0.9126984126984127,1.0,1.0,11/61,13.65%,Lcat;Apoe;Abca1;Lipg;Ap2b1;Ldlrap1;Angptl4;Ldlr;Pcsk6;Prkca;Nr1h2
prerank,Cristae Formation R-HSA-8949613,0.39590072194860493,0.6877983525391487,0.819672131147541,1.0,1.0,7/15,12.70%,Chchd3;Apool;Micos13;Micos10;Apoo;Dmac2l;Hspa9
prerank,Golgi Associated Vesicle Biogenesis R-HSA-432722,-0.38625229080211876,-0.6877663142029466,0.9084791386271871,1.0,1.0,5/52,7.48%,Hip1r;Homer2;Tpd52;Sh3gl2;Dtnbp1
prerank,Formation Of Tubulin Folding Intermediates By CCT/TriC R-HSA-389960,-0.41467444866618786,-0.6870865752069099,0.8672199170124482,1.0,1.0,2/20,11.36%,Tubb3;Tubb4a
prerank,CD209 (DC-SIGN) Signaling R-HSA-5621575,-0.423204512027184,-0.6867950466806594,0.8481894150417827,1.0,1.0,6/16,17.12%,Prkca;Relb;Rps6ka5;Lyn;Pkn2;Rela
prerank,RHO GTPases Activate PAKs R-HSA-5627123,0.39220282113337634,0.6860785606663358,0.8411552346570397,1.0,1.0,5/21,5.58%,Ppp1cb;Ppp1r12b;Calm1;Arhgef7;Myh9
prerank,Translesion Synthesis By Y Family DNA Polymerases Bypasses Lesions On DNA Template R-HSA-110313,-0.3845891941986766,-0.6856083294886282,0.8948069241011984,1.0,1.0,3/39,12.06%,Trim25;Usp43;Isg15
prerank,Triglyceride Catabolism R-HSA-163560,-0.42289877353649247,-0.6834903991501488,0.8556149732620321,1.0,1.0,3/18,12.43%,Cav1;Prkca;Fabp7
prerank,Processing Of Intronless Pre-mRNAs R-HSA-77595,0.38809604658852537,0.6814856232256972,0.7831325301204819,1.0,1.0,9/20,10.22%,Papola;Nudt21;Cstf3;Cpsf6;Pabpn1;Ncbp1;Cstf2t;Wdr33;Cpsf7
prerank,Transcriptional Regulation By VENTX R-HSA-8853884,-0.3930130047034074,-0.6807098317441731,0.8913043478260869,1.0,1.0,2/37,2.72%,Tcf7l2;Lef1
prerank,APC/C-mediated Degradation Of Cell Cycle Proteins R-HSA-174143,-0.3601291189281373,-0.6804463637689155,0.934228187919463,1.0,1.0,3/87,11.81%,Cdc14a;Cdk2;Psmb8
prerank,Signal Amplification R-HSA-392518,-0.39892031353808577,-0.6801635186199094,0.9003880983182406,1.0,1.0,9/32,13.36%,Gng4;Gnai1;Gna15;P2ry1;Gnb4;Gnai2;Gng12;Gng3;Pla2g4a
prerank,TNFR1-induced NFkappaB Signaling Pathway R-HSA-5357956,-0.4066618364245967,-0.6798322687561685,0.8866396761133604,1.0,1.0,1/26,3.38%,Birc3
prerank,Toll-like Receptor Cascades R-HSA-168898,-0.3440515422811878,-0.6793239627003064,0.9706959706959707,1.0,1.0,33/152,18.52%,Alpk1;Birc3;Ikbke;Irak4;App;Dusp6;Lgmn;Irak3;Tlr3;Kcnh8;Mapk11;Cd180;Myd88;Ptpn4;Irak2;S100a1;Nlrc5;Socs1;Gsdmd;Ly86;Mapk8;Rps6ka5;Nod2;Nkiras1;Map3k1;Usp14;Tlr1;Rela;Tlr4;Sarm1;Traf3;Itgam;Tlr5
prerank,DAP12 Interactions R-HSA-2172127,0.3764622190566698,0.6781736990392103,0.8817204301075269,1.0,1.0,4/30,4.80%,Vav3;Plcg2;Pik3cb;Fyn
prerank,DNA Damage Bypass R-HSA-73893,-0.3716057674327783,-0.678008796239849,0.9073569482288828,1.0,1.0,4/48,12.06%,Trim25;Usp43;Dtl;Isg15
prerank,Chondroitin Sulfate Biosynthesis R-HSA-2022870,-0.41113647307239665,-0.6769602026333811,0.871244635193133,1.0,1.0,6/19,9.90%,Bcan;Vcan;Chst3;Cspg5;Dcn;Cspg4
prerank,Acyl Chain Remodelling Of PE R-HSA-1482839,-0.3989532218087536,-0.6754312806002126,0.8948051948051948,1.0,1.0,8/26,18.07%,Pla2g5;Pla2g4c;Plaat1;Mboat1;Pla2g4a;Pla2r1;Pnpla8;Pla2g10
prerank,Reproduction R-HSA-1474165,0.31242023441988287,0.6732854335398506,0.9742489270386266,1.0,1.0,2/90,1.97%,Syne1;B4galt1
prerank,Recycling Pathway Of L1 R-HSA-437239,-0.398540480173165,-0.673125147348488,0.895397489539749,1.0,1.0,4/25,6.18%,Sh3gl2;L1cam;Ezr;Ap2b1
prerank,Endogenous Sterols R-HSA-211976,0.38726236866005315,0.6702767460805712,0.8638132295719845,1.0,1.0,1/21,0.63%,Cyp7b1
prerank,Platelet Sensitization By LDL R-HSA-432142,-0.408406332339846,-0.6694963424747631,0.8923705722070845,1.0,1.0,5/17,26.85%,Ppp2r5a;Pla2g4a;Pecam1;Ppp2r5c;Fgr
prerank,Mitotic Spindle Checkpoint R-HSA-69618,-0.34476042860960276,-0.6645937307696997,0.9531459170013387,1.0,1.0,7/106,8.14%,Nde1;Spdl1;Cenpn;Knl1;Ppp2r5a;Cenpf;Ndc80
prerank,Mitotic Anaphase R-HSA-68882,-0.3211298145972681,-0.6645280761978474,0.9900373599003736,1.0,1.0,17/218,17.05%,Vrk2;Nde1;Spdl1;Cenpn;Knl1;Tubb3;Ppp2r5a;Cenpf;Ndc80;Espl1;Tubb4a;Psmb8;Sgo1;Cenpk;Bub1;Spc25;Psma8
prerank,IL-6-type Cytokine Receptor Ligand Interactions R-HSA-6788467,0.3805239741927597,0.6638981936082439,0.8157894736842105,1.0,1.0,1/16,1.57%,Crlf1
prerank,Diseases Associated With N-glycosylation Of Proteins R-HSA-3781860,0.3843833588137685,0.6637313633931265,0.8617886178861789,1.0,1.0,1/20,1.97%,B4galt1
prerank,Mitotic Metaphase And Anaphase R-HSA-2555396,-0.31988222669418415,-0.6629180954197758,0.9900744416873449,1.0,1.0,17/219,17.05%,Vrk2;Nde1;Spdl1;Cenpn;Knl1;Tubb3;Ppp2r5a;Cenpf;Ndc80;Espl1;Tubb4a;Psmb8;Sgo1;Cenpk;Bub1;Spc25;Psma8
prerank,RHOBTB2 GTPase Cycle R-HSA-9013418,-0.39187105588007737,-0.6618062597548385,0.8938401048492791,1.0,1.0,3/23,11.81%,Myo6;Msi2;Tmod3
prerank,Synthesis Of Bile Acids And Bile Salts R-HSA-192105,-0.3935442592113704,-0.6597006029401046,0.912,1.0,1.0,10/28,17.77%,Osbpl1a;Cyp27a1;Osbpl9;Baat;Slc27a5;Osbpl3;Rxra;Nr1h4;Osbpl6;Ch25h
prerank,M Phase R-HSA-68886,-0.30675756288648937,-0.6586234951158424,0.9988276670574443,1.0,1.0,28/348,17.05%,Prkcb;Vrk2;Kif23;Nde1;Spdl1;Cenpn;Knl1;Tubb3;Ppp2r5a;Plk4;Cenpf;Ndc80;Alms1;Ncaph;Espl1;H2ac20;Tubb4a;Psmb8;Prkca;H3c7;Phf8;Nedd1;Sgo1;Cenpk;Bub1;Cnep1r1;Spc25;Psma8
prerank,Calnexin/calreticulin Cycle R-HSA-901042,-0.383156842206407,-0.6575077789487004,0.891566265060241,1.0,1.0,5/26,23.00%,Edem1;Uggt2;Sel1l;Rnf103;Man1b1
prerank,Host Interactions Of HIV Factors R-HSA-162909,0.2934762480075587,0.6571225162285999,0.9875,1.0,1.0,15/122,8.40%,Sgip1;Cul5;Fyn;Btrc;Ap1s2;Psmd13;Ndc1;Ap1g1;Slc25a5;Psip1;Ranbp2;Npm1;Uba52;Cdk9;Skp1
prerank,GPVI-mediated Activation Cascade R-HSA-114604,-0.37732848404140257,-0.6568418466104523,0.9158485273492286,1.0,1.0,5/32,11.02%,Pik3r1;Vav2;Pik3r5;Vav1;Lcp2
prerank,DNA Methylation R-HSA-5334118,-0.39370918598680543,-0.656610204456265,0.8857142857142857,1.0,1.0,7/22,29.67%,H2ac20;Uhrf1;H3c7;Dnmt3l;H2bc3;Dnmt3a;H2aj
prerank,Polymerase Switching On C-strand Of Telomere R-HSA-174411,-0.38846664989691426,-0.6561246313278298,0.8982826948480845,1.0,1.0,5/24,30.47%,Chtf18;Terf1;Rfc2;Pold4;Rfc3
prerank,DNA Replication Pre-Initiation R-HSA-69002,-0.33745804385849715,-0.6552114458599653,0.9847715736040609,1.0,1.0,7/114,14.23%,Mcm10;Cdk2;H2ac20;Mcm3;Psmb8;H3c7;Cdt1
prerank,Cytosolic Sensors Of Pathogen-Associated DNA R-HSA-1834949,-0.36332758703152335,-0.6547655512806325,0.9527665317139001,1.0,1.0,9/59,20.83%,Tlr3;Trim56;Myd88;Dtx4;Nkiras1;Rela;Ticam1;Irf7;Trim21
prerank,Glutathione Conjugation R-HSA-156590,-0.38562949440743005,-0.6541016619375054,0.9050802139037433,1.0,1.0,9/32,30.58%,Ggt5;Gstt2;Gsta2;Gstm2;Gclc;Gstt1;Mgst3;Gclm;Ggt1
prerank,Cooperation Of Prefoldin And TriC/CCT In Actin And Tubulin Folding R-HSA-389958,-0.3824753763467057,-0.654065149735609,0.8833333333333333,1.0,1.0,2/26,11.36%,Tubb3;Tubb4a
prerank,Apoptotic Factor-Mediated Response R-HSA-111471,-0.3979395647809319,-0.6522058436339121,0.89280868385346,1.0,1.0,4/19,11.46%,Septin4;Casp7;Uaca;Gsdmd
prerank,Prefoldin Mediated Transfer Of Substrate To CCT/TriC R-HSA-389957,-0.3835730324159225,-0.6515099220910303,0.8801089918256131,1.0,1.0,2/24,11.36%,Tubb3;Tubb4a
prerank,Gastrin-CREB Signaling Pathway Via PKC And MAPK R-HSA-881907,0.38760867410704997,0.649958308503189,0.8307692307692308,1.0,1.0,6/15,9.48%,Mapk1;Rps6ka2;Mapk3;Grb2;Mapk7;Sos1
prerank,Nonhomologous End-Joining (NHEJ) R-HSA-5693571,0.33876156120150897,0.6493390744779682,0.928030303030303,1.0,1.0,6/40,7.81%,Herc2;Tdp1;Paxip1;Babam2;H2ax;Brcc3
prerank,DNA Replication R-HSA-69306,-0.3282852240666375,-0.6492012686051808,0.98856416772554,1.0,1.0,16/142,24.26%,Mcm10;Lrig1;Cdk2;H2ac20;Mcm3;Psmb8;H3c7;Cdt1;Psma8;Orc5;Ube2c;Rfc2;H2bc3;Slc25a2;Psma1;Anapc11
prerank,Signaling By FGFR2 R-HSA-5654738,-0.35720823900974896,-0.6489602858570919,0.9481582537517054,1.0,1.0,2/68,2.21%,Pik3r1;Fgf1
prerank,Regulation Of Necroptotic Cell Death R-HSA-5675482,-0.3792555467307089,-0.647994243167333,0.8940027894002789,1.0,1.0,3/27,11.92%,Birc3;Flot1;Tnfsf10
prerank,DDX58/IFIH1-mediated Induction Of Interferon-Alpha/Beta R-HSA-168928,-0.35433580077304483,-0.6479754906698033,0.938858695652174,1.0,1.0,13/60,20.44%,Ikbke;App;Trim25;Rnf125;Nlrc5;Isg15;Ifih1;Nkiras1;Map3k1;Rela;Traf3;Ager;Irf7
prerank,Glycosphingolipid Metabolism R-HSA-1660662,-0.37482452889908574,-0.6472625521193274,0.9366576819407008,1.0,1.0,8/36,16.92%,Asah1;Gltp;Cerk;Neu4;Arsa;Arsg;Asah2;Neu2
prerank,Recruitment And ATM-mediated Phosphorylation Of Repair And Signal Proteins At DNA Double Strand Breaks R-HSA-5693565,-0.3630844382635502,-0.6466106872477289,0.9385847797062751,1.0,1.0,6/48,12.59%,Bard1;Cnksr3;Nsd2;Eya4;Artn;Mapk8
prerank,NGF-stimulated Transcription R-HSA-9031628,-0.3683164464619705,-0.6458568678761242,0.9157608695652174,1.0,1.0,11/38,19.27%,Id1;Vgf;Egr1;F3;Kcnh8;Id4;Id3;Trib1;Sgk1;Fosl1;Rrad
prerank,Glycerophospholipid Biosynthesis R-HSA-1483206,-0.3327502976980803,-0.6458513625787968,0.9898477157360406,1.0,1.0,27/123,18.52%,Cpne7;Pitpnm3;Pla2g5;Gpat3;Pla2g4c;Osbpl10;Chpt1;Plaat1;Sh2d3c;Mboat1;Agk;Pctp;Pla2g4a;Gpat2;Osbpl8;Pitpnm1;Ache;Gpam;Slc44a4;Pla2r1;Cpne3;Pnpla8;Pla1a;Slc44a3;Pla2g10;Lpgat1;Pld6
prerank,Synthesis Of Glycosylphosphatidylinositol (GPI) R-HSA-162710,0.3532566193721373,0.6445622113853732,0.8958333333333334,1.0,1.0,17/17,64.70%,Pigo;Pigw;Pigb;Pigp;Pigx;Pigg;Pigl;Dpm2;Pigm;Pigh;Pigv;Piga;Pigq;Pigz;Pigf;Pigc;Pign
prerank,Cyclin D Associated Events In G1 R-HSA-69231,-0.35964638296329987,-0.6423465355188968,0.9319371727748691,1.0,1.0,8/46,17.92%,Cdkn1c;Cdk2;Ccnd3;Cks1b;E2f1;Cdkn2c;Lyn;Ccnd1
prerank,Toll Like Receptor 4 (TLR4) Cascade R-HSA-166016,-0.32990093805590276,-0.6404236512964551,0.9875311720698254,1.0,1.0,29/132,18.06%,Alpk1;Birc3;Ikbke;Irak4;App;Dusp6;Irak3;Kcnh8;Mapk11;Cd180;Myd88;Ptpn4;Irak2;S100a1;Nlrc5;Socs1;Ly86;Mapk8;Rps6ka5;Nod2;Nkiras1;Map3k1;Usp14;Tlr1;Rela;Tlr4;Sarm1;Traf3;Itgam
prerank,RIPK1-mediated Regulated Necrosis R-HSA-5213460,-0.3714175668269778,-0.6396377102582083,0.9075862068965517,1.0,1.0,3/29,11.92%,Birc3;Flot1;Tnfsf10
prerank,Cyclin A/B1/B2 Associated Events During G2/M Transition R-HSA-69273,-0.3782072560481854,-0.6385778194871934,0.9022457067371202,1.0,1.0,3/24,16.26%,Cdk2;Cdc25b;Foxm1
prerank,Sema4D Induced Cell Migration And Growth-Cone Collapse R-HSA-416572,-0.3789314714360713,-0.6385626509407549,0.903663500678426,1.0,1.0,7/20,22.77%,Myh14;Myh10;Limk1;Arhgef11;Erbb2;Myl6;Plxnb1
prerank,Resolution Of Sister Chromatid Cohesion R-HSA-2500257,-0.3353348024048459,-0.6377871126845168,0.9725274725274725,1.0,1.0,7/102,8.14%,Nde1;Spdl1;Cenpn;Knl1;Ppp2r5a;Cenpf;Ndc80
prerank,Acyl Chain Remodelling Of PI R-HSA-1482922,-0.39316002730336463,-0.6376468479520663,0.907258064516129,1.0,1.0,6/16,21.38%,Pla2g5;Pla2g4c;Pla2g4a;Pla2r1;Pla2g10;Plbd1
prerank,JNK (c-Jun Kinases) Phosphorylation And Activation Mediated By Activated Human TAK1 R-HSA-450321,-0.3882899486071426,-0.6374380229196132,0.9111111111111111,1.0,1.0,3/18,14.07%,Irak2;Mapk8;Nod2
prerank,Branched-chain Amino Acid Catabolism R-HSA-70895,-0.38558094794681563,-0.6368904996598912,0.9124487004103967,1.0,1.0,4/21,17.18%,Bcat1;Bckdhb;Ldhd;Aldh6a1
prerank,XBP1(S) Activates Chaperone Genes R-HSA-381038,-0.3576918970693715,-0.6351056660820897,0.9488950276243094,1.0,1.0,3/45,7.64%,Edem1;Ddx11;Wfs1
prerank,Response Of Mtb To Phagocytosis R-HSA-9637690,-0.37933980180139215,-0.6346928064184943,0.9057873485868102,1.0,1.0,2/20,5.32%,Nanos2;Dusp16
prerank,G Beta:Gamma Signaling Thru PI3Kgamma R-HSA-392451,-0.37684307958638985,-0.6337428544988651,0.9214380825565912,1.0,1.0,5/24,11.83%,Gng4;Pik3r5;Gnb4;Gng12;Gng3
prerank,IRE1alpha Activates Chaperones R-HSA-381070,-0.35425960764188685,-0.6332225515507174,0.9392265193370166,1.0,1.0,3/47,7.64%,Edem1;Ddx11;Wfs1
prerank,Bile Acid And Bile Salt Metabolism R-HSA-194068,-0.3668029747885564,-0.6328534737469925,0.9397590361445783,1.0,1.0,10/36,17.77%,Osbpl1a;Cyp27a1;Osbpl9;Baat;Slc27a5;Osbpl3;Rxra;Nr1h4;Osbpl6;Ch25h
prerank,G Beta:Gamma Signaling Thru BTK R-HSA-8964315,-0.3927952846351584,-0.6320779603830258,0.9096945551128818,1.0,1.0,4/17,11.83%,Gng4;Gnb4;Gng12;Gng3
prerank,DNA Double Strand Break Response R-HSA-5693606,-0.35333456527268814,-0.6311228074035702,0.9425901201602136,1.0,1.0,6/49,12.59%,Bard1;Cnksr3;Nsd2;Eya4;Artn;Mapk8
prerank,Interleukin-10 Signaling R-HSA-6783783,-0.36658171907258447,-0.6308157716467265,0.9294436906377205,1.0,1.0,8/35,18.82%,Cd86;Tnfrsf1b;Cd80;Ccr5;Icam1;Ptafr;Il18;Il1a
prerank,Metabolism Of Steroid Hormones R-HSA-196071,-0.36513789950841813,-0.6295819019108704,0.9112343966712899,1.0,1.0,8/29,28.15%,Hsd17b2;Stard4;Hsd17b12;Hsd11b1;Chga;Hsd11b2;Hsd17b14;Cyp11b1
prerank,Transcriptional Regulation By Small RNAs R-HSA-5578749,0.3174134917827864,0.6295103428975016,0.9642857142857143,1.0,1.0,12/60,12.87%,Ago1;Ago2;Ndc1;Ranbp2;H2az1;H2ax;H2ac4;H2ac6;Polr2k;Pom121;Nup93;Polr2e
prerank,Regulation Of TP53 Expression And Degradation R-HSA-6806003,0.325956476170281,0.6262973528638647,0.9146341463414634,1.0,1.0,2/36,2.39%,Akt3;Usp2
prerank,DNA Strand Elongation R-HSA-69190,-0.368283106786234,-0.626116997359128,0.9276139410187667,1.0,1.0,2/31,11.16%,Lrig1;Mcm3
prerank,Cyclin E Associated Events During G1/S Transition R-HSA-69202,0.2967557387327484,0.6257332016560008,0.9916317991631799,1.0,1.0,17/82,15.24%,Akt3;Ccnh;Psmd13;Wee1;Cul1;Uba52;Skp1;Rbl2;Rbbp4;Mnat1;Psmc1;Ccne1;Rb1;Psmd3;Psmd2;Psmc5;Psmb6
prerank,Processing Of Capped Intronless Pre-mRNA R-HSA-75067,0.34790102414024626,0.6255039694861873,0.8939393939393939,1.0,1.0,11/28,10.22%,Papola;Nudt21;Cstf3;Cpsf6;Pabpn1;Ncbp1;Cstf2t;Snrpb;Snrpd3;Wdr33;Cpsf7
prerank,Ub-specific Processing Proteases R-HSA-5689880,0.26008696977598794,0.6244308220533189,1.0,1.0,1.0,17/171,8.69%,Tgfbr1;Usp2;Smad3;Usp47;Usp15;Usp32;Rnf128;Tnks;Usp34;Psmd13;Usp12;Axin2;Trrap;Uba52;Usp7;Otub1;Tomm20
prerank,"Gamma Carboxylation, Hypusine Formation And Arylsulfatase Activation R-HSA-163841",0.3375626500396599,0.623555585939475,0.9132075471698113,1.0,1.0,3/36,5.56%,Arsb;Arsj;Tpst1
prerank,Metabolism Of Polyamines R-HSA-351202,-0.3423778186803524,-0.6215281216503838,0.9578231292517007,1.0,1.0,10/57,27.77%,Smox;Psmb8;Slc38a1;Psma8;Agmat;Slc25a21;Srms;Psma1;Paox;Azin2
prerank,Transport Of SLBP Independent Mature mRNA R-HSA-159227,0.33783789617333676,0.6153271872785138,0.9318181818181818,1.0,1.0,10/31,19.03%,Ndc1;Ranbp2;Ncbp1;Eif4e;Pom121;Nup93;Nup155;Nup54;Alyref;Nup210
prerank,Mitotic Prometaphase R-HSA-68877,0.25921071580830995,0.6142243550092367,1.0,1.0,1.0,17/179,7.58%,Eml4;Cenpp;Odf2;Pds5b;Taok1;Nek6;Dync1i2;Ywhae;Dctn1;Tubgcp2;Pds5a;Sdccag8;Cep152;Hdac8;Ranbp2;Pcm1;Prkar2b
prerank,HSF1 Activation R-HSA-3371511,0.32651803595738094,0.6141667459337715,0.9239543726235742,1.0,1.0,4/27,8.34%,Ywhae;Eef1a1;Dnajb6;Tnfrsf21
prerank,SUMOylation Of Ubiquitinylation Proteins R-HSA-3232142,0.32648475699913543,0.6116784708742077,0.9136690647482014,1.0,1.0,8/35,15.40%,Pias1;Ndc1;Ranbp2;Vhl;Pom121;Nup93;Pias2;Nup155
prerank,TCR Signaling R-HSA-202403,-0.3167060245207816,-0.6109022533228979,0.9885204081632653,1.0,1.0,12/104,17.12%,Prkcq;Pik3r1;Cd101;Lcp2;Psmb8;Inpp5d;Was;Bcl10;Grap2;Pkn2;Psma8;Rela
prerank,Interleukin-12 Family Signaling R-HSA-447115,0.3143795502253968,0.6096793580675858,0.9686274509803922,1.0,1.0,5/49,7.43%,Crlf1;Pdcd4;Hnrnpdl;Rplp0;Tyk2
prerank,AURKA Activation By TPX2 R-HSA-8854518,-0.3257962318881571,-0.6088537363402116,0.975,1.0,1.0,18/71,27.83%,Nde1;Plk4;Alms1;Hmmr;Tubb4a;Prkca;Nedd1;Cep164;Ccp110;Dync1h1;Csnk1e;Cep290;Tubb4b;Tpx2;Tuba1a;Pcnt;Akap9;Cep63
prerank,Protein Ubiquitination R-HSA-8852135,-0.33271581796139305,-0.6061456732329592,0.9795361527967258,1.0,1.0,1/68,1.51%,Rnf152
prerank,EML4 And NUDC In Mitotic Spindle Formation R-HSA-9648025,-0.3203828485262667,-0.6060226060615045,0.9741496598639455,1.0,1.0,7/93,8.14%,Nde1;Spdl1;Cenpn;Knl1;Ppp2r5a;Cenpf;Ndc80
prerank,RNA Polymerase I Promoter Opening R-HSA-73728,0.3454332091255971,0.6050015504728635,0.9118773946360154,1.0,1.0,6/20,11.12%,Ubtf;Mapk3;H2az1;H2ax;H2ac4;H2ac6
prerank,Digestion And Absorption R-HSA-8963743,0.34092748410952145,0.6029090636759077,0.886986301369863,1.0,1.0,1/17,1.78%,Lct
prerank,G0 And Early G1 R-HSA-1538133,0.32488113530945884,0.6023357257255427,0.9214285714285714,1.0,1.0,2/27,3.73%,Hdac1;Dyrk1a
prerank,Infection With Mycobacterium Tuberculosis R-HSA-9635486,-0.3577092335482692,-0.6013301381685625,0.948069241011984,1.0,1.0,2/24,5.32%,Nanos2;Dusp16
prerank,Plasma Lipoprotein Remodeling R-HSA-8963899,-0.3609557096294867,-0.6000580595282496,0.9438502673796791,1.0,1.0,5/26,11.62%,Lcat;Apoe;Lipg;Angptl4;Pcsk6
prerank,SUMOylation Of SUMOylation Proteins R-HSA-4085377,0.3270681896644536,0.5991422729687655,0.96,1.0,1.0,5/31,12.52%,Sumo2;Ndc1;Ranbp2;Pom121;Nup93
prerank,RNA Polymerase III Chain Elongation R-HSA-73780,0.34320187688526427,0.5981478712240096,0.91796875,1.0,1.0,17/17,65.70%,Polr2k;Polr2e;Polr3g;Polr2h;Polr3b;Polr3gl;Crcp;Polr2l;Polr3e;Polr3f;Polr3k;Polr1d;Polr2f;Polr3a;Polr3h;Polr3d;Polr3c
prerank,Phase 4 - Resting Membrane Potential R-HSA-5576886,-0.3619519467809732,-0.5965456736953142,0.9362880886426593,1.0,1.0,5/18,15.26%,Kcnj12;Kcnj14;Kcnk4;Kcnk3;Kcnk5
prerank,Citric Acid (TCA) Cycle And Respiratory Electron Transport R-HSA-1428517,-0.30250853910549935,-0.5960637363970683,0.9974747474747475,1.0,1.0,15/146,19.93%,Cox16;Ucp3;Adhfe1;Ldhal6b;Ldlr;Idh2;Slc16a1;Pdk4;Rxra;Ldhd;Ldha;Ucp1;Tmem186;Ldhb;Pm20d1
prerank,Sema4D In Semaphorin Signaling R-HSA-400685,-0.34889653191784475,-0.5940968663575078,0.9492455418381345,1.0,1.0,7/24,22.77%,Myh14;Myh10;Limk1;Arhgef11;Erbb2;Myl6;Plxnb1
prerank,Negative Regulators Of DDX58/IFIH1 Signaling R-HSA-936440,-0.3410469991204934,-0.5926683140994934,0.9628099173553719,1.0,1.0,6/32,13.51%,Ikbke;Trim25;Rnf125;Nlrc5;Isg15;Ifih1
prerank,Anchoring Of Basal Body To Plasma Membrane R-HSA-5620912,0.27267114733918824,0.5921842110969584,1.0,1.0,1.0,12/96,7.58%,Ahi1;Odf2;Rab3ip;Dync1i2;Ywhae;Dctn1;Cc2d2a;Sdccag8;Nphp4;Cep152;Pcm1;Prkar2b
prerank,Export Of Viral Ribonucleoproteins From Nucleus R-HSA-168274,0.3146313301699696,0.5895550958572583,0.9485294117647058,1.0,1.0,11/32,19.03%,Ndc1;Ranbp2;Xpo1;Pom121;Nup93;Gnl3;Nup155;Bloc1s6;Nup54;Hspa1a;Nup210
prerank,Tight Junction Interactions R-HSA-420029,-0.34956713379901605,-0.5882326231803916,0.9445196211096076,1.0,1.0,10/25,21.22%,Cldn1;Cldn11;Cldn22;Cldn5;Cldn18;Crb3;Cldn10;Patj;Cldn23;Cldn14
prerank,Transcription Of E2F Targets Under Negative Control By DREAM Complex R-HSA-1362277,0.3287351350920278,0.586149648216407,0.910958904109589,1.0,1.0,3/19,10.04%,Hdac1;Rbl2;Rbbp4
prerank,Canonical Retinoid Cycle In Rods (Twilight Vision) R-HSA-2453902,0.3308319772541733,0.5821685978268656,0.9215686274509803,1.0,1.0,2/21,3.96%,Napepld;Stra6
prerank,Cyclin A:Cdk2-associated Events At S Phase Entry R-HSA-69656,0.27440032269451786,0.5789543816313949,0.995850622406639,1.0,1.0,17/84,15.24%,Akt3;Ccnh;Psmd13;Wee1;Cul1;Uba52;Skp1;Rbl2;Rbbp4;Mnat1;Psmc1;Ccne1;Rb1;Psmd3;Psmd2;Psmc5;Psmb6
prerank,Generation Of Second Messenger Molecules R-HSA-202433,-0.348289640086753,-0.577929798624057,0.9584487534626038,1.0,1.0,6/21,21.26%,Cd101;Lcp2;Was;Grap2;Pkn2;Vasp
prerank,Deposition Of New CENPA-containing Nucleosomes At Centromere R-HSA-606279,-0.33085782852596846,-0.5770565774232936,0.9609690444145357,1.0,1.0,4/41,10.86%,Hjurp;Cenpn;Knl1;H2ac20
prerank,TNF Signaling R-HSA-75893,0.2968131084086129,0.5768870653662816,0.9676113360323887,1.0,1.0,5/44,8.25%,Usp2;Bag4;Madd;Sppl2a;Uba52
prerank,Defects In Vitamin And Cofactor Metabolism R-HSA-3296482,-0.34670517999842293,-0.576688281287278,0.9401360544217687,1.0,1.0,3/21,13.69%,Tcn2;Cblif;Sp8
prerank,Dectin-2 Family R-HSA-5621480,0.32996393747592095,0.5758293178631336,0.9144981412639405,1.0,1.0,3/17,8.09%,Plcg2;Fyn;Muc15
prerank,Aberrant Regulation Of Mitotic Cell Cycle Due To RB1 Defects R-HSA-9687139,-0.3315400675419542,-0.575557807607224,0.9710344827586207,1.0,1.0,7/36,24.26%,Cdkn1c;Cdk2;Ccnd3;E2f1;Ccnd1;Ube2c;Anapc11
prerank,Regulation Of TNFR1 Signaling R-HSA-5357905,-0.332457162382533,-0.5750997949463453,0.9666221628838452,1.0,1.0,1/35,3.38%,Birc3
prerank,Ovarian Tumor Domain Proteases R-HSA-5689896,0.30118086192104443,0.5740134922503141,0.9740740740740741,1.0,1.0,9/37,8.62%,Zranb1;Otud7a;Tnip2;Rnf128;Otub2;Ube2d1;Otud5;Uba52;Otub1
prerank,PRC2 Methylates Histones And DNA R-HSA-212300,0.3109792762305642,0.5727065165530041,0.9628252788104089,1.0,1.0,11/30,11.12%,Mtf2;Aebp2;Ezh2;H2az1;H2ax;Rbbp7;Suz12;Dnmt1;Rbbp4;H2ac4;H2ac6
prerank,NEP/NS2 Interacts With Cellular Export Machinery R-HSA-168333,0.3046929796604852,0.5725830695757874,0.9710144927536232,1.0,1.0,10/31,19.03%,Ndc1;Ranbp2;Xpo1;Pom121;Nup93;Gnl3;Nup155;Bloc1s6;Nup54;Nup210
prerank,Separation Of Sister Chromatids R-HSA-2467813,-0.28389521520374433,-0.5717978302228619,0.9987046632124352,1.0,1.0,14/166,17.05%,Nde1;Spdl1;Cenpn;Knl1;Ppp2r5a;Cenpf;Ndc80;Espl1;Psmb8;Sgo1;Cenpk;Bub1;Spc25;Psma8
prerank,Antigen processing-Cross Presentation R-HSA-1236975,-0.3015020269416927,-0.5712711493490698,0.9933949801849405,1.0,1.0,8/93,17.47%,Ncf2;Itgb5;Myd88;S100a1;Psmb8;Tlr1;Psma8;Tlr4
prerank,Defective Pyroptosis R-HSA-9710421,0.3028353926689995,0.5696085822274033,0.9771863117870723,1.0,1.0,9/30,11.12%,Ezh2;H2az1;H2ax;Rbbp7;Suz12;Dnmt1;Rbbp4;H2ac4;H2ac6
prerank,SARS-CoV-2-host Interactions R-HSA-9705683,-0.284644873536597,-0.5693283653433349,0.9987421383647799,1.0,1.0,16/166,18.00%,Gja1;Cav1;Ikbke;Trim25;Masp1;Irak2;Il17ra;Isg15;Ifih1;Ywhaq;Nod2;Crb3;Il17f;Tlr1;Nlrp3;Traf3
prerank,Insulin Receptor Recycling R-HSA-77387,0.30901812257845795,0.5661957385972022,0.948905109489051,1.0,1.0,4/23,10.68%,Atp6v1a;Atp6v1c2;Atp6v0e2;Atp6v1d
prerank,Loss Of Nlp From Mitotic Centrosomes R-HSA-380259,-0.3015105146864332,-0.560371100991829,0.9860917941585535,1.0,1.0,16/68,27.83%,Nde1;Plk4;Alms1;Tubb4a;Prkca;Nedd1;Cep164;Ccp110;Dync1h1;Csnk1e;Cep290;Tubb4b;Tuba1a;Pcnt;Akap9;Cep63
prerank,Activated PKN1 Stimulates Transcription Of Androgen Receptor Regulated KLK2 And KLK3 R-HSA-5625886,-0.33365530157386686,-0.5572772349389689,0.9605442176870749,1.0,1.0,4/23,22.29%,H2ac20;H3c7;Klkb1;H2bc3
prerank,Hh Mutants Are Degraded By ERAD R-HSA-5362768,-0.3055970842010501,-0.5523492520488738,0.9893048128342246,1.0,1.0,4/55,18.03%,Shh;Psmb8;Psma8;Sel1l
prerank,Mitotic G1 Phase And G1/S Transition R-HSA-453279,-0.27832385940682014,-0.552157478634478,0.9987531172069826,1.0,1.0,16/145,20.25%,Mcm10;Cdkn1c;Top2a;Cdk2;Mcm3;Psmb8;Ccnd3;Cks1b;E2f1;Cdt1;Cdkn2c;Dhfr;Lyn;Ccnd1;Rrm2;Orc5
prerank,Transport Of Ribonucleoproteins Into Host Nucleus R-HSA-168271,0.2924443328280951,0.5514759525608328,0.960431654676259,1.0,1.0,10/31,19.03%,Ndc1;Ranbp2;Pom121;Nup93;Kpna1;Gnl3;Nup155;Bloc1s6;Nup54;Nup210
prerank,Nuclear Import Of Rev Protein R-HSA-180746,0.29886591285753894,0.5487078378981963,0.9601449275362319,1.0,1.0,8/30,19.03%,Ndc1;Ranbp2;Npm1;Pom121;Nup93;Nup155;Nup54;Nup210
prerank,E2F Mediated Regulation Of DNA Replication R-HSA-113510,-0.32817712494308304,-0.5466748069160594,0.9601648351648352,1.0,1.0,3/21,22.53%,E2f1;Orc5;Slc25a2
prerank,Attenuation Phase R-HSA-3371568,0.29335331265083486,0.5448151875600513,0.9708029197080292,1.0,1.0,4/24,8.34%,Hspa2;Crebbp;Dnajb6;Tnfrsf21
prerank,Transport Of Mature mRNA Derived From An Intronless Transcript R-HSA-159231,0.2852203834791544,0.5442070112090832,0.9845559845559846,1.0,1.0,10/38,17.53%,Ndc1;Ranbp2;Ncbp1;Wdr33;Eif4e;Pom121;Nup93;Nup155;Nup54;Alyref
prerank,SUMOylation Of DNA Replication Proteins R-HSA-4615885,0.2853953147668419,0.543110827031759,0.9851851851851852,1.0,1.0,7/41,12.52%,Top1;Sumo2;Ndc1;Ranbp2;Birc5;Pom121;Nup93
prerank,Beta-catenin Phosphorylation Cascade R-HSA-196299,0.30960079264083357,0.5405220488014212,0.9485294117647058,1.0,1.0,3/17,8.20%,Ctnnb1;Csnk1a1;Frat1
prerank,EPHA-mediated Growth Cone Collapse R-HSA-3928663,-0.3294979645745093,-0.5390768792481909,0.9453551912568307,1.0,1.0,4/15,21.19%,Myh14;Myh10;Lyn;Myl6
prerank,S Phase R-HSA-69242,0.23126632343586606,0.5387651725261475,1.0,1.0,1.0,21/161,11.99%,Akt3;Pds5b;Mcm6;Ccnh;Pds5a;Psmd13;Orc3;Ube2d1;Wee1;Cul1;Uba52;Skp1;Cdc27;Rbl2;Rbbp4;Wapl;Mnat1;Stag2;Orc6;Orc4;Psmc1
prerank,Acyl Chain Remodelling Of PC R-HSA-1482788,-0.31741056347352914,-0.5380283844255597,0.9738562091503268,1.0,1.0,6/26,18.07%,Pla2g5;Pla2g4c;Pla2g4a;Pla2r1;Pnpla8;Pla2g10
prerank,Interactions Of Rev With Host Cellular Proteins R-HSA-177243,0.2899867578199236,0.532449916678146,0.9591078066914498,1.0,1.0,6/33,12.52%,Ndc1;Ranbp2;Npm1;Xpo1;Pom121;Nup93
prerank,TP53 Regulates Transcription Of Cell Cycle Genes R-HSA-6791312,-0.2949911501139209,-0.5322833011062796,0.9873949579831933,1.0,1.0,5/47,13.12%,Plagl1;Plk2;E2f7;Cdk2;E2f1
prerank,Protein Methylation R-HSA-8876725,-0.32618398075167937,-0.5321251262165113,0.976,1.0,1.0,1/17,6.64%,Camkmt
prerank,Nef-mediated Downmodulation Of Cell Surface Receptors By Recruitment To Clathrin Adapters R-HSA-164938,-0.3225277513168372,-0.530717983240036,0.9581005586592178,1.0,1.0,4/18,26.58%,Ap2b1;Pacs1;Atp6v1h;Ap1b1
prerank,Fertilization R-HSA-1187000,-0.3222518586428196,-0.5300203997756925,0.9605077574047954,1.0,1.0,4/18,16.62%,Catsperb;Zp2;Hvcn1;Izumo4
prerank,CTNNB1 S33 Mutants Not Phosphorylated R-HSA-5358747,-0.32662324651876173,-0.5296427022719663,0.9601648351648352,1.0,1.0,1/15,6.72%,Ppp2r5a
prerank,Hh Mutants Abrogate Ligand Secretion R-HSA-5387390,-0.2893955875285045,-0.5280360118194943,0.9933333333333333,1.0,1.0,4/58,18.03%,Shh;Psmb8;Psma8;Sel1l
prerank,Transport Of SLBP Dependant Mature mRNA R-HSA-159230,0.2899729836853009,0.5270423948664418,0.98046875,1.0,1.0,10/32,19.03%,Ndc1;Ranbp2;Ncbp1;Eif4e;Pom121;Nup93;Nup155;Nup54;Alyref;Nup210
prerank,GSK3B And BTRC:CUL1-mediated-degradation Of NFE2L2 R-HSA-9762114,0.2610162306796374,0.5174932226368022,1.0,1.0,1.0,13/51,17.85%,Btrc;Psmd13;Cul1;Uba52;Skp1;Psmc1;Psmd3;Psmd2;Psmc5;Psmb6;Psmb4;Psmd8;Psmb3
prerank,Synthesis Of PIPs At Golgi Membrane R-HSA-1660514,-0.3134090780437866,-0.5169960589247036,0.9583911234396671,1.0,1.0,4/16,28.94%,Pi4k2b;Pik3c2a;Tpte;Pi4ka
prerank,NIK To Noncanonical NF-kB Signaling R-HSA-5676590,0.2557749220861523,0.5163176050441154,0.996078431372549,1.0,1.0,6/58,8.40%,Fbxw11;Btrc;Psmd13;Cul1;Uba52;Skp1
prerank,Mitochondrial Protein Import R-HSA-1268020,0.24893013532995853,0.513698825220454,1.0,1.0,1.0,12/59,12.88%,Chchd3;Ccni;Timm9;Hspd1;Timm17a;Tomm20;Pmpcb;Coq2;Gfer;Tomm6;Hspa9;Tafazzin
prerank,N-glycan Trimming In ER And Calnexin/Calreticulin Cycle R-HSA-532668,-0.2917547106380256,-0.5110240049109104,0.9866844207723036,1.0,1.0,5/35,23.00%,Edem1;Uggt2;Sel1l;Rnf103;Man1b1
prerank,Centrosome Maturation R-HSA-380287,-0.2707319499279746,-0.5109351297543826,0.9986225895316805,1.0,1.0,16/77,27.83%,Nde1;Plk4;Alms1;Tubb4a;Prkca;Nedd1;Cep164;Ccp110;Dync1h1;Csnk1e;Cep290;Tubb4b;Tuba1a;Pcnt;Akap9;Cep63
prerank,Recruitment Of NuMA To Mitotic Centrosomes R-HSA-380320,-0.2687560367242402,-0.5076907660389274,0.9986282578875172,1.0,1.0,16/77,27.83%,Nde1;Plk4;Alms1;Tubb4a;Prkca;Nedd1;Cep164;Ccp110;Dync1h1;Csnk1e;Cep290;Tubb4b;Tuba1a;Pcnt;Akap9;Cep63
prerank,Assembly Of ORC Complex At Origin Of Replication R-HSA-68616,-0.2957686932646616,-0.50643815130053,0.9825033647375505,1.0,1.0,5/26,22.53%,H2ac20;H3c7;Orc5;H2bc3;Slc25a2
prerank,G1/S Transition R-HSA-69206,-0.25463767582732155,-0.49717979869268225,1.0,1.0,1.0,11/127,20.25%,Mcm10;Cdk2;Mcm3;Psmb8;Cks1b;E2f1;Cdt1;Dhfr;Ccnd1;Rrm2;Orc5
prerank,Endosomal Sorting Complex Required For Transport (ESCRT) R-HSA-917729,-0.28755378158534606,-0.48833492722154903,0.9853137516688919,1.0,1.0,2/29,11.71%,Stam2;Vps25
prerank,SUMOylation Of Transcription Factors R-HSA-3232118,-0.29653906333646163,-0.4880272423640303,0.9664879356568364,1.0,1.0,8/17,32.60%,Pias3;Tfap2b;Hic1;Mitf;Cdkn2a;Tfap2c;Tfap2a;Foxl2
prerank,Defective TPR May Confer Susceptibility Towards Thyroid Papillary Carcinoma (TPC) R-HSA-5619107,-0.2840935620052989,-0.48665717332316655,0.984993178717599,1.0,1.0,1/28,7.19%,Map4k2
prerank,Mitochondrial Translation Initiation R-HSA-5368286,0.22932336465290895,0.48444821815473277,1.0,1.0,1.0,26/82,19.56%,Mrpl13;Mrpl53;Mrps25;Mrps17;Ptcd3;Mrps7;Mrpl37;Mrpl4;Mrps9;Mrpl15;Mrpl49;Mrpl32;Mrpl55;Mrps18a;Mrpl51;Mtif2;Mrps15;Mrps23;Mrpl57;Mrpl23;Mrps11;Mrpl47;Mrpl50;Mrps26;Mrpl3;Mrpl58
prerank,TP53 Regulates Transcription Of Genes Involved In G2 Cell Cycle Arrest R-HSA-6804114,0.2887093170477395,0.48420849064272786,0.9881422924901185,1.0,1.0,16/16,71.15%,Rbl2;Prmt1;Carm1;Tfdp1;Pcna;Rexo2;Bax;E2f4;Tfdp2;Ccnb1;Cdc25c;Aurka;Gadd45a;Cdk1;Ep300;Rbl1
prerank,Transport Of Mature mRNAs Derived From Intronless Transcripts R-HSA-159234,0.25060959323011645,0.4764631523907247,1.0,1.0,1.0,7/39,12.52%,Ndc1;Ranbp2;Ncbp1;Wdr33;Eif4e;Pom121;Nup93
prerank,Fanconi Anemia Pathway R-HSA-6783310,0.24886343225513874,0.47309672058067975,1.0,1.0,1.0,9/35,15.69%,Usp1;Ercc4;Uba52;Ube2t;Fan1;Faap20;Slx4;Eme2;Fancm
prerank,SIRT1 Negatively Regulates rRNA Expression R-HSA-427359,-0.27894450416541505,-0.47180099616741406,0.9893475366178429,1.0,1.0,2/25,12.69%,H2ac20;H3c7
prerank,Mitochondrial Translation R-HSA-5368287,0.22085712203777091,0.4713329868008364,1.0,1.0,1.0,26/88,19.56%,Mrpl13;Mrpl53;Mrps25;Mrps17;Ptcd3;Mrps7;Mrpl37;Mrpl4;Mrps9;Mrpl15;Mrpl49;Mrpl32;Mrpl55;Mrps18a;Mrpl51;Mtif2;Mrps15;Mrps23;Mrpl57;Mrpl23;Mrps11;Mrpl47;Mrpl50;Mrps26;Mrpl3;Mrpl58
prerank,Mitochondrial Translation Elongation R-HSA-5389840,0.22343209170636621,0.47040940709740425,1.0,1.0,1.0,25/82,19.56%,Mrpl13;Mrpl53;Mrps25;Mrps17;Ptcd3;Mrps7;Mrpl37;Mrpl4;Mrps9;Mrpl15;Mrpl49;Mrpl32;Mrpl55;Mrps18a;Mrpl51;Mrps15;Mrps23;Mrpl57;Mrpl23;Mrps11;Mrpl47;Mrpl50;Mrps26;Mrpl3;Mrpl58
prerank,Dectin-1 Mediated Noncanonical NF-kB Signaling R-HSA-5607761,0.22979410144960916,0.46931172956687556,1.0,1.0,1.0,6/61,8.40%,Fbxw11;Btrc;Psmd13;Cul1;Uba52;Skp1
prerank,RNA Polymerase III Transcription Initiation From Type 3 Promoter R-HSA-76071,0.26087766353747566,0.46846540142075455,0.9919678714859438,1.0,1.0,26/26,73.94%,Pou2f1;Polr2k;Polr2e;Bdp1;Tbp;Polr3g;Polr2h;Polr3b;Snapc2;Polr3gl;Crcp;Brf2;Polr2l;Polr3e;Snapc4;Polr3f;Polr3k;Polr1d;Snapc1;Polr2f;Polr3a;Polr3h;Polr3d;Polr3c;Snapc3;Snapc5
prerank,G1/S-Specific Transcription R-HSA-69205,0.25247330654897554,0.46689790284351695,1.0,1.0,1.0,1/29,2.61%,Hdac1
prerank,Mitochondrial Translation Termination R-HSA-5419276,0.2197288047478885,0.46499439951906646,1.0,1.0,1.0,25/82,19.56%,Mrpl13;Mrpl53;Mrps25;Mrps17;Ptcd3;Mrps7;Mrpl37;Mrpl4;Mrps9;Mrpl15;Mrpl49;Mrpl32;Mrpl55;Mrps18a;Mrpl51;Mrps15;Mrps23;Mrpl57;Mrpl23;Mrps11;Mrpl47;Mrpl50;Mrps26;Mrpl3;Mrpl58
prerank,SCF-beta-TrCP Mediated Degradation Of Emi1 R-HSA-174113,0.2315863488845081,0.4558072529952594,1.0,1.0,1.0,13/54,17.85%,Btrc;Psmd13;Cul1;Uba52;Skp1;Psmc1;Psmd3;Psmd2;Psmc5;Psmb6;Psmb4;Psmd8;Psmb3
prerank,Vif-mediated Degradation Of APOBEC3G R-HSA-180585,0.22661826461139434,0.45050035647355724,1.0,1.0,1.0,12/52,17.85%,Cul5;Psmd13;Uba52;Psmc1;Psmd3;Psmd2;Psmc5;Psmb6;Eloc;Psmb4;Psmd8;Psmb3
prerank,Diseases Of Mitotic Cell Cycle R-HSA-9675126,-0.25343721799307845,-0.4432745418140361,0.9986338797814208,1.0,1.0,7/38,24.26%,Cdkn1c;Cdk2;Ccnd3;E2f1;Ccnd1;Ube2c;Anapc11
prerank,Regulation Of Apoptosis R-HSA-169911,-0.24587809899422386,-0.44260190588843795,1.0,1.0,1.0,4/52,17.05%,Psmb8;Oma1;Pkn2;Psma8
prerank,Gene And Protein Expression By JAK-STAT Signaling After Interleukin-12 Stimulation R-HSA-8950505,0.2412129361005865,0.44196550739185386,0.991701244813278,1.0,1.0,3/32,5.75%,Pdcd4;Hnrnpdl;Rplp0
prerank,Orc1 Removal From Chromatin R-HSA-68949,-0.23801145487426012,-0.44176351860243274,0.9986842105263158,1.0,1.0,8/69,23.93%,Cdk2;Mcm3;Psmb8;Cdt1;Psma8;Orc5;Slc25a2;Psma1
prerank,Interleukin-12 Signaling R-HSA-9020591,0.2329183197819498,0.4401494815808452,0.9918367346938776,1.0,1.0,5/39,8.95%,Pdcd4;Hnrnpdl;Rplp0;Tyk2;Tcp1
prerank,Condensation Of Prophase Chromosomes R-HSA-2299718,-0.25403724749820966,-0.43330161010765655,0.9959016393442623,1.0,1.0,3/30,14.57%,H2ac20;H3c7;Phf8
prerank,Degradation Of AXIN R-HSA-4641257,0.21531948909308515,0.43294589571879777,1.0,1.0,1.0,13/54,17.85%,Tnks;Psmd13;Axin2;Uba52;Psmc1;Psmd3;Psmd2;Psmc5;Psmb6;Tnks2;Psmb4;Psmd8;Psmb3
prerank,AUF1 (hnRNP D0) Binds And Destabilizes mRNA R-HSA-450408,0.21539479190220717,0.432360998828412,1.0,1.0,1.0,14/54,19.00%,Pabpc1;Hnrnpd;Psmd13;Uba52;Psmc1;Psmd3;Psmd2;Psmc5;Psmb6;Psmb4;Psmd8;Psmb3;Hspa1a;Psmd14
prerank,Rev-mediated Nuclear Export Of HIV RNA R-HSA-165054,0.23663117224011493,0.4309097066446893,0.9925093632958801,1.0,1.0,8/31,19.03%,Ndc1;Ranbp2;Xpo1;Pom121;Nup93;Nup155;Nup54;Nup210
prerank,Cellular Hexose Transport R-HSA-189200,-0.2644793774746884,-0.4291280476816129,0.9904632152588556,1.0,1.0,5/15,36.68%,Slc5a1;Slc2a1;Slc2a10;Slc2a8;Slc5a2
prerank,Recognition Of DNA Damage By PCNA-containing Replication Complex R-HSA-110314,0.23034101028833123,0.4287554314700143,1.0,1.0,1.0,4/30,10.24%,Usp1;Ube2b;Uba52;Rad18
prerank,Diseases Associated With Glycosylation Precursor Biosynthesis R-HSA-5609975,0.2423012474399554,0.41898694386955493,0.9790940766550522,1.0,1.0,15/15,75.78%,Dpm1;Nus1;Slpi;Dhdds;Pmm2;Galt;Dolk;Pgm1;Dpm2;Srd5a3;Gale;Dpm3;Galk1;Gne;Gfpt1
prerank,Regulation Of RUNX3 Expression And Activity R-HSA-8941858,-0.23288261711622338,-0.41689364380093524,1.0,1.0,1.0,2/54,11.81%,Smurf1;Psmb8
prerank,Class I Peroxisomal Membrane Protein Import R-HSA-9603798,-0.2533730635030283,-0.41547209579740724,0.9944674965421854,1.0,1.0,5/20,27.58%,Abcd1;Pex13;Pxmp2;Pex12;Aldh3a2
prerank,Synthesis Of DNA R-HSA-69239,-0.21283559488432105,-0.4147846652086049,1.0,1.0,1.0,12/119,24.26%,Lrig1;Cdk2;Mcm3;Psmb8;Cdt1;Psma8;Orc5;Ube2c;Rfc2;Slc25a2;Psma1;Anapc11
prerank,SCF(Skp2)-mediated Degradation Of P27/P21 R-HSA-187577,-0.22552255638621205,-0.41110576004461824,1.0,1.0,1.0,4/59,17.92%,Cdk2;Psmb8;Cks1b;Ccnd1
prerank,Vpu Mediated Degradation Of CD4 R-HSA-180534,0.20495060052277825,0.40853095575647735,1.0,1.0,1.0,12/51,17.85%,Btrc;Psmd13;Uba52;Skp1;Psmc1;Psmd3;Psmd2;Psmc5;Psmb6;Psmb4;Psmd8;Psmb3
prerank,Cleavage Of Damaged Purine R-HSA-110331,0.21676873232947064,0.40631369411601853,0.9881422924901185,1.0,1.0,10/24,18.12%,H2az1;H2ax;Terf2;H2ac4;H2ac6;Terf2ip;Mutyh;H2az2;Tinf2;H2bc4
prerank,ER-Phagosome Pathway R-HSA-1236974,-0.21711165625180046,-0.40606868826703085,1.0,1.0,1.0,9/81,23.96%,Myd88;S100a1;Psmb8;Tlr1;Psma8;Tlr4;Btk;Psma1;Tlr6
prerank,APC/C:Cdc20 Mediated Degradation Of Cyclin B R-HSA-174048,0.22245876329791067,0.40029933970336273,0.9927797833935018,1.0,1.0,3/24,8.57%,Ube2d1;Uba52;Cdc27
prerank,Degradation Of GLI1 By Proteasome R-HSA-5610780,0.1994454574308508,0.3983592613813787,1.0,1.0,1.0,7/58,8.40%,Btrc;Psmd13;Prkacb;Cul1;Sufu;Uba52;Skp1
prerank,APC-Cdc20 Mediated Degradation Of Nek2A R-HSA-179409,0.21841007301445392,0.3947092724556775,0.996309963099631,1.0,1.0,26/26,78.18%,Ube2d1;Uba52;Cdc27;Cdc26;Anapc16;Ube2e1;Bub3;Rps27a;Cdc20;Ubc;Nek2;Anapc7;Anapc1;Cdc23;Ubb;Anapc15;Bub1b;Ube2s;Cdc16;Mad2l1;Anapc4;Anapc10;Anapc2;Anapc5;Anapc11;Ube2c
prerank,Translesion Synthesis By POLH R-HSA-110320,0.2209601132173849,0.38370284934068694,0.9921259842519685,1.0,1.0,19/19,77.92%,Uba52;Rchy1;Rfc4;Nploc4;Ufd1;Pcna;Rfc5;Rps27a;Ubc;Sprtn;Polr1a;Slc19a1;Ubb;Polh;Polr1b;Rpa3;Rfc3;Vcp;Rfc2
prerank,Phosphorylation Of APC/C R-HSA-176412,0.2183612662942272,0.3835676901886096,0.992831541218638,1.0,1.0,20/20,78.18%,Ube2d1;Cdc27;Plk1;Cdc26;Anapc16;Ube2e1;Anapc7;Ccnb1;Anapc1;Cdc23;Anapc15;Ube2s;Cdc16;Cdk1;Anapc4;Anapc10;Anapc2;Anapc5;Anapc11;Ube2c
prerank,Inactivation Of APC/C Via Direct Inhibition Of APC/C Complex R-HSA-141430,0.21836939923274595,0.3834455270290793,1.0,1.0,1.0,21/21,78.18%,Ube2d1;Cdc27;Cdc26;Anapc16;Ube2e1;Bub3;Cdc20;Anapc7;Anapc1;Cdc23;Anapc15;Bub1b;Ube2s;Cdc16;Mad2l1;Anapc4;Anapc10;Anapc2;Anapc5;Anapc11;Ube2c
prerank,Packaging Of Telomere Ends R-HSA-171306,-0.2304011111734433,-0.3779981371406321,0.9973262032085561,1.0,1.0,3/20,22.29%,H2ac20;Terf1;H2bc3
prerank,Aberrant Regulation Of Mitotic Exit In Cancer Due To RB1 Defects R-HSA-9687136,0.21836126629422709,0.37364208565370727,0.9960629921259843,1.0,1.0,20/20,78.18%,Ube2d1;Cdc27;Rb1;Cdc26;Anapc16;Ube2e1;Fzr1;Anapc7;Anapc1;Cdc23;Anapc15;Ube2s;Cdc16;Skp2;Anapc4;Anapc10;Anapc2;Anapc5;Anapc11;Ube2c
prerank,Postmitotic Nuclear Pore Complex (NPC) Reformation R-HSA-9615933,0.21002831172701547,0.3733437776307843,0.989247311827957,1.0,1.0,26/26,79.02%,Ndc1;Pom121;Nup93;Tnpo1;Nup155;Nup54;Kpnb1;Nup188;Nup133;Rcc1;Ahctf1;Seh1l;Nup43;Ube2i;Sumo1;Ran;Nup160;Nup98;Nup35;Sec13;Nup107;Nup62;Nup85;Nup37;Rangap1;Nup205
prerank,Cytosolic Sulfonation Of Small Molecules R-HSA-156584,0.2144828291938183,0.3712510966252592,0.9922480620155039,1.0,1.0,3/18,9.92%,Tpst1;Papss1;Tpst2
prerank,Assembly Of Pre-Replicative Complex R-HSA-68867,-0.1906328556964037,-0.3636006662591898,1.0,1.0,1.0,11/98,24.26%,H2ac20;Mcm3;Psmb8;H3c7;Cdt1;Orc5;Ube2c;H2bc3;Slc25a2;Psma1;Anapc11
prerank,Switching Of Origins To A Post-Replicative State R-HSA-69052,-0.1887408673965773,-0.35838007024913526,1.0,1.0,1.0,10/90,24.26%,Cdk2;Mcm3;Psmb8;Cdt1;Psma8;Orc5;Ube2c;Slc25a2;Psma1;Anapc11
prerank,Complex I Biogenesis R-HSA-6799198,0.17464578672632375,0.3488380405231055,1.0,1.0,1.0,50/50,82.57%,Ndufa6;Ndufs4;Ndufs3;Ndufv3;Ndufb2;Ndufs7;Ndufa5;Ndufb10;Ndufc2;Tmem126b;Ndufaf4;Ndufb6;Ndufa11;Ecsit;Ndufs1;Ndufb7;Ndufs6;Ndufb1;Ndufb9;Ndufaf3;Ndufaf1;Ndufa9;Ndufa13;Acad9;Ndufc1;Ndufab1;Ndufb4;Ndufv1;Ndufb5;Ndufb8;Ndufa8;Nubpl;Ndufaf6;Ndufv2;Ndufa7;Ndufa10;Ndufb11;Ndufs5;Ndufb3;Ndufs2;Ndufa12;Ndufs8;Ndufa2;Ndufa1;Ndufaf2;Ndufaf7;Ndufa3;Ndufaf5;Timmdc1;Tmem186
prerank,Regulation Of Activated PAK-2p34 By Proteasome Mediated Degradation R-HSA-211733,-0.1921999353714882,-0.3450658526112624,1.0,1.0,1.0,3/49,17.05%,Psmb8;Pkn2;Psma8
prerank,NS1 Mediated Effects On Host Pathways R-HSA-168276,-0.19197694651174052,-0.33984198798307824,1.0,1.0,1.0,10/37,40.55%,Eif2ak2;Isg15;Nup205;Kpna2;Nup37;Nup85;Nup62;Nup107;Sec13;Cpsf4
prerank,p53-Dependent G1 DNA Damage Response R-HSA-69563,-0.17759736412561872,-0.32799667198885185,1.0,1.0,1.0,3/62,17.05%,Cdk2;Psmb8;Psma8
prerank,G1/S DNA Damage Checkpoints R-HSA-69615,-0.1764077572256378,-0.3268560502452157,1.0,1.0,1.0,3/64,17.05%,Cdk2;Psmb8;Psma8
prerank,Regulation Of APC/C Activators Between G1/S And Early Anaphase R-HSA-176408,0.15554742625416923,0.3268363176840024,1.0,1.0,1.0,7/80,8.57%,Btrc;Psmd13;Ube2d1;Cul1;Uba52;Skp1;Cdc27
prerank,CDK-mediated Phosphorylation And Removal Of Cdc6 R-HSA-69017,-0.17395085112544342,-0.32435174294176705,1.0,1.0,1.0,15/72,39.65%,Cdk2;Psmb8;Psma8;Ube2c;Psma1;Anapc11;Anapc5;Sem1;Psma5;Ccne2;Psme2;Anapc2;Anapc10;Psma2;Anapc4
prerank,Removal Of Flap Intermediate From C-strand R-HSA-174437,0.18760706040068514,0.3127371625564323,1.0,1.0,1.0,16/16,81.25%,Terf2;Terf2ip;Tinf2;Pold1;Pcna;Acd;Pold3;Fen1;Pold2;Polr1a;Dna2;Wrn;Polr1b;Rpa3;Pold4;Terf1
prerank,Ubiquitin-dependent Degradation Of Cyclin D R-HSA-75815,-0.17322973442951367,-0.31206267222449724,1.0,1.0,1.0,4/51,23.93%,Psmb8;Psma8;Ccnd1;Psma1
prerank,"Respiratory Electron Transport, ATP Synthesis By Chemiosmotic Coupling, Heat Production By Uncoupling Proteins R-HSA-163200",-0.16214329087945262,-0.30997706016092713,1.0,1.0,1.0,16/97,36.59%,Cox16;Ucp3;Ucp1;Tmem186;Pm20d1;Timmdc1;Ndufaf5;Ndufa3;Ndufaf7;Ndufaf2;Sdha;Ndufa1;Uqcrc1;Taco1;Ndufa2;Sdhb
prerank,Regulation Of Ornithine Decarboxylase (ODC) R-HSA-350562,-0.16404105559954635,-0.2958103931316631,1.0,1.0,1.0,4/50,23.93%,Psmb8;Psma8;Slc25a21;Psma1
prerank,Cross-presentation Of Soluble Exogenous Antigens (Endosomes) R-HSA-1236978,-0.16145392115296667,-0.28680110446602547,1.0,1.0,1.0,8/46,38.59%,Psmb8;Psma8;Psma1;Sem1;Psma5;Mrc2;Psme2;Psma2
prerank,Autodegradation Of Cdh1 By Cdh1:APC/C R-HSA-174084,0.13426745745071567,0.268081087225762,1.0,1.0,1.0,13/63,17.85%,Psmd13;Ube2d1;Uba52;Cdc27;Psmc1;Psmd3;Psmd2;Psmc5;Psmb6;Psmb4;Cdc26;Psmd8;Psmb3
prerank,Role Of GTSE1 In G2/M Progression After G2 Checkpoint R-HSA-8852276,-0.14460052282748387,-0.26386238652702715,1.0,1.0,1.0,3/58,17.67%,Psmb8;Psma8;Gtse1
prerank,Activation Of APC/C And APC/C:Cdc20 Mediated Degradation Of Mitotic Proteins R-HSA-176814,0.11834739120698641,0.2490635673764084,1.0,1.0,1.0,76/76,88.20%,Psmd13;Ube2d1;Uba52;Cdc27;Psmc1;Psmd3;Psmd2;Psmc5;Psmb6;Plk1;Psmb4;Cdc26;Psmd8;Psmb3;Psmd14;Anapc16;Ube2e1;Bub3;Psmb11;Psme1;Psmb9;Rps27a;Psmd5;Cdc20;Ubc;Nek2;Psmc6;Anapc7;Psmb2;Psma4;Ccnb1;Psmd12;Psmd10;Psmb7;Anapc1;Psme3;Psma7;Cdc23;Psmd11;Psmb5;Psmc4;Psmd6;Psmd4;Ubb;Psmb1;Psmc3;Psmf1;Psmd7;Psme4;Psma6;Ccna1;Psmd9;Anapc15;Bub1b;Ube2s;Ccna2;Pttg1;Cdc16;Psmc2;Psma3;Mad2l1;Psmb10;Cdk1;Anapc4;Psma2;Anapc10;Anapc2;Psme2;Psma5;Sem1;Anapc5;Anapc11;Psma1;Ube2c;Psma8;Psmb8
prerank,APC/C:Cdc20 Mediated Degradation Of Mitotic Proteins R-HSA-176409,0.11834297443552899,0.24732042552573824,1.0,1.0,1.0,75/75,88.20%,Psmd13;Ube2d1;Uba52;Cdc27;Psmc1;Psmd3;Psmd2;Psmc5;Psmb6;Psmb4;Cdc26;Psmd8;Psmb3;Psmd14;Anapc16;Ube2e1;Bub3;Psmb11;Psme1;Psmb9;Rps27a;Psmd5;Cdc20;Ubc;Nek2;Psmc6;Anapc7;Psmb2;Psma4;Ccnb1;Psmd12;Psmd10;Psmb7;Anapc1;Psme3;Psma7;Cdc23;Psmd11;Psmb5;Psmc4;Psmd6;Psmd4;Ubb;Psmb1;Psmc3;Psmf1;Psmd7;Psme4;Psma6;Ccna1;Psmd9;Anapc15;Bub1b;Ube2s;Ccna2;Pttg1;Cdc16;Psmc2;Psma3;Mad2l1;Psmb10;Cdk1;Anapc4;Psma2;Anapc10;Anapc2;Psme2;Psma5;Sem1;Anapc5;Anapc11;Psma1;Ube2c;Psma8;Psmb8
prerank,APC:Cdc20 Mediated Degradation Of Cell Cycle Proteins Before Cycle Checkpoint Satisfied R-HSA-179419,0.11833414188155379,0.24472329230168757,1.0,1.0,1.0,73/73,88.20%,Psmd13;Ube2d1;Uba52;Cdc27;Psmc1;Psmd3;Psmd2;Psmc5;Psmb6;Psmb4;Cdc26;Psmd8;Psmb3;Psmd14;Anapc16;Ube2e1;Bub3;Psmb11;Psme1;Psmb9;Rps27a;Psmd5;Cdc20;Ubc;Nek2;Psmc6;Anapc7;Psmb2;Psma4;Psmd12;Psmd10;Psmb7;Anapc1;Psme3;Psma7;Cdc23;Psmd11;Psmb5;Psmc4;Psmd6;Psmd4;Ubb;Psmb1;Psmc3;Psmf1;Psmd7;Psme4;Psma6;Ccna1;Psmd9;Anapc15;Bub1b;Ube2s;Ccna2;Cdc16;Psmc2;Psma3;Mad2l1;Psmb10;Cdk1;Anapc4;Psma2;Anapc10;Anapc2;Psme2;Psma5;Sem1;Anapc5;Anapc11;Psma1;Ube2c;Psma8;Psmb8
prerank,Cdc20:Phospho-APC/C Mediated Degradation Of Cyclin A R-HSA-174184,0.11832972609896236,0.24430293181163304,1.0,1.0,1.0,72/72,88.20%,Psmd13;Ube2d1;Uba52;Cdc27;Psmc1;Psmd3;Psmd2;Psmc5;Psmb6;Psmb4;Cdc26;Psmd8;Psmb3;Psmd14;Anapc16;Ube2e1;Bub3;Psmb11;Psme1;Psmb9;Rps27a;Psmd5;Cdc20;Ubc;Psmc6;Anapc7;Psmb2;Psma4;Psmd12;Psmd10;Psmb7;Anapc1;Psme3;Psma7;Cdc23;Psmd11;Psmb5;Psmc4;Psmd6;Psmd4;Ubb;Psmb1;Psmc3;Psmf1;Psmd7;Psme4;Psma6;Ccna1;Psmd9;Anapc15;Bub1b;Ube2s;Ccna2;Cdc16;Psmc2;Psma3;Mad2l1;Psmb10;Cdk1;Anapc4;Psma2;Anapc10;Anapc2;Psme2;Psma5;Sem1;Anapc5;Anapc11;Psma1;Ube2c;Psma8;Psmb8
prerank,Autodegradation Of E3 Ubiquitin Ligase COP1 R-HSA-349425,0.11989692740577643,0.23635209519123285,1.0,1.0,1.0,12/49,19.00%,Psmd13;Uba52;Psmc1;Psmd3;Psmd2;Psmc5;Atm;Psmb6;Psmb4;Psmd8;Psmb3;Psmd14
prerank,Stabilization Of P53 R-HSA-69541,0.11825029832935538,0.23431647780294118,1.0,1.0,1.0,54/54,88.20%,Psmd13;Uba52;Psmc1;Psmd3;Psmd2;Chek2;Psmc5;Atm;Psmb6;Psmb4;Psmd8;Psmb3;Psmd14;Psmb11;Psme1;Psmb9;Rps27a;Psmd5;Ubc;Psmc6;Psmb2;Mdm2;Psma4;Psmd12;Psmd10;Mdm4;Psmb7;Psme3;Psma7;Psmd11;Psmb5;Psmc4;Psmd6;Psmd4;Ubb;Psmb1;Psmc3;Psmf1;Psmd7;Psme4;Psma6;Psmd9;Phf20;Psmc2;Psma3;Psmb10;Psma2;Psme2;Psma5;Sem1;Cdkn2a;Psma1;Psma8;Psmb8
prerank,Respiratory Electron Transport R-HSA-611105,0.10780905884357536,0.23065990652577395,1.0,1.0,1.0,15/89,17.21%,Ccni;Ndufa6;Cox6c;Ndufs4;Ndufs3;Etfb;Cox7a2l;Cox7c;Cox14;Sdhd;Ndufv3;Uqcrfs1;Ndufb2;Ndufs7;Ndufa5
prerank,Ubiquitin Mediated Degradation Of Phosphorylated Cdc25A R-HSA-69601,0.11867010560267376,0.22950175770215223,1.0,1.0,1.0,12/51,19.00%,Psmd13;Uba52;Psmc1;Psmd3;Psmd2;Chek2;Psmc5;Psmb6;Psmb4;Psmd8;Psmb3;Psmd14
prerank,APC/C:Cdh1 Mediated Degradation Of Cdc20 And APC/C:Cdh1 Targets In Late Mitosis/Early G1 R-HSA-174178,-0.12171178761362289,-0.22694484867231557,1.0,1.0,1.0,14/73,39.65%,Psmb8;Psma8;Aurkb;Ube2c;Psma1;Anapc11;Anapc5;Sem1;Psma5;Psme2;Anapc2;Anapc10;Psma2;Anapc4
prerank,APC/C:Cdc20 Mediated Degradation Of Securin R-HSA-174154,-0.12065900462958883,-0.22400357573894805,1.0,1.0,1.0,13/67,39.65%,Psmb8;Psma8;Ube2c;Psma1;Anapc11;Anapc5;Sem1;Psma5;Psme2;Anapc2;Anapc10;Psma2;Anapc4
